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ABSTRACT
IMPACT OF MTR4 STRUCTURAL DOMAINS ON ITS ENZYMATIC
ACTIVITIES, IN THE REGULATION OF
NUCLEAR RNA TURNOVER

Yan Li, B.S.
Marquette University, 2014

RNA processing and turnover plays an important role in RNA maturation,
metabolism and quality control, which contribute to gene regulation and cell health.
The TRAMP complex, composed of an RNA binding protein Air2p, a poly-A
polymerase Trf4p, and a RNA helicase Mtr4p, assist nuclear exosome-dependent
RNA processing and degradation in Saccharomyces cerevisiae, like tRNAiMet
turnover, 5’ETS degradation and rRNA processing. Mtr4p structure reveals a novel
protruding arch domain, which contains the recognizable KOW domain and a stalk
domain. Except for the two conserved RecA-like helicase domains, the helicase core
contains two other structural domains, a winged helix that connects arch to the core
and a ratchet domain of unknown function. The role of how structural domains assist
Mtr4p function remains unclear.
In this study, I created a library of Mtr4p structural domain mutants that were
defective in tRNAiMet turnover. KOW domain mutations K700N, P731S, S672N and
P802S, winged helix mutation K904N, and ratchet domain mutation R1030G were
characterized in cells and biochemically. Mtr4-904p and Mtr4-1030p showed
significant defects in tRNAiMet turnover in vivo, while the arch domain mutants didn’t
cause detectable growth phenotypes. Consistently, Mtr4-904p and Mtr4-1030p
exhibited decreased in vitro unwinding activities. However, the modest unwinding
defect of K700N was not reflected in cell. It suggests that structural domains in
helicase core are more essential for Mtr4p function than that of the arch domain.
KOW domain and ratchet domain contributed to RNA binding activities of Mtr4p in
vitro. Winged helix mutant K904N had modest effects on RNA binding in vitro, but
showed greater effects on protein stability. Structural domain mutants affected
ATPase activities. K700N and R1030G mutations reduced Mtr4p ATP affinity.
Overall, the results revealed that residues in structural domains affect Mtr4p
enzymatic activities from different aspects. In addition, I showed that single-stranded
RNA is a preferred substrate for Mtr4p binding, and activates higher enzymatic
activity of Mtr4p. My results also demonstrate that, as a helicase, Mtr4p is able to
modulate the balance between unwinding and re-annealing in a concentration and
ATP dependent manner.
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CHAPTER I. INTRODUCTION

Part I. The TRAMP Complex Plays a Role in Nuclear RNA Processing and
Degradation
Nuclear RNA Quality Control is Initiated by the TRAMP Complex

Degradation of RNA can modulate gene expression or help cells eliminate old
and abnormally formed RNAs. RNA processing is essential to modify and generate
varieties of mature and functional RNAs to perform their correct cellular functions.
The RNA quality control systems exist in nuclear, cytoplasm and mitochondria
compartments, including the ribosomal RNAs (rRNA) processing, small nuclear and
nucleolar RNAs (snRNAs and snoRNAs) processing, transfer RNAs (tRNA)
surveillance, mRNAs surveillance, and transcription byproducts degradation (Fig. 1-1)
(Houseley, LaCava & Tollervey 2006, Houseley, Tollervey 2009). Defective RNA
processing in human cells could result in cancer or other neurodegenerative diseases
(Philips, Cooper 2000).
In Saccharomyces cerevisiae, nuclear RNA processing and degradation by the
exosome are initiated by the Trf4/5p-Air1/2p-Mtr4p polyadenylation (TRAMP)
complex (LaCava et al. 2005, Vanacova et al. 2005). The TRAMP complex works on
a wide range of RNA substrates, including transcripts created by Pol I, Pol, II, and Pol
III(Houseley, LaCava & Tollervey 2006, Wyers et al. 2005, Anderson, Wang 2009,
Houseley, Tollervey 2008), in surveillance to maintain high quality RNA. The
TRAMP complex is involved in snRNA/snoRNA surveillance, rRNA processing,
tRNA surveillance,
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Figure 1-1. RNA quality control by the exosome.
Exosome is present in both nucleus and cytoplasm. Blue squares represents two layers of ring structure
of the exosome, consist of 9 non-enzymatic subunits, assembling the central RNA channel. Red pie
positioned at the bottom of exosome indicates Rrp44p. The other red pie located on top of the nucleus
exosome is Rrp6p. Co-factors of the exosome are described by red words. Arrow connects the
cofactors and RNA metabolism pathways which they play a role in. Nuclear exosome cofactors Rrp47p
and Mpp6p directly interact with Rrp6 and contain RNA binding activity. Rrp47p and Mpp6p
influence rRNA processing and CUTs stability (Chlebowski et al. 2013). Nab3p-Nrd1p-Sen1p,
interacte with the TRAMP complex and the nuclear exosome, may recruit TRAMP and exosome to
snoRNA and CUTs (Houseley, LaCava & Tollervey 2006, Lebreton, Séraphin 2008a, Chlebowski et al.
2013). Ski complex assist mRNA turnover and degradation of RNAi intermediates, by physical
interaction with Ski7p which binds with the cytoplasmic exosome (Chlebowski et al. 2013). AUBP
(AU binding proteins) AND RHAU (RNA helicase associated with AU rich elements) directs mRNA
with AU-rich elements to the cytoplasmic exsome (Houseley, LaCava & Tollervey 2006, Lebreton,
Séraphin 2008a).

pre-mRNA degradation, and degradation of pervasive transcription products like
cryptic unstable transcripts (CUTs), stable unannotated transcripts (SUTs), and Xrn1p
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unstable transcripts (XUTs) (Fig. 1-1) (Houseley, LaCava & Tollervey 2006, Wyers
et al. 2005, Anderson, Wang 2009, Houseley, Tollervey 2008, Chlebowski et al.
2013). The TRAMP complex is composed of a non- canonical poly (A) polymerase
Trf4/5p, an RNA binding zinc knuckle protein Air1/2p and a member of ski2-like
RNA helicase, Mtr4p. Association of Air1/2p with RNA substrates assists Trf4/5p to
create a poly (A) tail at the 3’ end of the RNAs (Kadaba et al. 2004, Houseley,
Tollervey 2006, Egecioglu, Henras & Chanfreau 2006b, Inoue et al. 2000a). After
poly (A) addition, Mtr4p prepares the highly ordered structure of RNA substrates for
degradation by the nuclear exosome (de la Cruz et al. 1998, Van Hoof, Lennertz &
Parker 2000a, Holub et al. 2012). All three subunits of the TRAMP4 complex are
highly conserved in eukaryotes, notably, all human homologs have been identified,
designated as ZCCHC7 (hAir2p), PAPD5p (hTrf4p), and SKIV2L2p (hMtr4p).
(Cristodero, Clayton 2007, Lubas et al. 2011, Shcherbik et al. 2010, Fasken et al.
2011).
In the cytoplasm of S. cerevisiae, mRNA quality control is mediated by two
pathways, 5’to 3’ degradation by Xrn1p, and 3’to 5’ degradation by the cytoplasmic
exosome (Fig. 1-1) (DECKER, PARKER 1994, Mitchell, Tollervey 2000, Caponigro,
Parker 1996). Like the TRAMP complex in the nucleus, the Ski complex, composed
of Ski2p, Ski3p and Ski8p (Anderson, Parker 1998, Brown, Bai & Johnson 2000),
stimulates the cytoplasmic exosome 3′-exonuclease activity through physical
interaction with a GTPase Ski7p (Fig. 1-1) (Araki et al. 2001). It’s reported that
besides the mRNA 3’-5’ degradation, not only is the exosome involved in functional
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mRNA turnover, it also plays a role in the degradation of aberrantly formed mRNAs,
such as nonsense-mediated decay (Mitchell, Tollervey 2003), RNA interference
(Orban, Izaurralde 2005), and nonstop decay (van Hoof et al. 2002). Ski2p, the
cytoplasmic homolog of Mtr4p plays a conserved helicase function to remove mRNA
secondary structure during exosome-mediated degradation. The crystal structure of
the Ski complex reveals that Ski3p and Ski8p play a role as scaffold of the complex
and assist RNA substrate channeling (Halbach et al. 2013).

The TRAMP Complex is Associated with the Nuclear Exosome

The exosome is found in archaea and eukaryotes, such as yeast, plants, flies
and humans (Mitchell et al. 1997, Allmang et al. 1999c, Chekanova et al. 2000,
Andrulis et al. 2002), and is highly conserved throughout organisms in both structure
and function (Lorentzen et al. 2005, Sloan, Schneider & Watkins 2012, Liu,
Greimann & Lima 2006, Lebreton, Séraphin 2008b). A similar multi-protein complex
called the degradosome, typically containing an endoribonuclease RNaseE, a
Polynucleotide Phosphorylase which is a 3’to 5’ exoribonuclease (PNPase) and a
DEAD-box RNA helicase B (RhlB), performs a exosome-like function in RNA
degradation in bacteria (Carpousis 2002, Py et al. 1996, Miczak et al. 1996, Carpousis
et al. 1994). The eukaryotic exosome, which is composed of 9 non-catalytic subunits
(Rrp4, Rrp40, Csl4, Ski6/Rrp41, Rrp42, Rrp43, Rrp45, Rrp46, Mtr3) and a tenth
nuclease Rrp44p/Dis3, can completely degrade RNA exonucleolytically and
endonucleolytically in 3’to 5’ polarity (Wang et al. 2007, Dziembowski et al. 2007,
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Mitchell et al. 1997, Bonneau et al. 2009). The exosome is coupled with specific
facilitating cofactors in different cellular compartments, with Rrp6p and Mtr4p in the
nucleus (Van Hoof, Lennertz & Parker 2000b, Allmang et al. 1999c, Briggs, Burkard
& Butler 1998), Ski2p and Ski7 in the cytoplasm (Mitchell, Tollervey 2003).
All exosome subunits and Rrp44p are essential for viability in S. cerevisiae.
(Allmang et al. 1999a, Mitchell et al. 1997). The 9 non-catalytic subunits form a
central RNA channel (also called the exosome core) that directs single-stranded RNA
to the exit site where Rrp44 is localized (Wasmuth, Lima 2012, Makino, Baumgartner
& Conti 2013, Bonneau et al. 2009). The exosome core consists two layers of protein
ring with a top and bottom orientation. Three subunits (Rrp4, Rrp40, Csl4) are
assembled in the top ring, forming the RNA entry site, which binds and melts the first
nucleotide pair of double stranded structure (Makino, Baumgartner & Conti 2013),
the other 6 subunits are localized to the bottom ring and this bottom ring resembles a
similar structure as the bacterial degradosome hexameric ring (Bonneau et al. 2009,
Wasmuth, Januszyk & Lima 2014). The exonuclease nuclear cofactor, Rrp6p,
associates with the top protein ring near the RNA entry site through its C-terminus,
which contributes to the long RNA central path structure of the exosome (Makino,
Baumgartner & Conti 2013). The TRAMP complex was found to stimulate and
enhance RNA degradation by the complete nuclear exosome, and Rrp6p alone in vivo
and in vitro (LaCava et al. 2005, Callahan, Butler 2010, Carneiro et al. 2007,
Schneider, Anderson & Tollervey 2007). Exosome stimulation by TRAMP is ablated
in Trf4p or Mtr4p mutants, suggesting a functional TRAMP complex is required for
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exosome activation (LaCava et al. 2005, Vanacova et al. 2005). It was recently
reported that the KOW domain of Mtr4p is the critical element of TRAMP that
mediates Rrp6 activation in vitro (Holub et al. 2012).

The TRAMP4 Complex Subunits and Assembly

The TRAMP4 (Air2-Trf4-Mtr4) complex has been extensively studied, but
less is known about the TRAMP5 (Air1-Trf5-Mtr4) complex (Houseley, Tollervey
2006). TRAMP4 seems to play a more predominant role in RNA surveillance than
TRAMP5 in vivo. The TRAMP4 component Trf4p is much more abundant than Trf5p.
A global analysis of protein expression in yeast revealed that Trf4p contains 7550
copies per cell, while there are only 2240 copies of Trf5p per cell (Ghaemmaghami et
al. 2003). The TRAMP4 is found to be involved in most of the TRAMP-associated
RNA surveillance and processing pathways, like tRNAiMet degradation and noncoding
RNAs degradation (Kadaba et al. 2004, de la Cruz et al. 1998, Wang et al. 2008a,
Wyers et al. 2005, Arigo et al. 2006). In this dissertation, TRAMP4 is referred the
TRAMP complex.
Air1p and Air2p (Arginine methyltransferase-interacting RING finger
protein) were first identified as factors that affect Hmt1p-mediated methylation of
Heterogeneous nuclear ribonucleoprotein (hnRNP) Npl3p (Inoue et al. 2000b). Air1p
and Air2p share 45% sequence identity, and have at least partial redundant functions
(Inoue et al. 2000b, LaCava et al. 2005). Either Air1p or Air2p deletion does not
induce detectable growth defects of S. cerevisiae, but deletion of both causes extreme
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slow growth (Inoue et al. 2000b, LaCava et al. 2005). Air1/2p contain five zinc
knuckles (Fig. 1-2A), which potentially binds RNA (LaCava et al. 2005, Vanacova et
al. 2005). The air1Δair2Δ double mutant accumulates poly (A) RNA in nucleus
(Inoue et al. 2000b). Studies on Air2p reveals that its zinc knuckles 2, 3 and 4 play a
role in RNA binding, while its N-terminus binds with Mtr4p and C-terminus
including zinc knuckle 5 interacts with Trf4p (Holub et al. 2012, Falk et al. 2014).
B

A
Zinc Knuckles
1 2 3 4 5
Air2

N’
Catalytic
Domain

Central
Domain

N’

Mtr4

Trf4

C’
1
Helicase Core

Arch Domain

Mtr4

C’

5

2
4

3

Trf4

Air2

Figure 1-2. Subunits and Assembly of the TRAMP4 Complex.
A. Schematic representations of TRAMP subunits, Air2p, Trf4p, and Mtr4p. Air2 is drawn in grey with
5 zinc knuckles in black. N-terminal and C-terminal sequences of Trf4 are indicated in yellow, the
catalytic domain is in dark green, and the central domain is shown in light green. Mtr4p helicase core is
colored in pink, and the arch domain is shown in red. B. Assembly of the TRAMP4 complex. The
TRAMP complex is drawn based on previous studies on structures of Mtr4p, Air2-Trf4p and the
TRAMP complex (Weir et al. 2010, Jackson et al. 2010, Falk et al. 2014, Hamill, Wolin & Reinisch
2010). Color assignments of each protein are the same as the schematic representations in the panel A.
N-terminus of Air2p wraps around Mtr4p helicase core and launchs onto the arch domain; its
C-terminus, the fifth zinc knuckle, and linker between the fourth and the fifth zinc knuckles interact
with the surface of Trf4p central domain. Trf4p also binds Mtr4p helicase core through its N-terminus.
Due to the incomplete TRAMP structure, whether additional interactions exist between Mtr4p-Air2p
and Mtr4p-Trf4p is still unknown.

Trf4p and Trf5p (DNA topoisomerase I-related function) are non-canonical
poly (A) polymerases, and share 58% identity in amino acids sequence (Castano et al.
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1996). Trf4p is localized to the nucleus, while Trf5p is localized into the nucleolus
(Houseley, Tollervey 2006, Egecioglu, Henras & Chanfreau 2006a, Huh et al. 2003).
Trf4/5p consists of a catalytic domain and a central domain (Fig. 1-2A), and both are
conserved with other eukaryotic Pol β polymerases, in sequence and structure (Martin,
Doublie & Keller 2008). Trf4/5p do not contain recognizable RNA binding domains,
and Air1p or Air2p is required for Trf4p to function as a polymerase activities in vitro,
thus air2p provides substrate binding for Trf4p (Wyers et al. 2005, LaCava et al. 2005,
Anderson, Wang 2009). Deletion of either Trf4p or Trf5p is not lethal; but loses of
both poly (A) polymerase activity by site mutagenesis or a trf4Δtrf5Δ double mutant
results in yeast inviability (Castano et al. 1996, LaCava et al. 2005, San Paolo et al.
2009). Overexpression of TRF5 rescues defects in degradation of hypomodified
tRNAiMet that caused by deleting TRF4, but TRF5 deletion by itself dose not cause
accumulation of hypomodified tRNAiMet (Kadaba, Wang & Anderson 2006). Trf5p
seems to be limited to its lower abundance and localization, however it may be able to
replace Trf4p in TRAMP4 (Anderson, Wang 2009).
Mtr4p is localized to both the nucleoplasm and nucleolus (Liang et al.
1996), plays an important role in RNA processing and turnover in both nucleus and
nucleolus, as a helicase with 3’ to 5’ polarity, that is dependent on ATP hydrolysis
(Wang et al. 2008b). MTR4 was first identified as a mutant through a genetic screen,
that sought genes involved in mRNA nucleocytoplasmic transport (Kadowaki et al.
1994). Previous studies from our lab suggested that Mtr4p is required for degradation
of hypomodified tRNAiMet by the nuclear exosome, as a component of TRAMP
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complex (Kadaba, Wang & Anderson 2006, Kadaba et al. 2004). It has been found
that Mtr4p, but not other TRAMP components, is critical for nuclear exosome
mediated pre-rRNA processing such as 7S precursor to 5.8S rRNA and for the rapid
degradation of 5’ externally transcribed spacer (5’ ETS) from 35S rRNA (de la Cruz
et al. 1998). The 3-dimensional (3D) structure of Mtr4p revealed a novel so-called
arch domain, protruding out of the common helicase base (Fig. 1-2A) (Weir et al.
2010, Jackson et al. 2010). It raised questions about its function, since it uniquely
exists in Ski2p and Mtr4p, but not been found in any other helicases (Halbach, Rode
& Conti 2012a).
The assembly of the TRAMP complex is not fully understood, but is
becoming clearer (Fig. 1-2B). Mtr4p lacking its arch domain is still able to form the
TRAMP complex, indicating it interacts with Trf4p-Air2p through the helicase base
(Weir et al. 2010, Falk et al. 2014). A few residues affecting TRAMP assembly in
Mtr4p RecA2 helicase domain and ratchet domain were identified (Falk et al. 2014).
Air2p is reported to function as a bridge in complex assembly, the N-terminus
associates with Mtr4p, and the C-terminus binds Trf4p (Holub et al. 2012, Falk et al.
2014). Trf4p also interacts with Mtr4p with its N-terminal low-complexity regions
(Falk et al. 2014). An Air2p-Trf4p crystal structure revealed that Air2p binds to the
surface of the Trf4p central domain, mainly through its fifth zinc knuckle and
C-terminus, and the fourth zinc knuckle is tethered to Trf4p by the linker region
(Hamill, Wolin & Reinisch 2010). In a model derived by small-angle X-ray scattering
(SAXS), Air2p-Trf4p is located at the bottom of Mtr4p helicase core, which is the
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opposite side relative to the Mtr4p arch domain (Falk et al. 2014). However, none of
the TRAMP molecular structures above contain full-length proteins of any subunit,
which raises the possibility that more interactions among the three proteins may exist.

Subunits of the TRAMP Complex Modulate and Assist Each Other’s Functions

As subunits of the TRAMP complex, Trf4p could modulate the RNA
substrates by adding adenosines to the 3’end, make them accessible to Mtr4p, since
Mtr4p cannot unwind substrates that don’t contain a 3’ extension (Wang et al. 2008a,
Bernstein et al. 2008). It was reported that Mtr4p could detect the number of 3’
adenosines of RNA substrates, and modulate the polymerase activities of Trf4p to
control the appropriate substrate A-tail length for unwinding, around 3~4 Adenosines
(Jia et al. 2011a). It seems that Trf4p polyadenylates RNAs to a proper overhang
length before Mtr4p unwinds them. There is also evidence that Mtr4p plays a role in
activating Rrp6 (Holub et al. 2012), which is a nuclear exosome cofactor, which
further suggests that Mtr4p might be the last step of the TRAMP function.
However, another study found that a 3’ overhang with at least three
nucleotides is required for Trf4p polymerase activities (Hamill, Wolin & Reinisch
2010). It indicates a potential model that Mtr4p may thread RNA first, providing a
proper 3’ overhang for Trf4p activities. A recent study on crystal structure of the
TRAMP complex indicates that Air2p-Trf4p wraps around the helicase core of Mtr4p,
and Trf4p catalytic domain is positioned below Mtr4p helicase base, which provides a
structural model that Mtr4p first unwinds RNA substrates that are then forwarded to
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Air2p-Trf4p for polyadenylation (Falk et al. 2014). Overall, both models suggest that
Mtr4p helicase activities and Trf4p polyadenylation activities are tightly coupled for
TRAMP function.
Besides Mtr4p’s function on modulating Trf4p activities, Trf4p-Air2 can also
elevate the unwinding activities of Mtr4p, compared to that of Mtr4p itself (Jia et al.
2012). In addition, Air2p with the fourth zinc knuckle mutated cannot maintain
polyadenylation activities of the TRAMP complex in vitro, indicating that the fourth
zinc knuckle of Air2p is required for Trf4p polymerase activities (Holub et al. 2012).
Taken together, the evidence suggests that Air2p, Trf4p and Mtr4p cooperate and
depend on each other structurally and functionally, assembling a stable and active
TRAMP complex. Instead of a serial reactions carried out by each subunit, The
TRAMP complex may have a more complicated mechanism, Air2p, Mtr4p and Trf4p
may optimize RNA substrates for each other, modulate each other’s activities, finally
reach the maximum activity of the TRAMP complex.
Since this study is specifically focused on characterizing functions of Mtr4p
structural domains on Mtr4p helicase activities. The next part will give an overview
of helicases classification and mechanisms, as well as which does Mtr4p belongs to.

Part II. Mtr4 is a Ski2-like Helicase, that belongs to Helicase Superfamily II

Helicase is defined as a class of enzyme that can display strand separation
activities in an NTP-dependent manner to unwind nucleic acid duplex (Walker,
Saraste et al. 1982), such as DNA-DNA, DNA-RNA and RNA-RNA. Helicases are
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involved in all kinds of nucleic acid metabolism, including DNA replication, DNA
repair, transcription, translation, RNA processing and degradation (Matson, Bean &
George 1994, Schmid, Linder 1992, Walker et al. 1982a).

Helicase Classification and Functions

Helicases are divided into 5 superfamilies (SF) according to motifs in the
helicase core domain (Gorbalenya, Koonin 1993a) (Fig. 1-3). The classification is
SF1 Upf1

DNA helicase
families
(no RNA helicase)

SF2 Mtr4
RNA helicase
families
(mainly RNA
Helicase)

RecG-like
RecQ-like
Rad3/XPD
Type 1 restriction enzyme
Swi/Snf
DEAD-box Transcription/Ribosome biogenesis/pre-mRNA splicing/ RNA
export/ NMD/miRNA processing/ snRNP biogenesis/ Translation/ RNA decay/
RNA storage/Mitochondrial RNA metabolism
DEAH/RHA Transcription/ Ribosome biogenesis/ pre-mRNA splicing/
Translation/Mitochondrial RNA metabolism
Viral DExH (NS3/NPH-II) Viral replication/ Transcription
Ski2-like Ribosome biogenesis/ pre-mRNA splicing/ nuclear RNA surveillance/
Translation/ RNA decay
RIG-I-like miRNA processing/ cytosolic PAMP recognition

SF3 SV40 large T Antigen
SF4 P4
SF5 bacterial Rho

Figure 1-3. Helicase Classifications.
SF1 and SF2 were listed together since helicases belong to them contain two Rec-A like helicase
domains. SF3, SF4 and SF5 were listed together due to their hexameric ring structure. Examples from
each family were formatted in italic. 10 subfamilies of SF2 were listed on the right. Functions of
helicases belong to RNA helicase subfamilies are indicated by red.

based on sequence and structure. Each family may contain both DNA helicases and
RNA helicases. The distinctions in sequence and unwinding mechanisms exist among
helicases from different superfamilies (Jankowsky, Fairman 2007c), rather than DNA
and RNA helicases from the same family. It was reported that Upf1, Sen1 and
IGHMBP2 that belong to superfamily I can unwind both DNA and RNA(Kim, Choe
& Seo 1999, Guenther et al. 2009a, Bhattacharya et al. 2000). Thus certain helicases
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do not recognize the specificities between DNA and RNA. The biggest difference
between DNA and RNA helicase is enzyme processivity, which is defined as the
protein unwinding abilities versus dissociation from substrates (Ali, Lohman 1997).
Most DNA helicases are highly processive enzymes, which could not dissociate
within hundreds or thousands of base pairs while unwind DNA substrates (Singleton,
Dillingham & Wigley 2007, Pyle 2008). However, most RNA helicases are not
processive, with the exception of Rho helicase and viral DExH RNA helicases
(Walstrom, Dozono & von Hippel 1997, Jankowsky et al. 2000, Pang et al. 2002).
Superfamily I (SF1) and superfamily II (SF2), which contain all eukaryotic
helicases and most of the bacterial and viral helicases, share similarities in many
aspects (Tanner, Linder 2001, Fairman-Williams, Guenther & Jankowsky 2010). The
helicase core of both superfamilies is composed of two helicase domains, which are
called the RecA-like domains. They are positioned across from each other, with the
conserved motifs facing the cleft in between (Singleton, Dillingham & Wigley 2007,
Subramanya et al. 1996). RNA and ATP binding sites exist on each side of the cleft.
Based on sequence, the two RecA-like domains contain seven conserved motifs in
total (motif I, Ia, II, III, IV, V, and VI) (Gorbalenya, Koonin 1993b, Jankowsky,
Fairman-Williams 2010) (Fig. 1-4). Motifs I and II, corresponding to the conserved
Walker A and Walker B in all P-loop proteins, are conserved among SF1 and SF2
(Leipe et al. 2002, Anantharaman, Koonin & Aravind 2002). Walker A and Walker B,
signatures of P-loop proteins, are motifs for ATP-GTP binding and hydrolysis
(Walker et al. 1982b). The sequences of the rest motifs are conserved among
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A
RecA 2

RecA 1
SF1/SF2
N-terminus

I Ia

IV

II III

V VI

C-terminus

B

C’

RecA 2
VI
I III II
N’

IV

V

Ia

RecA 1

Figure. 1-4. Conserved motifs in SF1 and SF2.
A. Schematic representations of helicase domains in SF1/SF2. ATP/GTP binding motifs (I, II, VI) are
colored in red, and RNA/DNA binding motifs (Ia, IV, V) are indicated by blue. Motif III shown in
orange is the linker motif. Additional N- or C- terminal domains are not shown. B. Structure of the two
RecA like domains in SF1/SF2 helicases. ATP/GTP binding motifs shown in red are clustered at one
side of the cleft between RecA1 and RecA2, while RNA/DNA binding motifs are gathered at the other
side. N- or C- terminal sequences may form additional structural domains in different helicases, but not
shown in this figure.

members of each superfamily, but not between SF1 and SF2, however, they are
characterized with similar functions in both superfamilies (Korolev et al. 1998,
Singleton, Dillingham & Wigley 2007). Cooperating with motifs I and II, motif VI is
also responsible for ATP/GTP binding and hydrolysis. Motifs Ia, IV and V play a role
in substrate (DNA or RNA) binding (Singleton, Dillingham & Wigley 2007). Motif
III is a linker that connects ATP and nucleic acid binding sites. The helicase core is
always connected with N-terminal or C-terminal structural domains, which could be
RNA binding domains, protein binding domains, or zinc fingers (Jankowsky, Fairman
2007a, Anantharaman, Koonin & Aravind 2002, Jankowsky, Fairman-Williams
2010).
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Superfamily III, IV and V (SF3, 4 and 5), are notably distinct from SF1 and
SF2, containing helicases that are hexameric toroids (Singleton, Dillingham & Wigley
2007). Enzymes of these superfamilies have one helicase domain. They are found in
bacteria and viruses, but not in eukaryotic organisms. RNA binding sites were located
on the top of the ring structure or inside of it, while the ATP binding sites are in
between two promoters (Skordalakes, Berger 2006). A representative helicase of SF3
is SV40 large T Antigen, known as a DNA helicase, which contributes to targeting of
the host cellular machinery for viral replication (Enemark, Joshua-Tor 2008). A
dominant helicase in SF4 is the RNA packing motor P4 that regulates RNA packing
into the phage (Kainov, Tuma & Mancini 2006). SF5 contains the bacterial Rho
protein that plays a role in transcription termination (Skordalakes, Berger 2006).

Superfamily II is the Largest Helicase Superfamily

SF2 is known as the largest helicase superfamily, which contains most of the
eukaryotic and bacterial helicases, as well as some of the archaeal and DNA/RNA
viral helicases (Singleton, Dillingham & Wigley 2007, Tanner, Linder 2001). For
example, 103 SF2 helicases were found in humans; 59 SF2 helicases were identified
in Saccharomyces cerevisiae (Jankowsky, Fairman-Williams 2010). SF2 is divided
into 10 subfamilies, based on the sequence of helicase core and their cellular
functions (Jankowsky, Fairman & Yang 2005, Jankowsky, Bowers 2006, Jankowsky,
Fairman 2007a) (Fig. 1-3). RNA helicases are found in 5 of the SF2 subfamilies.
They are defined as RNA helicase families, even though they includ a few DNA
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helicases. RNA helicase families are divided as followed, the DEAD-Box family, the
DEAH/RHA family, the viral DExH proteins and NS3/NPH-II family, the Ski2-like
proteins family, the RIG-I-like proteins family (Fig. 1-3). The other 5 families that are
only composed of DNA helicases, termed as DNA helicase families, including the
RecG-like proteins family, the RecQ-like proteins family, the Rad3/XPD family, the
type 1 restriction enzyme family and the Swi/Snf family (Fig. 1-3). The RNA helicase
families are discussed respectively below.
SF2 helicases are usually described as DEAD or DExD/H proteins, since they
are the first and second largest subfamilies of SF2 (Tanner, Linder 2001, Linder
2006). Helicases belong to DEAD-box families share D-E-A-D box in helicase motif
II. They are found in almost every RNA-related cellular metabolism, including
transcription, splicing, ribosome biogenesis, RNA processing, transport, RNA decay,
translation as well as mitochondrial RNA metabolisms (Linder 2006). DEAD-box
helicases have a distinct unwinding mechanism without a defined unwinding polarity.
They can load any place on the duplex region, and unwind RNA in any direction that
depends on ATP hydrolysis (Yang et al. 2007, Yang, Jankowsky 2006, Liu, Putnam
& Jankowsky 2008). The most well studied member of the DEAD box proteins is
eIF4A-III, which is a subunit of exon-junction complex that is required for nonsensemediated decay (Shibuya et al. 2004). Similar to the DEAD-Box family, the
DEAH/RHA family is named due to the conserved D-E-A-H box in helicase motif II.
RHA represents RNA helicase A. Helicases in this family are found in eukaryotes and
bacteria. They hydrolyze all NTPs & dNTPs, and unwind RNA in a 3’ to 5’ direction
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(Tanaka, Schwer 2005, Tanaka, Schwer 2006, Tanaka, Aronova & Schwer 2007)
(Jankowsky Fairman 2010). The third RNA helicase family contains Viral DExH
proteins and NA3/HPH-II proteins that play a role in remodeling chromosome,
displays similar unwinding mechanisms as the DEAH/RHA family with no
preference on the NTPs (Lain et al. 1991, Suzich et al. 1993, Shuman 1992). Fourthly,
the Ski2-like helicases such as Mtr4 in the nucleus, Ski2 in the cytoplasm, and Suv3p
in the mitochondria, mainly facilitate RNA degradation and processing (Anderson,
Parker 1998, LaCava et al. 2005, Stepien et al. 1992). They unwind RNA substrates
in a 3’ to 5’ direction, which is coupled with their ATPase activities (Anderson,
Parker 1998). The last RNA helicase family is the RIG-I-like proteins, containing
RIG-I which is a cytosolic pattern-recognition receptor found in enkaryotic immune
system and Dicer which is a helicase with RNase motif that is important for
microRNA maturation (Yoneyama et al. 2004, Bernstein et al. 2001). They also
display 3’ to 5’ unwinding activities, which is specific for hydrolyzing ATP (Takahasi
et al. 2008).

Unwinding Mechanisms of Superfamily II Helicases

Two distinct unwinding mechanisms have been identified through out SF2
helicases, one is duplex unwinding by local strand separation, and the other is
translocation based unwinding by canonical DNA and RNA helicases (Jankowsky
2011, Jankowsky, Fairman-Williams 2010).
DEAD-box family proteins recruit a distinct duplex unwinding mechanism by
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local strand separation (Fig. 1-5) (Jarmoskaite, Russell 2011, Yang et al. 2007). They
can load directly anywhere in the duplex region, move in either direction to pry open
the duplex, resulting in strand separation. DEAD-box proteins do not require a
single-strand extension for enzyme loading. Their unwinding is based on enzyme
translocation along substrates without a defined polarity (Yang et al. 2007). Protein
loading on to the substrates doesn’t require ATP hydrolysis, but depends on ATP
binding. But ATP hydrolysis is necessary for protein dissociation. Therefore,
helicase

ATP

Enzyme Loading
ATP

ATP Hydrolysis

ADP

Strand Separation

Strand Separation
ADP
ATP

Enzyme Dissociation
ATP Hydrolysis
ADP

Enzyme Dissociation

Strand Re-annealing

Figure 1-5. Unwinding by local strand separation.
DEAD box helicase is represented by a red circle. The order of helicase binding with RNA and ATP is
unclear, or they may occur simultaneously. Enzyme binding is followed by either ATP hydrolysis first
then strand separation (right arrow); or strand separation first by enzyme pealing then ATP hydrolysis
(down arrow). In both conditions, ATP hydrolysis happens before enzyme dissociation. Separated
single strands may be re-annealed under appropriate conditions.
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DEAD-box helicases completely unwind a substrate molecule, which is
normally coupled with one round ATP binding and hydrolysis (Liu, Putnam &
Jankowsky 2008, Henn et al. 2010, Chen et al. 2008). Since the length and stability of
double-strand region significantly affects the helicases unwinding efficiency,
DEAD-box helicases are not able to unwind duplex that is longer
than 12 base pairs (Bizebard et al. 2004, Chen et al. 2008, Cartier et al. 2010).
Translocation based unwinding mechanism (Fig. 1-6) is recruited by most of
the DNA helicases, viral RNA helicases of the NS3/NPH-II family, the Ski2-like
helicase

ATP

Enzyme Loading
ATP

ATP Hydrolysis & Enzyme translocation
ADP

ATP Hydrolysis & Enzyme translocation
ADP

Strand Re-annealing
Strand Separation

ADP

Enzyme Dissociation

Figure 1-6. Unwinding mechanism by helicase translocation.
Helicase is represented by a red circle. It’s unclear about order of helicase binding with RNA and ATP,
or they happened at the same time. ATP binding and hydrolysis is coupled with enzyme translocation
along the RNA substrates, due to the conformational changes. Enzyme translocation causes strand
separation. Separated single strands may be re-annealed under appropriate condition.
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family, the RIG-I-like family, the DEAH/RHA family and the Upf1-like family
(Zhang, Grosse 2004, Guenther et al. 2009b, Wang et al. 2008b, Takahasi et al. 2008,
Pyle 2008). This unwinding mechanism requires a 5’ or 3’ single-strand extension on
the duplex depending on the unwinding polarity of the specific helicases. That is, a 3’
overhang is required for a helicase that unwinds in a 3’ to 5’ polarity, and vice versa.
Helicases either bind with ATP or load onto single-strand extension at the first place,
followed by peeling off the other strand by translocation to the opposite end
(Singleton, Dillingham & Wigley 2007, Lohman, Tomko & Wu 2008, Pyle 2008,
Myong, Ha 2010). This unwinding process requires multiple rounds of ATP
hydrolysis, which is the driving force for enzyme translocation.
Both unwinding mechanisms requires one or several rounds of ATP binding
and hydrolysis, which cause the conformational change of the two RecA-like domains
that found in all SF1 and SF2 helicases (Singleton, Dillingham & Wigley 2007,
Lohman, Tomko & Wu 2008, Pyle 2008, Jankowsky, Fairman 2007b). The two
RecA-like domains are far apart without ATP bound, while ATP binding causes the
domains moving closed to each other, resulting in protein translocation. Canonical
DNA or RNA helicases normally move along the substrate by 1nt per round of ATP
hydrolysis (Myong et al. 2007). The details of unwinding mechanism are discussed
below. However, in the process of substrate unwinding, the link between DEAD-box
helicase translocation and ATP hydrolysis wasn’t clear yet on structure level.
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Mtr4p belongs to the Ski2-like Family, a Subfamily of SFII
Mtr4p belongs to the helicase superfamily II and is a member of Ski2-like
subfamily. The three-dimensional structure of Mtr4p contains a helicase core and a
protruding arch domain (Jackson et al. 2010, Weir et al. 2010) (Fig.1-5 A). The
helicase core consists of two highly conserved RecA-like domains that exist in all
superfamily II DNA and RNA helicases, a winged helix domain and a ratchet domain.
The arch domain, which is unique to exosome-linked helicases Mtr4 and Ski2 (Fig.
1-7 A&B), contains an arm (also called KOW domain due to the KOW motif) and a
fist (also called stalk domain) (Weir et al. 2010, Jackson et al. 2010, Halbach, Rode &
Conti 2012a). The KOW motif in Mtr4 fist wasn’t found in Ski2 (Weir et al. 2010,
Jackson et al. 2010, Halbach, Rode & Conti 2012a).
Studies on crystal structure of Hel308 (Fig. 1-7 C), which is an Archaea
DNA helicase also belongs to Ski2 helicase subfamily, provided a potential
unwinding mechanism for Mtr4 (Fig. 1-8) (Buettner, Nehring & Hopfner 2007,
Richards et al. 2008, Johnson, Jackson 2013). In Hel308, ATP binding to the interface
of two RecA-like domains causes RecA1 move closer to RecA2 (Buettner, Nehring &
Hopfner 2007, Richards et al. 2008). Upon ATP hydrolysis, RecA2 swings back,
resulting in enzyme translocation along RNA in 3’ to 5’ direction, which further leads
to strand separation by a conserved wedge-like β- hairpin structure in RecA2 domain
(Buettner, Nehring & Hopfner 2007). The winged helix and ratchet domains are also
found in Hel308, as part of he helicase core functioning in DNA substrates binding
(Buettner, Nehring & Hopfner 2007, Richards et al. 2008). The winged helix domain
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Figure 1-7. Structures of Ski2-like proteins.
Figure legend see next page.
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A. Schematic representation and crystal structure of Mtr4p (PDB ID zcgl) (Weir et al. 2010). Domain
colors are indicated in the schematic graph. RNA is colored in Black and ATP is colored in dark grey.
Front view and bottom view are showed. B. Schematic representation and crystal structure of Ski2p
(PDB ID 4A4Z) (Halbach, Rode & Conti 2012b). AMPPNP is shown in dark grey. C. Schematic
representation and crystal structure of Hel308p (PDB ID 2P6R) (Buettner, Nehring & Hopfner 2007).
Unwound DNA is shown in black. There is no arch domain in Hel308p. Red hairpin in RecA2 plays a
role to unwind DNA duplex, like a wedge to peel off one of the strand. Views from two directions are
showed.

was positioned as a connecting unit in both Mtr4p and Hel308, interacting with
RecA-like domains, ratchet domain in both proteins and also arch domain in Mtr4p
(Woodman, Bolt 2011, Johnson, Jackson 2013). Ratchet domain was found in most
SF II helicases, playing a role in DNA/RNA binding. It was believed that ratchet
domain serves as a scaffold for RNA binding and act as a surface keeping
protein-RNA interaction in unwinding mechanism (Fig. 1-8) (Johnson, Jackson 2013).
However, how the winged helix and ratchet domains play a role in different aspects of
Mtr4p enzymatic activities like ATP hydrolysis and unwinding activities are
unknown.
The novel Mtr4p arch domain with unknown function has raised a lot of
interests recently. The arch domain was found to be important for 5.8S rRNA
processing and 5’ETS degradation in vivo (Jackson et al. 2010). It also has been
demonstrated that the arch domain is sufficient for tRNAiMet binding in vitro but not
necessary (Weir et al. 2010). The KOW domain is reported to be required for
exosome activation in vitro (Holub et al. 2012). However, the mechanism how the
structural domains including arch domain, the winged helix and ratchet domain assist
Mtr4 RecA-like domains to display unwinding activities remains unknown. How
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Figure 1-8. Unwinding mechanisms of SF2 helicases.
Helicase is represented by three domains, the RecA1, RecA2 and the ratchet domain. RecA1and
RecA2 is shown in purple and blue. The ratchet domain is displayed in pink. Numbers indicate order of
the steps. Helicase is first loaded onto the 3’ overhang of the RNA substrates (2). Upon ATP binding,
RecA1 moves closer to RecA2, and the right arrow indicates the moving direction (3). When ATP is
hydrolyzed, RecA2 moves apart from RecA1, resulting in enzyme translocation towards 5’ end of the
loading strand, as well as strand separation (4). Steps 5 and 6 describe another round of ATP
hydrolysis, resulting in additional one base pair separation caused by enzyme translocation towards
5’end. The ratchet domain keeps binding with the loading strand, and is important for enzyme
translocation and processivity(Buettner, Nehring & Hopfner 2007, Johnson, Jackson 2013, Richards et
al. 2008). These steps are repeated until the substrate is fully unwound.

these structural domains contribute to protein conformational change and therefore
coordinate the helicase activity is a big question in the field (Philips, Cooper 2000,
Kolb, Sutton & Schoenberg 2010, Bruserud 2007). My thesis work is focused on
studying distinct functions of Mtr4p structural domains, by characterizing how they

25

assist RNA binding, ATP hydrolysis and unwinding activities. This work provides a
clearer view of how different domains of Mtr4p coordinate to display its enzymatic
activities.
Part III. Mtr4 Plays a Role in tRNAiMet Turnover in vivo, as a Component of
TRAMP Complex
Pre-tRNAs Need Processing and Modification to Produce Mature tRNAs
Transfer RNAs (tRNA) are essential for gene expression and protein synthesis,
since the distinct structured tRNAs discriminate and carry different amino acid
molecules to assemble functional proteins according to the genetic codons of mRNA.
Pre-tRNAs are transcribed by RNA polymerase III, and require several steps of
post-transcriptional modifications to form functional mature tRNAs. These processing
events include 5’ and 3’ end trimming, intron splicing, CCA addition to the 3’end, as
well as nucleotide modifications (Fig. 1-9) (Hopper, Phizicky 2003, O'Connor,
Peebles 1991).
5’ leader is cleaved by ribonuclease P (RNase P), an endonucleolytic
ribozyme that contains RNA subunit as catalyst (Fig. 1-9) (Lee, Engelke 1989, Lee et
al. 1997, Xiao et al. 2002). RNaseP ribozyme was found in bacteria, archeae as well
as eukaryotes (Xiao et al. 2002). Since the sequence around the 5’ trimming site is not
well conserved, RNaseP recognizes pre-tRNA substrates based on the structure,
mainly through the TψC/acceptor stems, variable arms, and the base-paired bulge (1
position unpaired) that is formed between the purine-rich 5’ leader and
pyrimidine-rich 3’ tailor (Schon 1999, Frank, Pace 1998, Lee et al. 1997).
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Figure 1-9. Structures of pre-tRNA and mature tRNA.
A. Structure of pre-tRNA before processing. Each circle represents a single nucleotide. Sequences that
will be removed are shown in grey, including 5’ leader, 3’ trailer and introns. Red pies indicate
enzymes function in processing specific sequences (RNase P for removing 5’ leader; endo-and
exo-nucleases for removing 3’trailer; endonuclease, ligase and phosphotransferase for removing
introns). Anticodon is displayed in green. B. Structure of mature tRNA. 3’ ACC is shown in blue,
added by nucleotidyl transferase. Adenosine at position 58 is shown in purple. It’s located in TψC-loop,
and methylated by Trm6p-Trm61p methyltransferase complex. Other nucleotide modifications were
not shown in this figure.

Removal of the 3’ extension is less well understood. More and more evidences
indicated that 3’ trailer processing is carried out by either endo or exonucleases or
both (Fig. 1-9) (Morl, Marchfelder 2001). In Saccharomyces cerevisiae, Lhp1p is
required for endonucleolytic cleavage. Lhp1p is homologous to human La protein, a
RNA chaperone that stabilizes and binds with all Pol III transcripts that contain
UUUOH sequence, serves as termination factor (Yoo, Wolin 1997). Without Lhp1p, 3’
extension trimming of pre-tRNA is carried out by exonuclease instead (Morl,
Marchfelder 2001, Yoo, Wolin 1997, Hopper, Phizicky 2003).
Subsequently, CCA is added to the mature 3’end (positions-C74C75A76) by
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tRNA nucleotidyltransferase (Fig. 1-9) (Yue, Maizels & Weiner 1996). tRNA
nucleodyltransferasess, also termed as CCA-adding enzymes, are a group of RNA
polymerases that utilize CTP and ATP as substrates to faithfully synthesize CCA to
the 3’ terminus of pre-tRNA, independent of a nucleic acid template (Shi, Maizels &
Weiner 1998). The CCA sequence is required for amino acid cognation onto tRNA
(aminoacylation), by aminoacyl-tRNA synthetase (Sprinzl, Cramer 1979). The CCA
sequence, on one side, directly binds with ribosomal RNA during protein translation
(Green, Noller 1997), on the other side, provide tRNA turnover signal when
duplicated at 3’ terminus (positions-C74C75A76C77C78A79) (Weiner 2004, Tomita,
Yamashita 2014).
Since introns were found in tRNAs in bacteria, archaea, and eukarya, the
following step of tRNA maturation is splicing. In yeast, introns were first cleaved by
splicing endonuclease SEN complex at each side of the intron, forming two exons
(two half tRNA molecules) and a spliced intron (Fig. 1-9). Next, tRNA ligase
functions to ligate back the two half molecules into an entire tRNA, generating a
2′-phosphate at the spliced junction (Hopper, Phizicky 2003). Finally, 2′
phosphotransferase removes the extra 2’- phosphate to complete the splicing process
(Abelson, Trotta & Li 1998, Culver et al. 1997). The tRNA splicing mechanism is
conserved in eukaryotes (Zillmann, Gorovsky & Phizicky 1991). The pre-tRNA
splicing event happens in the nucleus in vertebrates (Melton, De Robertis & Cortese
1980). However, in yeast, tRNA splicing endonuclease SEN complex is located at the
cytoplasmic surface of mitochondria (Yoshihisa et al. 2003, Yoshihisa et al. 2007),
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and tRNA ligase is found to be distributed in the cytoplasm (Hopper 2013), indicating
yeast pre-tRNA splicing event takes place in the cytoplasm (Yoshihisa et al. 2007).
Spliced tRNA in yeast could retro-transport back into the nucleus to complete
subsequent processing steps (Shaheen, Hopper 2005, Takano, Endo & Yoshihisa
2005, Murthi et al. 2010).
tRNAs are highly modified in achaea, eubacteria and eukarya (Rozenski,
Crain & McCloskey 1999). Notably, around 92 different tRNA modifications were
reported throughout all organisms (Phizicky, Hopper 2010). In S. cerevisiae, 25
modifications were found in 34 sequenced cytoplasmic tRNAs (Phizicky, Hopper
2010, Hopper 2013). These modifications include base or ribose methylation,
formation of pseudouridine (Ψ) or dihydrouridine (D), and addition of sugar or amino
acids (Hopper, Phizicky 2003). Generally, modifications inside or near the anticodon
are crucial for translation fidelity and cell growth. Due to defective anticodon-codon
interactions, S. cerevisiae strains lacking these modifications are normally unviable or
display severe growth defects (Phizicky, Hopper 2010). Modifications in the tRNA
main body influence molecule structure and stability. Lacking body modifications
may lower the Tm of tRNA molecule, cause alternative structures or activate RNA
degradation mechanisms (Phizicky, Hopper 2010). Some specific modifications
provide tRNA identity and prevent mis-acylation. For example,
2’-phosphoribosylated modification of adenosine at position 64 is used to distinguish
initiator tRNAiMet from elongator tRNAeMet in S. cerevisiae (Astrom, Bystrom 1994).
This modification helps initiator factor 2 (eIF2) recognizes and interact with tRNAiMet,
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while elongator factor 1 (eEF1α) specifically binds with tRNAeMet (Astrom, Bystrom
1994, Shin et al. 2011, Hopper 2013).
With all of the post-transcription modifications, mature tRNAs can display
different roles in protein synthesis. These correctly processed tRNAs are dynamic in
cells, trafficking between nucleus and cytoplasm to display their functions. In vivo
tRNA level is controlled by an accurate RNA quality mechanism, which was
introduced in Part I. Pre-tRNAs that are incorrectly or insufficient modified are
recognized and degraded by the nuclear RNA quality control system.
Trm6p-Trm61p Methyltransferase Complex Plays a Role in tRNAiMet m1A58
Modification

One of the tRNA nucleotide mofidications, 1-methyladenosine at position 58
(m1A58) universally exists in tRNAs from organisms of achaea, eubacteria and
eukarya. In S. cerevisiae, m1A58 modification is found in 23 of 34 sequenced tRNAs
(Sprinzl, Vassilenko 2005, Hiley et al. 2005). m1A58 is required for mature and stable
initiator tRNAiMet (Fig. 1-9) (Basavappa, Sigler 1991, Kadaba et al. 2004). It was
reported that an important nuclear heteromeric methyltransferase (Mtase) complex,
the Trm6p-Trm61p (formally named Gcd10p-Gcd14p) complex, is responsible for the
1-methyladenosine modifications. TRM6 and TRM61 genes (formally named
GCD10/GCD14) encode the two subunits Trm6p and Trm61p in the Mtase complex
(Anderson, Phan & Hinnebusch 2000, Anderson et al. 1998). The Mtase mutant yeast
strain trm6-504 exhibits a temperature-sensitive (ts-) phenotype at 36oC (Anderson et
al. 1998). m1A58 modification was not detected in trm6 deletion (trm6Δ) yeast strain,

30

which also contains a lower level of stead-state mature tRNAiMet (Anderson et al.
1998). Overall, Trm6p is necessary for m1A58 modification, which is further required
for maturation and stability of tRNAiMet. Growth defect of trm6-504 mutant strain is
caused by a reduced level of mature tRNAiMet, and could be suppressed by
overexpressing mature tRNAiMet (Anderson et al. 1998). In this dissertation, trm6-504
strain is used for in vivo experiments to study how Mtr4p structural domains
contribute to its helicase function when regulating tRNAiMet turnover.
Trm6p-Trm61p methyltransferase complex showed MTase activities on
modifying tRNA 1-methyladenosine in vitro (Anderson, Phan & Hinnebusch 2000).
Trm61p is a homolog of S-adenosylmethionine dependent methyltransferases, uses
S-adenosylmethionine (AdoMet) as the methyl donor (Kagan, Clarke 1994, Calvo et
al. 1999). Trm61p itself didn’t confer tRNA binding activities (Anderson, Phan &
Hinnebusch 2000). Trm6p alone was able to bind with RNA substrates (Garcia-Barrio
et al. 1995). Overall, in the methyltransferase complex, Trm6p provides tRNA
binding, and Trm61 catalyze the methylation of m1A58 of tRNAiMet through
interacting with AdoMet (Anderson, Phan & Hinnebusch 2000).
TRAMP Complex Plays a Role in Hypomodified tRNAiMet Turnover
Previous work of our lab characterized the TRAMP-dependent degradation
pathway of tRNAiMet when it’s lacking m1A58 modification. First, TRF4, RRP44, and
SUP3 were identified as suppressors for trm6-504 ts- phenotype through selecting for
spontaneous reversion of the trm6-504 ts− phenotype in S. cerevisiae (Kadaba et al.
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2004). TRF4 encodes Trf4p, a subunit of the TRAMP complex, plays a role in
polymerize RNA substrates (LaCava et al. 2005). Hypomodifed tRNAiMet was
accumulated without polyadenylation in trm6-504/trf4-20 double mutant (Kadaba,
Wang & Anderson 2006). Overexpression of Trf4p cause longer poly(A)+ tail of
hypomodifed tRNAiMet. Furthermore, TRF4 deletion caused stabilized higher level of
hypomodified tRNAiMet, on the opposite, Trf4p overexpression leads to
destabilization of hypomodified tRNAiMet in trm6-504 strain (Kadaba et al. 2004).
Overall, these evidences suggest that Trf4p plays a role in adenylation of
hypomodified tRNAiMet, which is further required for its degradation. Rrp44p is the
3’-5’ exoribonuclease subunit found in both nuclear and cytoplasmic exosome
(Allmang et al. 1999b, Van Hoof, Lennertz & Parker 2000a, Mitchell et al. 1997),
which is introduced in part I. The exosome specifically binds with Rrp6p and Mtr4p
in the nucleus (Van Hoof, Lennertz & Parker 2000b, Allmang et al. 1999c, Briggs,
Burkard & Butler 1998). Rrp6p deletion could rescue the trm6-504 ts- phenotype,
causing an increased level of hypomodified tRNAiMet, while Ski2p deletion didn’t
affect hypomodified tRNAiMet level (Kadaba et al. 2004). It suggests that degradation
of hypomodified tRNAiMet happened in the yeast nucleus rather than in the cytoplasm,
by the exosome that is facilitated by Trf4p.
The continuous work in our lab further proved that, SUP3, the third suppressor
identified for trm6-504, is actually MTR4 gene through a complementation test (Wang
et al. 2008a). Mutation in Mtr4p conserved helicase domain motif (mtr4-20) cause
stabilization of hypomodified tRNAiMet as a polyadenylated species in vivo (Wang et
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al. 2008a). Mtr4p-20 can interact with Trf4p and assemble the TRAMP complex,
which displays polyadenylation activities in vitro just like wild-type complex (Wang
et al. 2008a). Taken together, hypomodified tRNAiMet is degraded by the exosome in a
TRAMP complex-dependent pathway in the nucleus. It’s still unclear how he
TRAMP complex recognizes and targets the hypomodified tRNAiMet. It could be
Air2p that mainly plays a role for RNA binding (LaCava et al. 2005). It has been
raised recently that Mtr4p may target tRNAiMet through its KOW domain, which only
bind with structured RNA(Johnson, Jackson 2013, Halbach, Rode & Conti 2012b,
Falk et al. 2014). A working model for the TRAMP complex has been proposed and
believed for a long time (Fig. 1-10). In this model, depending on Air2p bound with
the RNA substrates, Trf4p is able to polyadenylate the 3’end of the substrates.
Subsequently, Mtr4p could load onto the 3’ poly (A) extension that is created by
Trf4p, unwind the RNA substrates, and recruit the exosome for complete degradation.
A second model was proposed by a recent paper, in which the crystal structure of
TRAMP complex was reported (Falk et al. 2014). In their model, Trf4p polymerase
core is positioned just below the helicase core of Mtr4p. They propose that Mtr4p
unwind RNA duplex first then forward the single-stranded RNA to Trf4p for
polyadenylation. More knowledge on the activities of each subunit and how they
facilitate each other is required to analyze and distinguish between these models.
As a component of the TRAMP complex, we know Mtr4p plays a role as a
helicase in various RNA processing and degradation process including tRNAiMet
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Figure 1-10. Hypomodified tRNAiMet is degraded by the nuclear exosome, which requires the
TRAMP complex.
A. The TRMAP complex may target and bind with hypomodified tRNAiMet by Air2p or the KOW
domain of Mtr4p. Air2p binding is shown in this figure B. Trf4p adds poly (A) tail to the 3’ end of
hypomodified tRNAiMet. C. Mtr4p removes secondary structure of hypomodified tRNAiMet. D. Mtr4p
recruits the exosome directly or indirectly for complete degradation of hypomodified tRNAiMet. Mtr4p
is drawn in light grey, Air2p is shown in black, and Trf4p is represented by a white circle. Blue squares
represents the central structure of exosome, consist of 9 non-enzymatic subunits, forming the central
RNA channel. Red pie positioned at the bottom of exosome indicated Rrp44. The other red pie located
on top of the exosome is Rrp6.

turnover. But the how Mtr4p recognize and bind substrates, as well as how its distinct
structure differently displays the helicase activity are still unclear. How Mtr4p
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structural domains (arch domain, winged helix and ratchet domain) facilitate its
enzymatic functions in the regulation of tRNAiMet attracts our interests. In this
dissertation, I studied Mtr4p structural domains in cell and biochemically. I created a
library of Mtr4p structural domain mutants that were defective in tRNAiMet turnover.
The KOW domain mutations K700N, P731S, S672N and P802S, winged helix
mutation K904N, and ratchet domain mutation R1030G were studied. In vivo studies
suggest that structural domains in the helicase core are more important for tRNAiMet
turnover than the arch domain. The KOW domain and ratchet domain contributed to
RNA binding activities of Mtr4p in vitro. The winged helix domain had modest
effects on RNA binding in vitro, but showed greater effects on protein stability. The
KOW, winged helix and ratchet domain mutants do not affect ATP binding, but
influence ATPase hydrolysis. Overall, it revealed that residues in structural domains
affect Mtr4p enzymatic activities from different aspects. In addition, I showed that
single-stranded RNA is a preferred substrate for Mtr4p binding, and activates higher
enzymatic activity of Mtr4p. My results also demonstrate that, as a helicase, Mtr4p is
able to modulate the balance between unwinding and re-annealing in a concentration
and ATP dependent manner.
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CHAPTER II. MATERIALS AND METHODS

Part I. Plasmids and Oligonucleotides
All plasmids and oligonucleotides used in this study are listed in Tables 2-1
and 2-2.
Table 2-1. Plasmids.
Plasmid Description

References

pUG19

pUG19 empty vector

Stratagene

B129

GCD10 in YCplac33

J. Anderson

B184

YEplac195 vector

A. Hinnebusch

B187

YCplac111 vector

A. Hinnebusch

B281

4kb HA tagged MTR4 gene on pRS316

A. Tartakoff

B451

His-tagged Mtr4 ORF in pET15 expression vector

X. Wang

B534

Flag-tagged Trf4 and His-Tagged Air2 co-expressed on Petduet vector

X. Wang

B568

A 4kb fragment containing entire Mtr4 gene cloned into YEplac195 high

This study

copy number plasmid
B575

Mtr4-S672N mutant created from B451 by site-directed mutagenesis

This study

(Stratagene)
B577

Mtr4-P731S mutant created from B451 by site-directed mutagenesis

This study

(Stratagene)
B578

Mtr4-P802S mutant created from B451 by site-directed mutagenesis

This study

(Stratagene)
B573

Mtr4-K904N mutant created from B451 by site-directed mutagenesis

This study

(Stratagene)
B576

Mtr4-K700N mutant created from B451 by site-directed mutagenesis
(Stratagene)

This study
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Table 2-1. Plasmids (continued).
Plasmid Description

References

B579

This study

Mtr4-R1030G mutant created from B451 by site-directed mutagenesis
(Stratagene)

B493

pUG6, carrying geneticin resistant gene

EUROSCARF

B484

pAG32, carrying hygromycin resistant gene

EUROSCARF

B587

Mtr4-K904N mutant on Yeplac195 vector rescued from trm6-504 in

This study

dominant-negative screen
B586

2kb truncated mtr4 containing arch & C-terminal domain sequence

This study

(1472-stop codon) plus C-terminal downstream sequence (228bp) cloned
into YIplac211 plasmid
B580

Mtr4-S672N mutant created from B586 by site-directed mutagenesis

This study

(Stratagene)
B581

Mtr4-SK700N mutant created from B586 by site-directed mutagenesis

This study

(Stratagene)
B582

Mtr4-P731S mutant created from B586 by site-directed mutagenesis

This study

(Stratagene)
B583

Mtr4-P802S mutant created from B586 by site-directed mutagenesis

This study

(Stratagene)
B584

Mtr4-K904N mutant created from B586 by site-directed mutagenesis

This study

(Stratagene)
B585

Mtr4-R1030G mutant created from B586 by site-directed mutagenesis

This study

(Stratagene)
B587

YEplac195 plasmid carrying mtr4-904 mutant, rescued from
dominant-negative screen

This study
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Table 2-2. Deoxyoligonucleotides
* indicates the deoxyoligonucleotides used for Northern blot analysis.
OLIGO

TARGET

SEQUENCE

JA747

MTR4 arch and C-terminal domains

TTGGAGCATTCTTTCTTCCAA

JA748

MTR4 arch and C-terminal domains

AGCAGATACGATATCTCTATG

JA950

2kb truncated mtr4 containing accessory

NNNNNNGGTACCTTTCAAGAGGGA

domain sequence (1472-stop codon) plus

TTTTTGAAGGTGTTG

C-terminal downstream sequence (228bp)
JA951

2kb truncated mtr4 containing accessory

NNNNNNGAATTCCAGATACAGTGA

domain sequence (1472-stop codon) plus

GATACTATTTGGCTGG

C-terminal downstream sequence (228bp)
JA304

Genomic MTR4 5’UTR region

GGCTGAATATGCCATCGCACA

JA780

M13 sequence on YIplac211 plasmid

CGCCAGGGTTTTCCCAGTCACGAC

(M13 Forward Primer)
JA11 *

tRNAiMet

TCGGTTTCGATCCGAGGACATCAG
GGTTATGA

JA995*

7S rRNA

GGCCAGCAATTTCAAGTTA

JA125*

5.8S rRNA

GCGTTSTTCATCGATGC

JA99*

5S rRNA

TCGCGTATGGTCACCCACTACA

JA760

Forward primer for mtr4-S672N

CCGGCAAACGCCTTAAATTTCCTA

site-directed mutation

CAACCAGGC

Reverse primer for mtr4-S672N

GCCTGGTTGTAGGAAATTTAAGGC

site-directed mutation

GTTTGCCGG

Forward primer for mtr4-K700V

GCTGTTGTCGATTTTGCTAATAGA

site-directed mutation

ATTAACAAACGCAACC

Reverse primer for mtr4-K700N

GGTTGCGTTTGTTAATTCTATTAG

site-directed mutation

CAAAATCGACAACAGC

Forward primer for mtr4-P731S

GTATATAGACTCTTCAGTCAACTT

site-directed mutation

GTTGAAACCTTTCAACCC

JA761

JA910

JA911

JA758
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Table 2-2. Deoxyoligonucleotides (continued)
OLIGO

TARGET

SEQUENCE

JA759

Reverse primer for mtr4- P731S

GGGTTGAAAGGTTTCAACAAGTTG

site-directed mutation

ACTGAAGAGTCTATATAC

Forward primer for mtr4-P802S

GGGAGGTTAATCGGAGGTTCTCTG

site-directed mutation

ATGGTATTCCCGTGCTGG

Reverse primer for mtr4- P802S

CCAGCACGGGAATACCATCAGAGA

site-directed mutation

ACCTCCGATTAACCTCCC

Forward primer for mtr4-K904N

CCTAATGACATTATTGAACTGAAC

site-directed mutation

GGTAGAGTTGCATGTG

Reverse primer for mtr4- K904N

CACATGCAACTCTACCGTTCAGTTC

site-directed mutation

AATAATGTCATTAGG

Forward primer for mtr4-R1030G

GATCAGAATGTTCAAGGGATTAGA

site-directed mutation

GGAATTGGTG

Reverse primer for mtr4- R1030G

CACCAATTCCTCTAATCCCTTGAA

site-directed mutation

CATTCTGATCAAC

Forward primer for leu2 knock out with

ATGTCTGCCCCTAAGAAGATCGTC

hygromycinr gene, target 5' sequence of leu2

GTTTTGCCAGGTGACCACGTTGGTC

JA803

JA804

JA894

JA895

JA910B

JA911B

JA866

AGCCTCGTCCCCGCCGGGTCA
JA867

JA868

Reverse primer for leu2 knock out with

TTAAGCAAGGATTTTCTTAACTTCT

hygromycinr gene, target 3' sequence of

TCGGCGACAGCATCACCGACTTCG

leu2

GCAGTATAGCGACCAGCATTC

Forward primer for mtr4 knock out with

ATGGATTCTACTGATCTGTTCGATG

kanamycinr gene, target 5' sequence of mtr4

TTTTCGAGGAAACACCTGTTGAGCT
TAGGTCTAGAGATCTGTTTA

JA869

Reverse primer for mtr4 knock out with

CTATAAATACAAAGAACCAGCAGA

kanamycinr gene, target 3' sequence of mtr4

TACGATATCTCTATGAATTAATTTC
AATTAAGGGTTCTCGAGAGCT

JA874

Forward primer outside of 5' KpnI site to

GTGGGAAAAGGATCAGGAGAAAA

test Mtr4 deletion

TA
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Table 2-2. Deoxyoligonucleotides (continued)
OLIGO

TARGET

SEQUENCE

JA906

Forward primer to synthesize template of

NNNNNNGGATCCTAATACGACTCA

single strand RNA R108

CTATAGGGTTGAAACGTTAACAAA
TAATCGTAAATAATACACATACAC
TTACCCTACCACTCT

JA907

Reverse primer to synthesize template of

NNNNNNGGTACCCAAGTGAGGATG

single strand RNA R108

GCTATGGCATGTGGTAGTGGGATT
AGAGTGGTAGGGTAAGTGTATGTG
TATTATTTACGATTAT

JA947

Forward primer to synthesize template of

NNNNNNGGTACCTAATACGACTCA

single strand RNA R76

CTATAGGGTTGAAACGTTAACAAA
TAATCGTAAATAATACACATACAC
TTACCCT

JA948

Forward primer to synthesize template of

NNNNNNGGATCCGGCATGTGGTAG

single strand RNA R76

TGGGATTAGAGTGGTAGGGTAAGT
GTATGTGTATTATTTACGATTATTT
GTTAAC

JA322

KanamycinR gene reverse primer for testing

CTGCAGCGAGGAGCCGTAAT

MTR4 knockout

Part II: In vivo Yeast Techniques
Yeast Strains
Yeast strains used in this study were listed in Table 2-3. Genetic
manipulations of trm6-504 strain are described below.
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Table 2-3. Yeast Strains.
Strain
Y190
(trm6-504)
Y200

Genotype

Reference

MATa trm6-504, gcn2-101, his1-29, ura3-52, ino1 (HIS4-lacZ,

S. Kadaba

ura3-52)
MATa TRM6, gcn2-101, his1-29, ura3-52, ino1 (HIS4-lacZ,

S. Kadaba

(TRM6)

ura3-52)

F11

MATa, thr4

A. Hinnebusch

F12

MAT@, thr4

A. Hinnebusch

F56

MATa, his3Δ, leu2Δ, met15Δ, ura3Δ, MTR4

Open

MAT@, his3Δ, leu2Δ, lys2Δ, ura3Δ, mtr4::KanMX4

Biosystem

Y539

Y190 (leu2:: hygromycinr)

This study

Y540

Y539 transformed with pRS316 plasmid carrying HA-tagged

This study

MTR4 (B281 plasmid)
Y541

Y540 (mtr4:: kanamycinr)

This study

Y542

Y190 with wild-type MTR4-URA3 integrated into genomic MTR4

This study

locus (mtr4:: MTR4-URA3)
Y543

Y190 with mtr4-S672N-URA3 integrated into genomic MTR4

This study

locus (mtr4:: mtr4-672-URA3)
Y544

Y190 with mtr4-K700N-URA3 integrated into genomic MTR4

This study

locus (mtr4:: mtr4-700-URA3)
Y545

Y190 with mtr4-P731S-URA3 integrated into genomic MTR4

This study

locus (mtr4:: mtr4-731-URA3)
Y546

Y190 with mtr4-P802S-URA3 integrated into genomic MTR4

This study

locus (mtr4:: mtr4-802-URA3)
Y547

Y190 with mtr4-K904N-URA3 integrated into genomic MTR4

This study

locus (mtr4:: mtr4-904-URA3)
Y548

Y190 with mtr4-R1030G-URA3 integrated into genomic MTR4

This study

locus (mtr4:: mtr4-1030-URA3)
Y549

Y547 without URA3 (mtr4:: mtr4-904)

This study
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Yeast Transformation
Cells were streaked on YPD plate and grown at 30 oC for 3 days. A single
colony was inoculated into 5 ml of YPD liquid medium and grown overnight at room
temperature on a roller drum. The cells were diluted to an OD600 of 0.2 in 30 ml of
fresh YPD medium, incubated at 30oC with shaking at 225 rpm until reached OD600
of 1.0. The cells were harvested at 5000 rpm with a refrigerated centrifuge
(Eppendorf 5804R) at 4oC. The cell pellets were washed with 15 ml of sterile water,
spun down as above. The cell pellets were resuspended in 300 µl of sterile water and
transferred into a fresh microcentrifuge tube. The cells were pelleted at 6000 rpm in a
tabletop centrifuge, resuspended in 300 µl sterile water and stored at 4oC. Standard
transformation mixture was set up in a total volume of 400 µl, which consisted of
0.1~1µg target DNA in 72 µl sterile water, 3 µl of preheated 10 mg/ml sheared
salmon sperm DNA, 35 µl of 1M Lithium Acetate, 240 µl of 50% PEG 3350, and 50
µl of prepared cell suspension. The transformation mix was mixed by vortexing at a
low speed (less than 6). The transformation reactions were incubated at 30 oC for 1
hour by vortexing intermittently at every 15 min, followed by heat shock in 42 oC
water bath for exact 15 min. The transformation was mixed with1 ml sterile water,
spun down in the tabletop centrifuge at top speed for 30 sec. Supernatant was
discarded, the cells were washed with 1ml sterile water and centrifuged as above. The
cells were finally resuspended in 300 µl sterile water, and 100 µl of it was spread on
indicated plates, which would be incubated at appropriate temperature for up to 3
days or until transformants grew.
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Error-prone PCR
Error-prone PCR was designed (Cadwell, Joyce 1994) to introduce on average
2 mutations in the ~1400 bp MTR4 sequence encompassing the arch domain and C
terminus (Fig. 2-1 A). PCR was set up in 1x Taq polymerase buffer, 7 mM MgCl2,
0.5 mM MnCl2, dATP mix (0.2mM dGTP, 0.2mM dATP, 1mM dCTP, 1mM dATP),
20 fmoles of DNA template (B589), 30 pmoles of each primer, and 5U/100ul Taq
polymerase. Varied ratio of dNTPs was used to induce random mutations. Increased
MgCl2 is to stabilize noncomplementary base pairs. MnCl2, functions to diminish the
complementation specificity, is directly related with mutation rate. To determine ideal
Mn2+ concentration, different MnCl2 concentrations between 0.01mM ~0.5mM
MnCl2 were tested in Mutagenic PCR, followed by TA cloning into pGEMT easy
vector (Progema). Ligation products were transformed into DH5a cells (New England
Biolabs), which were grown on LB/Ampicillin/IPTG/X-Gal plates for Blue/White
screening. White colonies from each plate with different MnCl2 concentration was
picked, underwent mini plasmid prep (Promega), and sequenced to determine
mutation rate. 0.05mM MnCl2 was selected for mutagenic PCR to introduce
1~2mutations/1000bp.

Dominant-negative Screen

Yeast high-copy number plasmid YEplac195 (HC) harboring the entire
wild-type MTR4 gene was digested at two restriction sites BClI and BStEII,
generating a ~1000bp gapped vector with 200~300bp complementary to each end of
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A. Experimental design of dominant-negative screen. MTR4 ORF is composed of N-terminal helicase
domains, followed by half of the winged helix domain, the arch domain, the other half of the winged
helix, and the ratchet domain. Black box represents N-terminal helicase domains. A white box
indicates the arch domain. Winged helix and ratchet domains are shown in grey. Mutagenic PCR
region covers the entire arch domain, C-terminal half of the winged helix domain and most of the
ratchet domain. BstEII and BclI restriction sites are present ~200bp inside each end of the mutagenic
PCR region. Asterisks indicate potential mutations by made by mutagenic PCR. YEplac195 high-copy
plasmid (HC plasmid) harboring MTR4 ORF was digested with BstEII and BclI, generating a ~1000bp
gapped vector with 200~300bp complementary to each end of the PCR products. trm6-504 was
transformed with both gapped YEplac195 and PCR products, which underwent homologous
recombination in vivo. B. Schematic representation of the wild-type TRAMP complex in trm6-504.
Endogenous wild-type Mtr4p is drawn in light grey, Air2p is shown in black, and a white circle
represents Trf4p. The TRAMP complex is represented by assembly of Air2p, Trf4p and Mtr4p. Mtr4p
exits both inside and outside of the TRAMP complex. C. Schematic representation of the mutant
TRAMP complex when trm6-504 when transformed with mutagenic PCR products and YEplac195
harboring gapped MTR4 ORF. Mtr4p mutants, shown in dark grey, expressed at high copy number
level and replaced wild-type Mtr4p in TRMAP complex.

the error-prone PCR products. Y190 (trm6-504), a tRNA methytransferase yeast
mutant, is temperature sensitive (ts-) due to degradation of hypomethylated tRNAiMet.
Y190 was transformed with the mutagenic PCR products and the gapped vector,
which underwent homologous recombination, resulting in stable plasmid
transformants (Fig. 2-1A). The plasmid contains full-length MTR4 gene, which is
consist of wild-type N-terminal helicase domains and mutagenic arch & C-terminal
domains recombined from PCR products. Defects in Mtr4p function will lead to
initiator tRNAiMet accumulation, which can in turn rescue the trm6-504 ts- phenotype.
A dominant-negative screen was performed for Mtr4 mutants that are defective in
tRNAiMet turnover. If Mtr4 mutant protein can replace endogenous wild-type Mtr4
protein in the TRAMP complex and cause defects in tRNAiMet turnover, trm6-504 tsphenotype would be rescued (Fig. 2-1B). The screen for trm6-504 suppressor-like
phenotype performed at 33°C, a semi-restrictive temperature. The mutant plasmids
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causing phenotype suppression of trm6-504 were rescued from yeast, sequenced, and
then retested in trm6-504 transformations to confirm the phenotype.

Creation of MTR4 Knockout Strain

Procedures of creating MTR4 knockout strain with trm6-504 genetic
background are shown in Figure 2-2. First, LEU2 gene was replaced by hygromycin
resistance (Hygr) gene through homologous recombination in trm6-504 to provide
additional selection marker (Fig. 2-2). Hygr gene was amplified using primers JA866
and JA867 with LEU2 complementary sequence on each end. PCR products were
cleaned up with Wizard SV gel and PCR Clean-Up System (Promega). 50 µl
trm6-504 competent cells (prepared with standard Yeast transformation procedures)
were transformed with ~1µg PCR products, recovered for 3 hrs by shaking in YPD
media at 30oC before plating (YPD- Hygromycin plates). Colonies were printed onto
another fresh YPD- Hygromycin plate by replica plating for a second selection.
Successful LEU2 deletion was further confirmed by cell viability on
YPD-Hygromycin plate and inviability on SC-Leu plate.
Since MTR4 is essential, trm6-504 (LEU2:: Hygr) was first transformed with
wild-type MTR4 on pRS316 vector expressing Ura3p to support the growth (Fig 2-2).
Next, the entire chromosomal MTR4 gene was replaced by geneticin resistance (Kanr)
gene using the same method as LEU2 knockout (Fig. 2-2). Primers JA868 and JA869
were used to amplify Kanr gene on pAG32, added complementary sequence on each
end targeting MTR4 locus. MTR4 knockout (MTR4Δ) was confirmed by PCR using
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Figure 2-2. Schematic representation of MTR4 knockout in trm6-504 strain.
Chromosome is represented by a black line, and plasmid is drawn by a circle. Genotypes are described
with blue words under each yeast cell. Recombined genes are shown in red. The chromosomal LEU2
was knockout first and replaced by a hygr gene to provide additional genetic marker, followed by
transformation with pRS316 harboring wild-type MTR4 gene. Then the chromosomal MTR4 was
knockout and replaced by kanr gene. Wild-type Mtr4p expression from pRS316 kept cells viable since
MTR4 is an essential gene. Then the MTR4 knockout strain was transformed with mtr4 mutants on
YEplac111, followed by replica printing onto 5’FOA to remove URA3 marker plasmids pRS316
harboring wild-type MTR4. Finally mtr4 mutants on LEU2 marker plasmid YEplac111 became the
only copy of MTR4 gene in trm6-504 (LEU2:: Hygr; MTR4:: Kanr) strain.

forward primer that targets MTR4 5’ UTR and reverse primer targeting Kanr ORF.
trm6-504 (LEU2:: Hygr; MTR4:: Kanr) strain was subsequently transformed with
YCplac111 single-copy plasmids (with LEU2 marker) harboring HA tagged MTR4
single mutants. The transformants were plated on 5’FOA to eliminate wild-type
MTR4 plasmid pRS316.

Creation of Mutant Integrated trm6-504 Strains
To create MTR4 mutation on the chromosome in trm6-504 strain, a truncated
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wild-type MTR4 sequence that contains the arch & C-terminus (1472-stop codon)
plus 228 bp C-terminal downstream sequence was cloned into an integrative plasmid
YIplac211 (Fig. 2-3). The mutant constructs were made by site-directed mutagenesis
2
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3’UTR
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BspEI

1
2kb mtr4 + 3’UTR
full length
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Figure 2-3. Creation of mtr4 mutant integrated trm6-504 strain.
The left bottom red circle represents the constructed YIplac211 plasmid (1). The black box represents
the truncated MTR4 gene, that contains ~2kb C-terminal half of MTR4 but lacks N-terminal helicase
domain. Asterisk indicates single mutation in the arch domain or C-terminal region. Light grey box
indicates the 3’UTR of MTR4. The constructed YIplac211 plasmid was linearized by BspEI, which
cuts upstream of the arch domain. The scissors and arrow points to the BspEI digestion site. Dotted box
shows the URA3 marker on the plasmid. This is followed by trm6-504 transformation (2), resulting in
plasmid integrated onto chromosome by homologous recombination (3). “X” indicates site of
recombination happened at the free ends of the linear plasmid. Sequence of the plasmid is shown with
red line or red lined box. The integrated chromosome (4) contains a full-length MTR4 mutant gene that
is consist of N-terminal helicase region from the chromosome, and C-terminal arch, WH & ratchet
domains from the plasmid. It is followed by the rest of the plasmid including ~200bp 3’UTR and the
URA3 marker. Further downstream is a truncated MTR4 that contains the chromosomal sequence of the
C-terminal half.

(Stratagene). YIplac211 plasmids harboring wild-type or mutant truncated MTR4
gene were linearized by BspEI restriction enzyme (NEB). This was followed by
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trm6-504 transformation with 1 µg of linear integrative plasmid, which integrated into
chromosomal MTR4 locus via homologous recombination. It resulted in a full length
MTR4, which contains the chromosomal N-terminal half of the gene, integrated
C-terminal half that had mutations, followed by the integrated C-terminal downstream
sequence, and the rest of the plasmid including URA3 marker (Fig. 2-3). The
C-terminal half of the original chromosomal MTR4 existed further downstream but
maintain inactive without promoter region and N-terminal helicase half of the gene
(Fig. 2-3). Integration was tested by PCR using a forward primer targeting the 5’
promoter region and a reverse primer targeting YIplac211 plasmid. Genomic DNA of
the integrated strains was also isolated and mutations were confirmed by sequencing.

Isolation of Total Cell Protein from Yeast

Cells were streaked on YPD plate and grown for 3 days. A single colony was
inoculated into 2 ml of YPD media, and grown overnight at RT on a roller drum.
Saturated culture was diluted to OD600 0.2 with fresh YPD media, grown at 30 oC by
shaking at 225 rpm to OD600 1. Cells were harvested at 30000 x g at 4 oC for 10 min,
and washed with 20 ml of cold 1x TBS buffer (150 mM NaCl, 2 mM KCl, 25 mM
Tris pH 7.5). The cells were pelleted as above, resuspended in residual liquid and
transferred into fresh microcentrifuge tubes. Cells were pelleted in a tabletop
centrifuge for 1min at top speed. Supernatants were removed, cell pellets were
weighed and resuspended in cold breaking buffer (1X TBS, 1 mM DTT, 1/5 of
cOmplete protease inhibitor cocktail tablet EDTA free (Roche)) at a ratio of 2 ml
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buffer /1g wet cells. 250 µl of acid-washed glass beads (Sigma) were added to the
resuspended cells. The cells and glass beads mixtures were vortexed 5 times, each
time with 15 sec vortexing followed by 30 sec ice incubation. Cell and glass beads
mixtures were centrifuged at 14, 000 x g for 10 min at 4oC, and supernatants were
carefully taken out by U-100 1cc insulin syringe (28G, ½ inch) (Becton Dickinson) to
avoid sucking up any glass beads, and transferred into fresh pre-chilled
microcentrifuge tubes. This was followed by another centrifugation as above to
remove insoluble part in the total cell protein. Supernatant was transferred into a new
tube, and Bradford assays were performed to determine protein concentrations.
Proteins were mixed with 4x laemmli buffer and stored at -20 oC.

Western Blotting
Protein samples were prepared with 4x Laemmli buffer, denatured at 85 oC for
5 min and loaded on 8 % SDS-PAGE gel (Table 2-4) with equal amount. Protein
samples were separated by running in a Biorad minigel apparatus at 150 Volts for 90
min with 1x SDS-glycine running buffer (Table 2-4). PageRuler prestained protein
ladder (Thermo Scientific) was used to visualize protein size. Proteins were
transferred onto a nitrocellulose membrane (Pall Corporation) in an Invitrogen
XCELL II Mini Cell at 30 Volts for 90 min, which was performed in 1X transfer
buffer (Table 2-4) at 4 oC. The nitrocellulose membrane was stained with ponceau
stain solution (Table 2-4) to visualize if proteins were successfully transferred, and
thoroughly washed by 1X PBST (Table 2-4) 3 times (5min each) to remove any
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ponceaus. 5% milk was made with PBST, dissolved over 30 min at RT with
continuous stirring, and adjusted to pH 7.5. Membrane was blocked in 5% milk for 1h
at RT, and followed by primary antibody (1:5000 dilution in 5% milk-PBST)
incubation overnight on a nutator at 4oC. The membrane was washed in 1X PBST
with gently shaking 3 times at RT (10 min each time), and incubated with secondary
antibody (1:5000 dilution in 5% milk-PBST) at RT for 90 min with gently shaking.
The blot was washed 3 times with PBST and 1 time with PBS at RT (10 min each),
developed with ECL reagents (Table 2-4) and visualized by exposing to an X-ray
film.
Table 2-4. Reagents Used in Western Blotting.
Buffers and Reagents

Composition

4X Laemmli Buffer w/DTT

60 mM Tris-HCl pH 6.8, 10% glycerol, 0.005% Bromophenol
Blue, 50 mM DTT

10x Tris-Glycine SDS Running

250 mM Tris, 2.5 M Glycine, 1% SDS

Buffer
8% SDS Separating Gel

8% 37.5:1 Acrylamide, 0.375 M Tris (pH 8.8). 0.1% SDS,
0.1% APS, 0.04% TEMED

5% SDS Stacking gel

5% 37.5:1 Acrylamide, 0.1875 M Tris (pH 6.8), 0.05% SDS,
0.05% APS 0.05% TEMED

Ponceau Stain

0.1% (x/v) Ponceau S in 1% (v/v) acetic acid

10X PBS

1.37 M NaCl, 27 mM KCl, 100 mM Na2HPO4, 18 mM
KH2PO4. Adjust pH to 7.5 when diluting to 1X.

1X PBST

1 X PBS with 0.1% NP-40

10X Transfer Buffer

480 mM Tris, 390 mM Glycine, 0.375% SDS

1x Transfer Buffer

100 ml 10 X transfer buffer, 200 ml Methanol, 700 ml sterile
water

ECL Reagents

Solution I
265 µl 1.875 M Tris-HCl pH 8.8, 50 µl luminal (44 mg/ ml
DMSO), 22 µl p-cumaric acid (15 mg/ ml DMSO), 4.66 ml
sterile ddH2O
Solution II
265 µl 1.875 M Tris-HCl pH 8.8, 3µl 30% Hydrogen
peroxide, 4.73 ml sterile ddH2O
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Total RNA Isolation from Yeast
Yeast cells were prepared as above in protein isolation. The harvested cells
were resuspended in AE buffer (Table 2-5) at a ratio of 2.5 ml/g cell, with 1/10
volume of 10% SDS in a 50 ml conical tube. 1.2 volumes of pre-warmed 65 oC
phenol was added to the cells, and incubated in 65 oC water bath for 5 min with
intermittent vortexing. Samples were cooled down on ice for 2 min, and followed by
separation of aqueous and organic phases by centrifugation at 3000 x g (Eppendorf
5804R) at RT for 10 min. The lower organic phase was carefully taken out, leaving
the aqueous phase, interphase and cells in the same tube. Re-extraction was repeated
with equal volume of 65oC preheated AE-saturated phenol as above. After
centrifugation, the aqueous phase was removed, transferred into a new 50 ml conical
tube, extracted with an equal volume of Chloropane (Table 2-5). This was followed
by vortexing for 2 min, and separating phases by centrifugation as described. The
aqueous phase was transferred into another fresh 50 ml tube, extracted with equal
volume of chloroform -isoamyl alcohol (24:1) (Table 2-5), and centrifuged as above
to get aqueous phase. The aqueous phase was separated into different microcentrifuge
tubes with adding 1/10 volume 3 M NaAc pH 5.3 and 2.5 volumes EtOH. RNA was
precipitated at -20 oC overnight. The following day, RNA was pelleted at 15000 x g
in a tabletop centrifuge at 4 oC for 15 min. Supernatant was decanted, and RNA was
washed with 1 ml of 70% ethanol and centrifuged as above. RNA pellets was
air-dried for 10 min in hood, and dissolved with 50 µl of DEPC-treated dH2O. RNA
concentration was determined at OD260 by Nanodrop.
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Table 2-5. Reagents Used in Yeast Protein Isolation
Buffer and Reagents

Composition

AE Buffer

50 mM NaAc pH 5.0, 10mM EDTA

ANE Buffer

10 mM NaAc pH 6.0, 100mM NaCl, 1mM EDTA

AE-saturated Phenol

500ml of phenol was liquefied at 68oC in brown
bottle, adding 0.5% 8-hydroxy quinolone and
500ml of dH2O, stir until dissolved and allow
phase separating at 4oC overnight. The following
day, upper aqueous phase was removed by
vacuum aspiration. Phenol was saturated with
equal volume of AE buffer, stir to mix and allow
phase separating overnight at 4oC. Test pH of the
lower organic phase using pH indicator strips.
Repeat AE saturation if necessary until phenol
reaches pH 4~5.

Chloropane

100 ml liquefied phenol, 100ml chloroform,
equilibrated with 100 ml ANE buffer (10 mM
NaAc pH 6.0, 100 mM NaCl, 1mM EDTA)

Chloroform- isoamyl Alcohol (24:1)

Mix 12 ml of Chloroform with 1ml of isoamyl
alcohol, mix well, make fresh every time.

Northern Blotting
6% denaturing PAGE gel (8M Urea) was prepared as described (Table 2-6),
pre-running for 30 min at 450 V before loading. 10 µg RNA samples were mixed with
2X RNA loading dye (Table 2-6), heated at 95 oC for 3 min right before loading,
separated on the gel in 0.5X TBE buffer (Table 2-6). Gel was left on one piece of the
glass plate, wrapped with two rubber bands to stabilize, gently shaking in fresh 0.5 X
TBE buffer for 20 min to remove extra urea. This was followed by transferring onto a
Hybond-N+ membrane (GE Healthcare) at 12 V for 5 h in 0.5 X TBE at 4 oC. RNA
blots were subsequently UV-crosslinked (UVP CL-1000 Ultraviolet Crosslinker), and
pre-hybridized with hybridization buffer (Table 2-6) at 55 oC in a hybridization oven
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(Hybraid) for 1 h. Radiolabelled deoxyoligonucleotide probes were prepared as
described (Kadaba, Wang & Anderson 2006). Briefly, the radiolabelling reaction was
performed at 37 oC for 1 h in 50 µl volume, which contains 10 picomoles of indicated
deoxyoligonucleotides, 5 µl of 10 X T4 polynucleotide kinase (PNK) buffer (NEB), 5
µl of γ-32P-ATP (＞5000 Ci/mmol, 10 uCi/µl stock) and 1µl PNK enzyme (10
units/µl, NEB). Another 1 µl of PNK enzyme was added to the reaction at 30 min of
incubation for better labeling. 1 ml of G-50 sephadex resin was prepared in a
microspin centrifugation column by repeating centrifugation at 2000 X g until 100 µl
dH2O could be collected back when adding 100 µl. The 50 µl radiolabelling reaction
was mixed with 50 µl sterile dH2O, mixed well, and spun through the prepared G-50
sephadex resin in microspin column at 2000 X g to remove extra unincorporated γ
-32P-ATP. Exactly 5ml of hybridization buffer was added to the pre-hybridized blot,
with 10 µl of preheated radiolabelled probe. Hybridization reaction was performed at
55oC rolling in the hybridization oven overnight. Blots were subsequently washed in
2 X SSC (Table 2-6) at 55 oC for 1 hour to remove any unspecific binding. Signal was
detected by phosphorimager (Molecular Dynamics), and quantified by the
ImageQuant 7.0 software. In some cases, blots were washed with 1% boiling SDS by
shaking for 1 h to remove any radiolabel, and ready to be exposed to another
radiolabelled deoxyoligonucleotide probe.
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Table 2-6. Reagents Used in Northern Blotting.
Buffers

Composition

6% Denaturing Polyacrylamide-Urea Gel

3.75 ml of 40 % acrylamide (19:1, EMD
chemicals), 5 ml 5 X TBE, 5 ml dH2O, 12 g urea
were mixed together in a beaker, heating while
stirring to dissolve all the urea, volume to 24.75
ml, filter by 0.2 µm nylon syringe filter. 250 µl
10% Ammonium persulphate (Sigma) and 9 µl
TEMED were added to the prep before pouring.
The two glass plates were prepared by
Sigma-Coat for easy peel, and stabilized by large
clamps. Gel prep was added between glass plates
and allow at least 30 min to polymerize.

5X TBE

1.1M Tris, 900 mM Borate, 25 mM EDTA, filter
and adjust pH to 8.0

Hybridization Buffer (pH 8.0)

0.25 M Sodium Phosphate Dibasic (pH 7.5), 1
mM EDTA, 1% BSA, 7% SDS

2x RNA Loading Dye

80% Formamide, 10mM EDTA pH 8.0, 1 mg/ml
Xylene cyanol FF, 1 mg/ml Bromophenol Blue

20x SSC (pH 7.0)

175.3 g NaCl, 88.2 g sodium citrate dissolved in
~700ml distilled water, adjust pH to 7.0, finalize
volume to 1liter and autoclave to sterilize.

Genomic DNA Isolation
A single colony was inoculated in 2 ml of YPD media, and grown overnight at
RT on a roller drum. 1.5 ml of saturated culture was transferred into a microcentrifuge
tube and harvested by spinning at 14,000 X g in a tabletop centrifuge for 2 min. Pellet
was washed with 0.5 ml sterile water and spun as above. Pellet was vortexed to break
up in residual liquid, and added with 0.2 ml of Extraction Buffer (10 mM Tris-Cl pH
8.0, 1.5 mM EDTA pH 8.0, 100 mM NaCl, 2% Triton X-100, 1% SDS), 0.2 ml of
phenol/chloroform/isoamyl alcohol (25:24:1; near neutral pH), and 0.3 g of acid
washed glass beads (Sigma 425-600 microns). Samples were vortexted vigorously for
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4 mins. 0.2 ml of TE (pH 8.0) was added, and phases were separated by
centrifugation at 14,000 x g for 5 min. Aqueous layer was transferred into a fresh
microcentrifuge tube. Genomic DNA was precipitated with 1ml of 100% Ethonal,
centrifuged at 14,000 x g in a tabletop centrifuge at RT, and resuspended in 0.4 ml of
TE. Subsequently, samples were added with 3 µl of 10 mg/ml RNaseA, incubated at
37 oC for 5 min. DNA was precipitated by 10 µl of 4 M ammonium acetate and 1 ml
of 100% Ethonal, and centrifuged at 14,000 x g for 2 min at RT. DNA pellets were
washed with 1 ml of ice-cold 70% ethonal, and pelleted by centrifugation as above.
With air dry for up to 10 min, genomic DNA was finally resuspended in 50 µl of
sterile water.

Plasmid Rescue from Yeast

5 ml of indicated overnight YPD culture was harvested by spinning at 14,000
x g for 5min. Solutions provided in Wizard plus SV Minipreps DNA Purification
system (Promega) were utilized for yeast plasmid rescue. 250 µl of Cell
Resuspentsion Solution was added to the cell pellets and mixed well by vortexing or
pipetting. Subsequently 250 µl of Cell Lysis Solution and 250 µl acid-washed glass
beads (Promega) were added to the cells, vortexing for 5 min. This was followed by
adding 350 µl of Neutralization Solution, mixing by inverting the tubes and
centrifugation for 10 min at 14,000 x g. Clear supernatant were transferred into the
Spin Column, avoiding any glass beads, followed by spinning at top speed for 1min.
Column was washed twice with 750 µl and 250 µl Wash Solution separately. Rescued
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plasmids were finally eluted by adding 50 µl sterile water and the concentration was
determined by Nanodrop.

Spot Test by Serial Dilution

A single colony of indicated strains was picked and inoculated in YPD or
selective media, grown overnight until saturation. The first dilution was 1000 X
dilution from overnight culture, mixing 1µl of saturated culture with 999 µl of sterile
water. The second dilution was 10 X dilution from the first one, adding 100 µl of
well-mixed first dilution into 900 µl sterile water. Similarly, The third dilution was 10
X diluted from the second one, while the fourth dilution was 10 X diluted from the
third one. 5 µl of each dilution was spotted on indicated growth plates in a row, and
grown under appropriate temperature.

Part III. In vitro Biochemical Techniques
Recombinant Mtr4p Induction Expression

Recombinant Mtr4 protein was expressed in BL21 (DE3) competent E. coli
cells by auto-induction (Studier 2005, Jackson et al. 2010). Media and buffers used in
auto-induction are listed in Table 2-7. A single BL21 transformant was inoculated in
2 ml of P-0.5G minimal media, grown overnight at 37 oC until saturation. P-0.5G
minimal media makes the cells grow at high densities without expressing target
proteins. Saturated cells were transferred into 1 liter of ZY media in a 4-liter flask that
improves aeration. Cells grew at 37 oC overnight in an orbital shaker at 290 rpm. The
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following day, growth temperature was adjusted to 20 oC with shaking at 190 r.p.m
for 30 hrs to induce Mtr4 expression. Cells were collected and stored at -80 oC.
Table 2-7. Reagents Used in Autoinducation.
Media/Buffer

Composition

20 x NPS

0.5 M (NH4)2SO4, 1 M KH2PO4, 1 M Na2HPO4

50 x 5052

25% glycerol, 2.5% glucose, 10% alpha-lactose

1000 x Trace Metal Mix

50 mM FeCl3, 20 mM CaCl2, 10 mM MnCl2, 10 mM ZnSO4, 2
mM CoCl2, 2 mM CuCl2, 2 mM NiCl2, 2 mM Na2MoO4, 2 mM
Na2SeO3, 2 mM H3BO3

P-0.5G Minimal Media

1 mM MgSO4, 0.1 x Trace Metal Mix, 0.5% glucose, 1x NPS,
50 µg/ml Ampicillin

ZY Media (1L)

10 g tryptone, 5 g yeast extract, 1 mM MgSO4, 1 x Trace Metal
Mix, 1 x 5052, 1 x NPS, 50 µg/ml Ampicillin

Recombinant Mtr4p Purification
Cell pellets were resuspended in equilibration buffer (50mM sodium
phosphate pH 7.4, 10 mM β-ME, 10% Glycerol, with complete EDTA-free protease
inhibitor cocktail (Roche)), followed by disrupted by sonication. Cell lysate was
clarified by centrifugation at 40,000 x g for 30 min at 4 oC, and loaded onto a column
(connected with a pump) that contains 2 ml of pre-equilibrated His60 Ni superflow
Resin (Clontech). His-tagged Mtr4p was bond with the Ni resin via column loading.
Subsequently, the resins were washed with 10-column volumes of equilibration buffer
that contains 20 mM imidazole. Recombinant Mtr4 protein was finally eluted in 10 ml
of the same buffer containing 300 mM imidazole, and concentrated by Macrosep
advance centrifugal devices (Pall Corporation). Purified Mtr4 protein underwent gel
filtration chromatography, which was performed in gel filtration buffer (20 mM
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HEPES (pH 7.5), 150 mM NaCl, 1 mM DTT), using HiPrep 16/60 Sephacryl S-200
column (GE Healthcare). Protein fractions that contained pure Mtr4 were collected
and concentrated using Macrosep advance centrifugal devices (Pall Corporation).
Protein aliquots were stored at -80 oC in a buffer containing 50 mM sodium phosphate
pH 7.4, 10 mM β-ME and 20% Glycerol.

In vitro Reconstitution of the TRAMP Complex

In vitro TRAMP reconstitution was modified from previous description (Jia et
al. 2011b). Procedures are described in details in Fig. 2-4. Recombinant His-tagged
wild-type or mutant Mtr4p was overexpressed in BL21 (DE3) competent E. coli cells
(NEB) by auto-induction (described above). Recombinant Flag-tagged Trf4p and
His-tagged Air2p were also co-overexpressed by the same method. Cells were
collected and weighed. 100 mg of each kind of cells (Mtr4 expressing cells &
Trf4-Air2 expressing cell) were separately suspended in 1 ml of equilibration buffer
(50 mM NaH2PO4 pH 7.0, 250 mM NaCl, 1 mM ZnCl2, 10% glycerol, with cOmplete
EDTA-free protease inhibitor cocktail (Roche)). This was followed by sonication
disruption and centrifugation. Supernatants were mixed in a ratio of 800 µl of Mtr4
expressing cell lysate (mutant or wild-type) to 100 µl of Trf4-Air2 expressing lysate.
Another 100 µl of Trf4-Air2-expressing cells were mixed with 800ul equilibration
buffer as a negative control. Cell mixtures were rotating on a nutator at 4oC overnight,
which allows the complex assembly. 50ul of EZ-view red anti-Flag M2 affinity gel

59

His
Air2

Western Blotting by Anti-his Ab

Mtr4

Trf4

His

Flag

Sonication
Centrifuge

Sonication
Centrifuge
1

His
Air2

:
8
Mix
soluble TCP)

Trf4

Mtr4

Flag

His

An
m ti-F
BE Ab LA
G
AD
S

Flag Purification

His

His

Air2

Air2
Trf4

Overnight

Mtr4

Trf4

incubation
Flag
His

Flag

Mtr4
His

Figure 2-4. Schematic representation of TRAMP reconstitution.
His-tagged Mtr4p is drawn in light grey, his-tagged Air2p is shown in black, and Flag-tagged Trf4p is
represented by a white circle. Cells co-expressing Trf4p and Air2p were collected and sonicated in one
tube, while equivalent cells expressing Mtr4p were sonicated in another independent tube. Soluble
proteins were mixed at a ratio of 1 time of Trf4p-Air2p to 8 times of Mtr4p, gently rotating overnight
for reconstitution. This was followed by Flag purification which precipitates Trf4p. Pull-down of
Mtr4p and Air2 was tested by western blot using anti-his antibody.

(Sigma-Aldrich) was pre-equilibrated in separate microcentrifuge tubes. The
overnight cell lysate mixtures were added to the tubes containing Flag resins,
incubated on the nutator for 3 hrs at 4 oC. This was followed by three washes with the
equilibration buffer. Each wash was performed with gently shaking for 10 min on the
nutator followed by centrifugation at 10,000 x g. The reconstituted TRAMP comples
was finally eluted by directly adding 4X laemmli buffer to the Flag resins. Samples
were heated at 95 oC for 5 min, and spinning for 1min at top speed before loading to
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avoid sucking up any resins. Pull-down of Mtr4p and Air2p were detected by western
blotting using anti-his antibody (Calbiochem).

Design of Single-stranded RNA and in vitro RNA Synthesis

75nt single-stranded RNA (R75) (Table 2-8) and 108nt single-stranded RNA
(R108) (Table 2-9) were designed by random sequence. RNA fold web server was
used to determine RNA structure and calculate minimum free energy (MFE).
Sequence with a MFE between 0 kcal/mol ~ -10 kcal/mol was determined as single
strand (Mathews et al. 1999, Mathews et al. 2004, Zuker, Stiegler 1981, Wuchty et al.
1999). R75 has a MFE at -0.10 kcal/mol and the R108 has a MFE at -7.4 kcal/ mol.
DNA template for R75 was constructed with a T7 promoter for in vitro transcription,
with KpnI and BamHI restriction sites on 5’ and 3’ end (Fig. 2-5). Forward and
Reverse primers (listed in Table 2-2, detailed in Table 2-8) that shared a 40 nt overlap
region were designed for an overlap PCR to produce target DNA template (Table 2-8).
PCR reactions were set up in a total volume of 10 ul, which was consist of 1 X Taq
polymerase buffer, 1 nmole of forward primer, 1 nmole of reverse primer, 10 mole of
dNTPs mix, 1.5 mM MgCl2, and 2.5 unit Taq Polymerase. First, reactions without
Taq polymerase were incubated at 94 oC denaturing for 10 min. This was followed by
primers annealing sequentially at 75 oC, 65 oC, and 55 oC, each for 5 min.
Subsequently, reactions were stopped, added with 2.5 unit Taq polymerase
immediately, and followed by 72 oC extension for 20 min. The PCR products and
pUC19 vector were double-digested by KpnI and BamHI restriction endonucleases
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(NEB), ligated, and transformed DH5a cells (Fig. 2-5). Successful transformants were
selected by Blue-white screening on LB/Ampicillin/IPTG/X-gal, and confirmed by
sequencing. R75 template plasmids were linearized by BamHI prior to in vitro
transcription reaction that was performed at 37 oC for 4 hrs by using T7 RiboMAX
Express Large Scale RNA Production System (Promega). Promega protocol was
followed for in vitro transcription. RNA concentration was determined at OD260 by
Nanodrop.
Table 2-8. R75 Related Sequences
Forward Primer

NNNNNNGGTACCTAATACGACTCACTATAGGGTTGAAACGT
TAACAAATAATCGTAAATAATACACATACACTTACCCT

Reverse Primer

NNNNNNGGATCCGGCATGTGGTAGTGGGATTAGAGTGGTA
GGGTAAGTGTATGTGTATTATTTACGATTATTTGTTAAC

Template DNA Sequence

NNNNNNGGTACCTAATACGACTCACTATAGGGTTGAAACGTT
AACAAATAATCGTAAATAATACACATACACTTACCCTAC
CACTCTAATCCCACTACCACATGCCGGATCCNNNNNN

RNA Sequence

UUGAAACGUUAACAAAUAAUCGUAAAUAAUACACAUACA
CUUACCCUACCACUCUAAUCCCACUACCACAUGCCG

*NNNNNN is 6 random nucleotide designed for efficient digestion by corresponding restriction
enzymes. Underlined sequences indicate designed restriction endonucleases site for plasmid
construction. Italic sequence indicates T7 promoter region. Bolded part is the overlap region of forward
and reverse primers.
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PCR
Forward Primer
MCS

Double-digestion

Reverse Primer

Double-digestion

pUG19&
pUG19

Template

Ligation

pUG19
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miniprep

Sequencing
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Figure 2-5. Template construction of R75/R108 in pUG19.
In the right panel, each big arrow indicates a primer. Forward primer is consist of one restriction site on
5’end (solid line), T7 promoter (stripped box), its own template sequence (dark grey box), and
complementary sequence for reverse primer (white dotted black box). Dotted line indicates the
extension part by the overlap PCR, using the reverse primer as template. Reverse primer contains
another restriction site on 5’end (solid line), its own template sequence (light grey box), and
complementary sequence for reverse primer (white dotted black box). Template was generated by an
overlap PCR (See Material & Methods). Template sequence contains the restriction sites on each end,
T7 promoter, complementary sequence and sequences from each primer. This was followed by double
digestion on each end, and ligated into pUG19. Ligated pUG19 harboring R75/R108 template can be
rescued after DH5α transformation for sequencing. RNA could be produced by in vitro T7
transcription.

R108 template was designed similarly (listed in Table 2-2, detailed in Table
2-9), but with BamHI at 5’end and KpnI at 3’end. Since KpnI restriction enzyme
produces 3’ overhang which generates the possibility for extraneous transcripts in
addition to the expected transcript, EcoRI restriction site which located in
multi-cloning site of pUC19, 6nt downstream of KpnI site, was used for plasmid
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linearization instead of KpnI. B204 is the clone with tRNAiMet template under T7
transcription promoter. BstNI was used to linearize the plasmid for in vitro
transcription of tRNAiMet. All other procedures are the same as R75 in vitro synthesis
(Fig 2-4). E.coli total tRNA was commercial available (Roche). RNA products were
running on a 15% denaturing PAGE gel and visualized by UV-shadowing.
Table 2-9. R108 Related Sequences.
Forward Primer

NNNNNNGGATCCTAATACGACTCACTATAGGGTTGAAACGT
TAACAAATAATCGTAAATAATACACATACACTTACCCTACC
ACTCT

Reverse Primer

NNNNNNGGTACCCAAGTGAGGATGGCTATGGCATGTGGTA
GTGGGATTAGAGTGGTAGGGTAAGTGTATGTGTATTATTTA
CGATTAT

DNA Template Sequence

NNNNNNGGATCCTAATACGACTCACTATAGGGTTGAAACGTT
AACAAATAATCGTAAATAATACACATACACTTACCCTAC
CACTCTAATCCCACTACCACATGCCATAGCCATCCTCACTT
GGGTACCNNNNNN

RNA Sequence

UUGAAACGUUAACAAAUAAUCGUAAAUAAUACACAUACA
CUUACCCUACCACUCUAAUCCCACUACCACAUGCCAUAGC
CAUCCUCACUUGGGUACCGAGCUCGAAUU

*NNNNNN is 6 random nucleotide designed for efficient digestion by corresponding restriction
enzymes. Underlined sequences indicate designed restriction endonucleases site for plasmid
construction. Italic sequence indicates T7 promoter region. Bolded part is the overlap region of forward
and reverse primers.

ATPase Assay

ATP/NADH coupled assay was carried out and modified from previously
described (Bernstein et al. 2008). Upon one molecule of ATP hydrolyzed by Mtr4p,
pyruvate kinase (PK) converts phosphoenolpyruvate (PEP) into pyruvate, which is
subsequently converted into lactate by L-Lactate dehydrogenase (LDH), which
further drives the reaction that one NADH molecule is oxidized to NAD+ (Fig. 2-6).
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Reactions were prepared in quartz cuvettes and running in a Shimadzu UV-1800
spectrophotometer with multi-cell holder at 30 oC. 83 nM of Mtr4p was pre-incubated
and stimulated with indicated amount of corresponding RNA substrates for 5 min in
assay buffer (50 mM HEPES, 50 mM KCl, pH 7.6) that contains 8 mM MgSO4, 1.5
mM PEP (Roche), 0.15 mM NADH, 2 units of PK (Roche) and 7 units of LDH
(Roche) (Reaction preparation listed in Table 2-10). ATP was added to the cuvette to
initiate the reactions at indicated concentration. Reactions were incubated in cuvettes
at 30 oC for 15 min, continuously monitored by Shimadzu UV-1800
spectrophotometer. Reaction rate of NADH depletion over time was recorded at
wavelength of 340 nm. Every reagent in this assay was fresh made for each use.
NAD+

Pi

NADH

OD340

Pyruvate
ADP

Mtr4
(RNA)

lactate
Lactatedehydrogenase (LDH)

Pyruvate kinase
(PK)
ATP

Phosphoenolpyruvate(PEP)

Figure 2-6. Schematic representation of ATPase assay.
Upon ATP hydrolyzed by Mtr4p, pyruvate kinase (PK) converts phosphoenolpyruvate (PEP) into
pyruvate, which is subsequently converted into lactate by L-Lactate dehydrogenase (LDH), followed
by one NADH molecule oxidized to NAD+. NADH depletion over time was recorded at wavelength of
340 nm.
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Table 2-10. ATPase Assay Reaction Composition
80 mM MgSO4 in Assay Buffer

100ul

15 mM PEP in Assay Buffer

100ul

1.5 mM NADH in Assay Buffer

100ul

RNasin (Promega)

0.25ul

PK (1unit/µl in Assay Buffer)

2ul

LDH (1unit/µl in Assay Buffer)

7ul

10 X ATP stock in Assay Buffer (Indicated Concentrations)

100ul

RNA Substrates

Indicated Amount

Mtr4p (10mg/ml)

1ul

Assay Buffer (50mM HEPES, 50mM KCL, pH 7.6)

Fill up volume to 1ml

RNA Labeling and Duplex Preparation

RNAs used in unwinding reactions were commercial synthesized. R1 and R4
are purchased from Thermo Scientific. R16-1 top and R16-2 sequences are
generously provided by Jankowsky lab. RNA sequences are listed in Table 2-11.
Table 2-11. RNA Substrates Used in Unwinding Assay.
Name

Sequence

R1 (bottom)

5’-GCGUCUUUACGGUGCUAGCUUA-3’

R4 (top)

5’-AGCACCGUAAAGACGC-3’
5’-GCGUCUUUACGGUGCUAGCUUA-3’
3’-CGCAGAAAUGCCACGA-5’
5’-GCGUCUUUACGGUGCU-3’

R1-4
R16-1 (bottom)
R16-2 (top)
R161-2

5’-AGCACCGUAAAGACGC -3’
5’-GCGUCUUUACGGUGCU-3’
3’-CGCAGAAAUGCCACGA-5’

RNA top strands were 5’ radiolabelled by T4 polynucleotide kinase (New England
Biolabs). A 10 µl reaction was performed at 37 oC for 1 h, containing 100 picomole of
indicated RNA top strand, 50 picomoles of γ32 p-ATP, 100 picomoles of unlabeled
ATP in 1 X T4 PNK buffer with 1.5 µl of 10 units/ µl T4 polynucleotide kinase.
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Reactions were mixed with equal volume of 2 X RNA loading dye, and separated on
a 20% denaturing urea PAGE gel (Table 2-12) in 0.5 X TBE buffer at 450 V for 1 hr.
Radiolabelled RNA substrates were detected by film, and the largest band (full-length
RNA) was precisely cut, transferred into a fresh microcentrifuge tube, and crashed
into tiny pieces. 600 µl of gel elution buffer (Table 2-12) was added into the tube,
which was subsequently rotating at 4 oC on a nutator overnight for RNA elution. The
following day, supernatant that contains RNA was drawn out after a brief spin,
divided into half (~300 µl each), transferred into separate microcentrifuge tubes, and
mixed with 3 fold (~900ul) 200 proof alcohol and 1µl glycerol. Labeled RNA was
precipitated on dry ice for at least 30 min, followed by centrifugation at 14,000 x g for
30 min at 4 oC. Supernatant was removed. The pellet was air dried for 10 min and
further by a twisted tissue wipes to remove any residual liquid. Radiolabelled
top-strand RNA was either eluted with RNA resuspension buffer (Table 2-12) for
future use, or with 35 µl of sterile DEPC-treated dH2O (Table 2-12) for radiolabelled
duplex preparation.
To make duplex RNA substrates, 4 µl of annealing buffer (Table 2-12) and
100 picomol of corresponding RNA bottom stand (1 µl) were added to the 35 µl
DEPC-treated dH2O eluted radiolabelled RNA top strand. Reaction was heated at
95oC for 2min, followed by slowly cool down at room temperature over 2 hrs for
strand annealing. The duplex RNA was separated on a 15 % native PAGE gel (Table
2-12) at 250 V for 1 hr in 0.5 X TBE buffer. Radiolabelled RNA top strand run
together on the gel as a negative control. Signal was detected on a film and RNA
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duplex was eluted from the gel as above. Duplex RNA was stored in RNA
resuspension buffer (Table 2-12). Concentration of radiolabelled RNA substrates was
determined by a liquid scintillation counter.
Table 2-12. Reagents Used in RNA Labeling and Duplex Preparation
Buffer and Reagents

Composition

20% Denaturing Urea PAGE Gel

12 ml of 40% acrylamide (19:1, EMD chemicals),
5 ml 5 x TBE, 0.5 ml dH2O, and 12 g urea were
mixed in a beaker, dissolved by heating and
stirring. Volume was filled up to 24.75 ml with
sterile dH2O. Gel preps are filtered by 0.2-µm
nylon syringe filter. 250 µl 10% Ammonium
persulphate (Sigma) and 9ul TEMED were added
before pouring. Two glass plates were treated
with Sigma-Coat, aligned together, and stabilized
by large clamps. Gel preps were loaded in
between the two glass plates and allow at least 30
min to polymerize.

15% non-denaturing PAGE Gel

9 ml of 40% acrylamide (29:1), 10 ml of dH2O,
4.8 ml of 5 x TBE, 250 µl of 10% Ammonium
persulphate (Sigma) were added to a beaker, and
stirred to mix. 9 µl TEMED was added before
pouring. Gels were prepared as above.

Gel Elution Buffer

3 M sodium acetate, pH 5.3, 1 mM EDTA, 0.5%
SDS

DEPC-treated dH2O

dH2O was treated with 0.1% DEPC (Promega),
incubated at room temperature at least overnight,
followed by autoclave.

Annealing Buffer

10 mM MOPS pH 6.5, 1 mM EDTA, 50 mM KCl

RNA Resuspension Buffer

50 mM Tris-HCl pH 7.0, 30 mM NaCl

CIAP Stop Buffer

10 mM Tris-HCl (pH 7.5), 1 mM EDTA (pH 7.5),
200 mM NaCl, 0.5% SDS

TE Buffer

10 mM Tris-HCl (pH 8.0), 1 mM EDTA

Dephosphorylation of RNA
Commercially purchased RNA could be labeled simply as above. RNA that
synthesized by the T7 RiboMAX Express Large Scale RNA Production Kit needs
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additional dephosphorylation procedure to release a free 5’ end before labeling.
Reactions were carried out at 37oC for 1h, containing 10 picomoles of indicated RNA
substrates (R75 or R108), 1 x Calf intestinal alkaline phosphatase (CIAP) reaction
buffer (Promega) and 0.05 units of CIAP (Promega) in a total volume of 50 µl.
Another 0.05 units of CIAP were added to the reaction at 30 min during incubation.
300 µl of CIAP stop buffer (Table 2-12) was added to stop the dephosphorylation
reaction. RNA was extracted by equal volume of AE-saturated- phenol (pH 4 –5):
chloroform: isoamyl alcohol (125:24:1). RNA mixtures were vortexed for 1min, and
phases were separated by spinning for 2 min at 14, 000 x g in a tabletop centrifuge.
The upper aqueous phase was transferred into a fresh tube, adding equal volume of
chloroform: isoamyl alcohol (24:1). RNA mixtures were vortexed as above,
centrifuged, and the upper aqueous phase was transferred into another fresh tube. Any
chloroform that transferred along could be removed by a brief spin and pipetting from
bottom of the tube. 0.1 volume of 3M Sodium Acetate (pH 5.2) and 2.5 volumes of 95%
ethanol were added to precipitate RNA at -20 oC overnight. The following day, RNA
was pelleted at 15, 000 x g at 4 oC for 15min. Supernatant was decanted, RNA was
washed by 1 ml of 70% ethanol and centrifuged as above. RNA pellets were air-dried
for 10 min, dissolved DEPC-treated dH2O. RNA concentration was determined at
OD260 by Nanodrop. Dephosphorylated RNA was ready to be radiolabeled as above.
Unwinding Reactions

Unwinding reactions were performed as described (Jia et al. 2012). Aliquots
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of 10 µg/µl frozen recombinant Mtr4p enzyme was taken out from -80 oC freezer,
centrifuged for 10 min at 4 oC to avoid any precipitants or aggregates, and diluted 5.4
times with protein storage buffer. Further dilution will cause obvious decrease of
enzyme activities (data not shown). 50 nM of Mtr4p (wild-type or mutants) was
pre-incubated and stimulated with 0.5 nM indicated radiolabelled RNA duplex in a 60
µl reaction containing 40 mM Mops (pH 6.5), 100 mM NaCl, 0.5 mM MgCl2, 5%
glycerol (vol/vol), 0.01% Nonidet P-40 (vol/vol), 2 mM DTT, and 0.7 U/µL Protector
RNase Inhibitor (Promega), at 30 oC for 5min. Then MgCl2-ATP was added to start
the reactions with a final concentration of 2 mM. Aliquots were taken out at indicated
serial time points (0 min = time of ATP-MgCl2 added to reactions) and stopped by
adding equal volume of reaction stop buffer (1% SDS, 50 mM EDTA, 0.1% xylene
cyanol, 0.1% bromophenol blue, 20% glycerol). Reactions were run on a 15%
nondenaturing PAGE gel (Table 2-21) to separate duplexes and unwound single
strands. Gels were dried, visualized by phosphorimager (Molecular Dynamics), and
quantified by the ImageQuant 7.0 software. Kinetics data were calculated as previous
described (Yang, Jankowsky 2005).
Re-annealing reactions were performed with the same condition as the
unwinding assay, except that the RNA duplex was denatured before adding to the
reactions, by boiling for 5 min.

Electrophoretic Mobility Shift Assays (EMSA)

EMSA was modified from previously reported protocols (Hellman, Fried
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2007). Radiolabelled single-stranded RNA or RNA duplex preps were used in EMSA.
Gradient concentrations of recombinant Mtr4p (wild-type or mutant) were incubated
with 0.5 nM of indicated radiolabeled RNA in 30 µl reactions containing 10 mM Tris
(pH 7.5), 1 mM EDTA, 100 mM KCl, 0.1 mM DTT, 5% vol/vol glycerol, and 1%
NP40 on ice for 30 min. Reactions were prepared with 4 µl of loading buffer (10 mM
Tris, 1 mM EDTA, 50% glycerol, 0.001% wt/vol bromophenol Blue, 0.001% wt/vol
xylene cyanol FF). Prepared samples were loaded on a 5% nondenaturing PAGE gel,
and separated at 120 V for 120 min in 0.5 X TBE at 4oC. Gels were dried and
visualized by phosphorimager (Molecular Dynamics).
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CHAPTER III. RESULTS

Part I: In vivo Characterization of Mtr4 Structural Domain Mutants
I. Creation of Mtr4 Structural Domain Mutant Library
A Mutant Library of Mtr4p Structural Domains by a Dominant-Negative Screening

Crystal structure of Mtr4p (Weir et al. 2010, Jackson et al. 2010) has revealed
that other than the two conserved RecA-like domains that provide ATPase and
helicase activities, Mtr4p also contains structural domains with unclear function. A
Schematic diagram of Mtr4p shows that the RecA-like domains reside in the
N-terminal half of Mtr4p, while the C-terminal half contains the structural domains
including the arch, winged helix (WH) and ratchet domains (Fig. 3-1A). The
RecA-like domains, winged helix and ratchet domain assemble the helicase core, and
the protruding arch domain exits the core from the middle of the winged helix domain
and reenters (Jackson et al. 2010, Weir et al. 2010) (Fig. 3-1B). The arch domain is
unique to the exosome-linked helicases Mtr4p and Ski2p. The arch domain of Mtr4p
contains a recognizable KOW domain and a stalk domain (so-called arm) that
connects the KOW domain to the helicase core(Weir et al. 2010, Jackson et al. 2010,
Halbach, Rode & Conti 2012a) (Fig. 3-1B). The arch domain begins with two
α-helices, α1 and α2, that form half of stalk (arm), then it continues into the KOW
domain, which possesses a globular structure containing five β-strands (β1-β5), two
long loops (loops between β2-β3 and β3-β4), and one α-helices (Fig. 3-1B).
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Figure 3-1. Schematic Diagram and Structure of Mtr4p.
A. Schematic diagram of Mtr4p and region of random mutagenesis. Black box indicates N-terminal of
Mtr4p. The two RecA-like domains are shown in stripped boxes. The winged helix domains are
represented with dotted boxes in a white background. Light grey boxes represent the stalk domains,
while the dark grey box indicates the KOW domain. Ratchet domain is drawn with dotted box in a
black background. A left-right arrow covering amino acid sequence from residue 610 to 1057 indicates
the mutagenic region. B. Crystal structure of Mtr4p (PDB ID zcgl) (Weir et al. 2010). Lavender and
Blue regions indicate the first and second RecA-like domains. The winged helix domain is depicted in
yellow. Orange colored region indicates stalk domain, and the KOW domain is designated in red.
Ratchet domain is shown in pink. RNA is colored in Black and ATP is colored in dark grey. C. The
same view of Mtr4p crystal structure as panel B, with mutagenesis region depicted in green. D.

180o

horizontal rotated view of Panel C.

Finally the arch domain turns back into and enters the core helicase domain through
two α-helices, α3 and α4 (Fig. 3-1B). To detect how structural domains play a role in
manipulating Mtr4p function, error-prone PCR was done to introduce on average 2~4
mutations encompassing a ~1400 bp region that includes the entire arch domain, and
partial winged helix and ratchet domains (Fig. 3-1A, C, D). A yeast high-copy
number plasmid YEplac195 (refer as “HC”) bearing the MTR4 gene with promoter
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and 3’ UTR, was digested at two restriction sites, generating a 1000 bp gapped vector
with 200~300bp complementary to each end of the mutagenic PCR products.
trm6-504, a Saccharomyces cerevisiae strain which is temperature-sensitive
(ts-) due to a TRAMP-dependent degradation of hypomodified tRNAiMet (Anderson,
Phan & Hinnebusch 2000) (see Introduction), was used in this study to detect in vivo
defects of Mtr4p structural domain mutants in the regulation tRNAiMet turnover .
Mutagenic PCR products with the gapped YEplac195 plasmid carrying MTR4 gene
were introduced into trm6-504 and underwent homologous recombination, resulting
in stable plasmids that harbor full-length MTR4 gene with mutations in the PCR
amplified region. Mutant Mtr4p that expressed to higher levels from HC plasmid
could readily replace the endogenous wild-type (WT) Mtr4p in the TRAMP complex.
Simultaneously, if the Mtr4p mutant was defective in degradation of tRNAiMet, it
would lead to tRNAiMet accumulation, and rescue the trm6-504 ts- phenotype. We
called this a dominant-negative screen since it’s a dominant screen for phenotype (ts+
better growth), but a negative screen for sequence (mutant). This screen for trm6-504
suppressor-like phenotype was performed at 33 °C, a semi-restrictive temperature
(Fig. 3-2). Compared to wild-type MTR4 (MTR4-YEplac195) transformant, Mtr4p
mutant transformants with the best growth at 33oC were picked and considered as
Mtr4p defective mutants (Fig. 3-2). More than 50% of Mtr4p structural domain
mutants suppressed trm6-504 ts- phenotype, which indicated these domains are
important for Mtr4p function in tRNAiMet turnover. Formation of the mutant library
resulted in creation of 80 potential Mtr4p structural domain mutants, 51 of which
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33oC
trm6-504 + HC Mtr4 WT
trm6-504 + HC vector only

Defective mutants
trm6-504 + Mutagenic PCR
products & gapped HC

Non-defective mutants

Figure 3-2. Dominant-negative screen for Mtr4 structural domain mutants.
In the top panel, yeast strain trm6-504 was transformed with high-copy plasmid YEplac195 (HC)
carrying Mtr4 WT or empty HC as positive controls. Growths were measured with serial dilutions
spotted on YPD at 33 oC. Simultaneously, trm6-504 was transformed with mutagenic PCR products
and gapped HC vector, which would undergo homologous recombination in vivo. Each serial dilution
shown in the bottom two panels was one colony picked from transformants. Middle panel showed
mutants considered as defective mutant with a better growth compared to positive controls, and the
bottom panel contains non-defective mutants with a wild-type-like phenotype.

suppressed trm6-504 ts- phenotype. 16 out of the 51 were isolated from yeast and
subjected to DNA sequencing (Table 3-1). Finally 13 arch domain mutations 4
winged helix domain mutations, and 9 ratchet domain mutations were identified.

Mutations Selected in Arch, Winged helix, and Ratchet domains
In order to study distinct functions of the arch, winged helix and ratchet
domains, 1-2 mutants were chosen from each domain for further in vivo and in vitro
studies. It was reported that the KOW domain binds duplex RNA and tRNAiMet in
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Table 3-1. Structural Domain Mutants Library.
Structural Domain Mutants

Mutations

Mutant 3-1

T712P

Mutant 4-1

P731S

Mutant 4-2

S672N

Mutant 4-3

L903M

Mtr4-22

R883C

Mtr4-23

Mtr4-24

Mtr4-25
Mtr4-26
Mtr4-27
Mtr4-28
Mtr4-29

K700N
R1030G
F673L
R678K
F924S
Q946H
P802S
M825I
A965T
M825V
Y853F
N925D
F698Y
P802S
A965T
F945S
F1010Y

Mtr4-30

K904N

Mtr4-31

V1019A

Mtr4-32

D899N

Mtr4-33

K768M

*indicates mutants identified in error-prone PCR, all the others were identified by the
dominant-negative screen. Mutations in the arch domain are shown in black. Mutations in the
winged-helix domain are indicated by orange, and mutations in the ratchet domain are shown in blue.

Vitro (Weir et al. 2010, Halbach, Rode & Conti 2012a). Its long loops that protrude
out into solvent may contact the RecA2 surface where it could form a channel for
RNA entry (Weir et al. 2010, Jackson et al. 2010). The K700N mutation in the KOW
domain was selected not only due to its position in one of the long loops (β2~β3 loop)
(Fig. 3-3) but also because the positively charged lysine can potentially bind the RNA
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Figure 3-3. Structural domain mutations in Mtr4p structure (PDB ID zcgl).
Color assignments are shown on top right. Lavender and Blue regions indicate the first and second
RecA-like domains. The winged helix (WH) domain is depicted in yellow. Orange colored region
indicates stalk domain, and the KOW domain is designated in red. Ratchet domain is shown in pink.
RNA is colored in Black. All mutation residues are shown in green sticks. Proline 731 is zoomed in a
left-side view, and lysine 904 is zoomed in a right-side view. Proline 802 is zoomed in from the back,
and Arginine 1030 is zoomed from the bottom.

phosphate backbone. P731S was selected as another KOW mutation that is located on
the β3~β4 loop, which is the second long loop protruding out of the KOW domain. In
Mtr4p structure, Proline731 is at a position that may make contact with the RecA2
domain (Fig. 3-3). Proline commonly results in tight turns, and plays an important
role in protein structure. Taken together, K700N and P731S were chosen for studies
on the functions of the KOW domain. Mutation P731S is not detected by our screen,
but appeared in the process of testing manganese conditions for the mutagenic PCR. It
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could be a negative control to test efficiency of the dominant-negative screen.
Proline802 is located in the loop connecting the α-helix of the KOW domain
and α-helix (α3) of the stalk domain (Fig. 3-3) (Jackson et al. 2010, Weir et al. 2010).
It is a region that connects the KOW domain to the stalk domain when the KOW is
turning back, and potentially directs the KOW domain movement within Mtr4p.
(Jackson et al. 2010). The P802S mutation was selected because it appeared in two
independent mutants from the dominant-negative screen. S672N was selected as a
comparison of P802S, since S672 is also located at the transition area between the
stalk and the KOW domain. S672 is the first amino acid of the KOW domain, where
the Stalk is ending and forming the KOW domain. Both S672N and P802S are chosen
to study the role of the connecting area between the KOW and the stalk domain.
The KOW domain mutation K700N appeared in our screen as a double mutant
together with R1030G. Since either one of them or both might cause the in vivo
defects, R1030G was chosen to study function of the ratchet domain. R1030G became
a strong candidate for RNA binding because this positively charged arginine is
located on the surface of ratchet domain sticking out towards RNA substrate in the
crystal structure (Fig. 3-3) (Weir et al. 2010). Finally, K904N mutation in the winged
helix domain showed up in the screen as a single mutant, indicating it was sufficient
to disrupt Mtr4p function alone. The winged helix (WH) domain connects domains of
Mtr4p together, including the RecA2, arch and ratchet domains. K904 is also
positioned at the interface of the winged helix and ratchet domain (Fig. 3-3), which
indicates its potential role in coordinating domain-domain interaction. Lysine might
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also provide an RNA binding site as part of the RNA channel found inside of the
helicase core.
All amino acids found in this dominant-negative screen are highly conserved
throughout species. Lysine 904 is 100% conserved from Mtr4p in different species as
well as its cytoplasmic homolog Ski2 (Fig. 3-4). Lysine 700, Proline 802 and
700

731

Arch (KOW)

672

802

Arch (transition area
between KOW & stalk)

904

1030

C-terminal (WH &Ratchet)

Figure 3-4. Multiple alignment of Mtr4 amino acids sequence across species.
Mtr4 across species (Saccharomyces cerevicea, Schizosaccharomyces pombe, Arabidopsis thaliana,
Mus musculus, Homo Sapiens) and Ski2 of Saccharomyces cerevicea were selected for comparative
analysis. The online alignment tool MUSCLE was used to analyze and create the alignment file.
Figures were generated with GeneDoc. Black shaded areas indicate 100% identity. Grey shaded areas
with white letters designate 75%-99% identity while with black letters designate 50%-74% identity.
Black arrow indicates the random mutations from dominant-negative screening.

Arginine 1030 are 100% conserved through Mtr4p of different organisms but not
conserved in Ski2p (Fig. 3-4). As mentioned above, Proline 731 and Serine 672 are
mutations that did not exhibit suppression phenotypes in the sreen, and they are not
conserved in Mtr4p from other species. It reflects that our screen is designed in an
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efficient way, since it identified mutations in conserved amino acids, and because of
the conservation they tend to be important for Mtr4p function.
II. Growth Analysis of Mtr4p Structural Domain Mutants
None of the Structural Domain Mutants are Null Mutants
In order to exclude null mutants from our study, all initial MTR4 mutants
(Table 3-1) were analyzed to determine if they could support cell growth in the
absence of wild-type Mtr4p. Heterozygous MTR4 deletion diploids
(MTR4/MTR4::Kanr) were transformed with YEplac195 plasmids (HC) bearing mtr4
mutants that were recovered from the dominant-negative screen. Transformants were
sporulated, and a tetrad was completed to score viable spores. Two spores will be
wild-type MTR4 on the chromosome, and the other two MTR4 knockout cells (mtr4Δ)
containing mtr4 mutants on HC plasmid. Mtr4-AAVH mutant (Mtr4-21) is known to
be a null mutant and was used as a negative control (Wang et al. 2008a). Tetrads
carrying the mtr4-AAVH mutant contained only two or less viable spores (Fig. 3-5).
As a positive control, four intact spores were observed from tetrads transformed with
wild-type MTR4 plasmids. Mtr4-24 mutant, which contains four mutations (Table
3-1), was found to be a null mutant since no more than two spores were viable in one
tetrad (Fig 3-5). Mtr4-22, Mtr4-23 and Mtr4-25, that contains mutations selected for
further studies (Table 3-1), were not null mutants. At least one tetrad from these

80

Mtr4-22

Mtr4-25

Mtr4-23

Mtr4-24( Null)

Mtr4 AAVH (null)

Mtr4-WT

Figure 3-5. Tetrad analysis of heterozygous MTR4 deletion diploids transformed with Mtr4
structural domain mutants.
Each line contains four spores from one tetrad. 6~8 tetrads were dissected for each mutant. Red arrow
indicates growth of all four spores of one tetrad. Mtr4 AAVH mutant is a null mutant, working as a
negative control. Wild-type Mtr4 is a positive control.

mutants contained four intact spores (Fig. 3-5). All spores tested to insure they were
haploid and all four spore tetrads were tested for mating type to insure a 2:2
segregation of mating type.

mtr4-20 and mtr4-30 Cause slow growth during Germination not Vegetative
Growth
Tetrad analysis revealed that Mtr4-30 (mtr4-904) was able to support cell
growth. All four spores were viable, however, two of them grow slower compared to
the other two (Fig. 3-6 A). All four spores were confirmed to be from one tetrad
through mating test, two of which are mating type a and the other two are mating type
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α. Upon replica plating to YPD-G418 (Kanamycin), the smaller spores were viable,
while the other two did not grow. It confirmed the two spores with growth defects are
mtr4-904 mutants. The slow growth of mtr4-904 mutants during germination may
reflect a slow growth phenotype of mtr4-904. To test this idea, mtr4-904 mutant
haploids were grown vegetatively in rich media and compared to those haploids
expressing HC Mtr4 (Fig. 3-6 B). As a negative control, Mtr4-20 contains a single
mutation methionine 540 to leucine was tested similarly. The mtr4-20 mutant residues
in helicase core motif VI, and it was reported to exhibit only 20% of the helicase
activity compared to WT Mtr4 (Wang et al. 2008a). It’s a mutant that only retains ~
20% helicase activities (Wang et al. 2008a). Surprisingly, mtr4-20 exhibited similar
growth defects during spore germination but not vegetative growth, as mtr4-30.
Overall, this preliminary analysis of mtr4-904 in heterozygous mtr4 deletion diploids
revealed its defects in spore germination but not vegetative growth. Curiously,
another subunit of the TRAMP Complex, Trf4p, was reported to be required for
sporulation germination (Kloimwieder, Winston 2011). Similar with Mtr4-20 and
Mtr4-30 mutants, TRF4 deletion strain exhibits growth defects during germination but
a comparable phenotype as wild-type strains during vegetative growth (Kloimwieder,
Winston 2011). Taken together, the TRAMP complex is important for yeast
sporulation germination, probably through regulation of rRNA processing. rRNA
processing and ribosome assembly are crucial for protein synthesis at early
developmental stages. Further investigation is required to test this hypothesis and
study how the TRAMP complex affects early germination.
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A

Mtr4-30
K904N

Mtr4-WT

B

Mtr4-20

HC mtr4-30
Tetrad + HC mtr4-30

HC mtr4-30
ED WT
ED WT
ED WT

Tetrad + HC mtr4-20

HC mtr4-20
ED WT
HC Mtr4-20
ED WT

Tetrad + HC MTR4-WT

HC WT

Figure 3-6. Mtr4-30 (K904N) performs germination defects.
A. Tetrad analysis of heterozygous MTR4 deletion diploids transformed with MTR4-WT, mtr4-20 or
mtr4-30. Each line contains four spores from one tetrad. 6~8 tetrads were dissected for each mutant.
Mtr4-20p and Mtr4-30p cause growth defects during germination. Red arrows indicate smaller colony
formation of mutant spores. Mtr4-WT serves as a positive control. B. Vegetative growth of the spores
from the tetrads transformed with HC MTR4-WT, HC mtr4-20 or HC mtr4-30, compared by serial
dilutions spotted on YPD plates. Each left bracket includes fours spores sporulated from one tetrad.
Chromosomal MTR4 knockout spores containing HC plasmids are indicated by the plasmids (HC
mtr4-30, HC mtr4-20, HC MTR4-WT). Mutant spores that exhibited slower growth in germination are
shown in red. Spores contain endogenous MTR4 are indicated by ED WT.

III. In vivo Characterization of Mtr4p Structural Domain Mutants in tRNAiMet
turnover
Chromosomal MTR4 knockout creates growth defects
The dominant-negative screen was performed in the strain trm6-504 with
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mutants expressed on high-copy plasmids, which theoretically will compete for
endogenous wild-type Mtr4p during assembly of the TRAMP complex. Trm6-504
strain, which provides observable phenotypes, is used to study whether the structural
domain single mutants affect tRNAiMet turnover in vivo. In order to study accurate
effects of each mutation, S672N, K700N, P731S, P802S, K904N and R1030G were
individually created on a MTR4 single-copy plasmid YCplac111 (LEU2 marker) to
mimic endogenous Mtr4 protein level. To make the screen possible, the genomic
wild-type MTR4 gene deleted, (See materials & Methods; Fig. 2-2) but since MTR4 is
essential, before MTR4 knockout, trm6-504 was transformed with wild-type MTR4 on
plasmid pRS316 (URA3 marker) to support the growth prior to deletion of
chromosomal MTR4. The MTR4 knockout (mtr4Δ) strain was transformed with
single-copy plasmid YCplac111 (LEU2 marker) harboring mtr4 single mutants, or
sild-type MTR4–Ycplac111 as a control. Transformants were plated on 5’FOA to
select against the presence of wild-type MTR4 pRS316 plasmid 5’FOA, and mtr4
mutant on YCplac111 became the only copy of MTR4 in vivo. The growth of
trm6-504 (MTR4::Kanr) with mtr4 mutants was compared to the growth of trm6-504
(MTR4::Kanr) with MTR4 wild-type or initial trm6-504, to detect whether
hypomodified tRNAiMet degradation is affected by mutant Mtr4p. Unexpectedly,
trm6-504 (MTR4::Kanr) strain supplemented with plasmid bearing wild-type MTR4,
strain showed slower growth than the parental trm6-504 (Fig. 3-7). The trm6-504 and
trm6-504(mtr4::kanr) are isogenic accept at the leu2 and mtr4 locus, where the
corresponding WT genes were replaced by selectable markers using homologous
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recombination.
trm6-504
trm6-504
+
WT TRM6

trm6-504(MTR4:: Kan r)
+
WT MTR4 & WT TRM6

trm6-504(MTR4:: Kan r)
+
mtr4-700 & WT TRM6

trm6-504(MTR4:: Kan r)
+
WT MTR4

trm6-504(MTR4:: Kan r)
+
mtr4-700

TRM6

Figure 3-7. MTR4 knock-out strain creates its own phenotype.
Growth phenotypes of trm6-504 (MTR4::Kanr) strains supplemented with wild-type MTR4 or mtr4-700
were compared with trm6-504 (Y190). Each strains was transformed with wild-type TRM6 to
complement trm6-504 ts- phenotype. TRM6 (Y200) is a wild-type S.cerevisiae. Each strain was
streaked on YPD plate, grown at 30oC for 2 days. The red arrow points to a colony of typical-size of
that particular strain.

Before continuing the mutant phenotype analysis, I first examined if the MTR4
deletion caused any growth defects. Wild-type TRM6 on pRS316 was used to
transform trm6-504 (MTR4::Kanr) to complement the trm6-504 phenotypes. The
parental trm6-504 strain transformed with plasmid TRM6 grew just like yeast
expressing TRM6 from the chromosome (Fig. 3-7). The trm6-504 (mtr4:: kanr ) with
wild-type MTR4 and wild-type TRM6 did not grow as well as yeast where TRM6 and
MTR4 are wild type at the their chromosomal locus bearing plasmid (Fig.3-7 ),
suggesting that the knockout of the chromosomal MTR4 gene affects expression of
neighbor genes, resulted in detectable growth defects. From the chromosomal location
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of MTR4 gene (Fig. 3-8), distance between MTR4 and the surrounding genes could be
helpful, and genes YJL049W and YJL051W became strong candidates that were
affected by MTR4 knockout. YJL049W, a protein of unknown function, located right
downstream of MTR4, might lose its promoter region in the knockout. On the other
side, YJL051W, a bud tip protein of unknown function, located upstream of MTR4,
might have its 3’UTR deleted or disrupted by MTR4 knockout.

Figure 3-8. Chromosomal location of MTR4 in Saccharomyces cerevisiae (Picture obtained and
modified from Saccharomyces Genome Database).
Entire Chromosome X was drawn on the top of the figure. Enlarged chromosome sequence at the
bottom shows genes located on Chromosome X from 332 kbp to 356 kbp. Each Pentagon represents
ORF of a specific gene. MTR4 (systematic name YJL050W), indicated by the red arrow, was located
within 342522 kbp ~ 345743 kbp. Black arrows indicate genes YJL049W and YJL051W, which are
located downstream and upstream of the MTR4 gene.

In Vivo Effects of Mtr4 Structural Domain Mutants on tRNAiMet Turnover
Another approach to studying mutant genes on cell viability and phenotypes is
chromosomal integration, attempt to replace the wild-type genomic MTR4 gene with
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mtr4 mutants to mimic endogenous conditions as closely as possible. Every MTR4
single mutants (mtr4-S672N, mtr4-K700N, mtr4-P731S, mtr4-P802S, mtr4-K904N,
mtr4-R1030G) were engineered into genomic MTR4 loci by chromosomal integration
in the trm6-504 strain (See materials & Methods; Fig. 2-3). Mutant mtr4 gene became
the only copy of functional mtr4 gene at MTR4 loci, followed by a short 3’UTR
sequence, the URA3 marker, and a truncated non-functional mtr4 sequence missing
the DNA coding for the N-terminal helicase region. This method works to minimize
any negative affects to the surrounding genes from removing the chromosome context.
In this way, genes downstream or upstream of MTR4 would not be affected by
integration since all the genetic information still existed. The possibility that the
integration causes growth defects was excluded, since wild-type MTR4 integrated into
trm6-504 (refer as trm6-504/MTR4 WT) grew the same as original trm6-504 (Fig.3-9).
Cultures of the mtr4 mutant integrated strains (refer as trm6-504/mtr4-X) were
serially diluted, plated and grown at permissive temperature (30 oC) or restrictive
temperature (36 oC) (Fig.3-9). All arch domain single mutants (trm6-504/mtr4-672,
trm6-504/mtr4-700, trm6-504/mtr4-731, trm6-504/mtr4-802) showed no obvious
growth defects, compared to trm6-504/MTR4 WT at 30 oC, suggesting that the arch
domain might not play an important role in tRNAiMet degradation in vivo. On the
opposite, the winged helix domain mutant trm6-504/mtr4-904 and the ratchet domain
mutant trm6-504/mtr4-1030 grew much better than trm6-504/MTR4 WT at 30oC,
indicating the importance of lysine 904 and arginine 1030 of Mtr4p in tRNAiMet
turnover in vivo. Growth of strains trm6-504/mtr4-904 and trm6-504/mtr4-1030 at
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30oC

36oC

TRM6
trm6-504
trm6-504/MTR4 WT
trm6-504/mtr4-700
trm6-504/mtr4-731
trm6-504/mtr4-904
trm6-504/mtr4-1030
trm6-504/mtr4-802
trm6-504/mtr4-672

Figure 3-9. Phenotype analysis of mtr4-mutant integrated trm6 strains.
Trm6-504 strains expressing wild-type or mutant Mtr4p were serially diluted and spotted on YPD, and
grew at 30oC or 36oC for 2 days. Strains were created by replacement of endogenous MTR4 gene by
mtr4 mutant, via chromosome integration. Growth of wild-type yeast strain TRM6 (Y200) was used as
a positive control.

36 oC indicates that these mutants are suppressors of trm6-504, suggesting there is
reduced degradation of hypomodified tRNAiMet degradation.
Correlation between suppressor phenotype and tRNAiMet degradation was
confirmed by northern blots testing steady-state tRNAiMet levels from these strains
(Fig.3-10). Consistent with what was observed for growth conditions, all arch domain
integrated strains (trm6-504/mtr4-672, trm6-504/mtr4-700, trm6-504/mtr4-731,
trm6-504/mtr4-802) had similar levels of tRNAiMet as trm6-504/MTR4 WT. In contrast,
trm6-504/mtr4-904 and trm6-504/mtr4-1030 had higher levels of mature tRNAiMet
(140% and 130% tRNAiMet compared to trm6-504/MTR4 WT, respectively). Northern
mutants blot analysis confirmed that phenotypes of mutant integrated trm6-504 strains
were due to functional defects of Mtr4p on tRNAiMet turnover. Mtr4p is required for
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Figure 3-10. In vivo tRNAiMet level of Mtr4 structural domain mutant integrated trm6-504
strains.
tRNAiMet level in Mtr4 WT or mutant integrated trm6-504 strains was analyzed with Northern blot.
Total RNA was isolated from each strain that grew at 30 oC, separated on 6% denaturing acrylamide
gel (8M Urea). Radiolabelled probes (Table 2-2) were used to target tRNAiMet and 5S rRNA. 5S rRNA
was performed as a loading control. RNA amount of each strain were normalized to 5S rRNA level.
Trm6-504/MTR4 WT contained slightly higher tRNAiMet level than original trm6-504, probably due to
change of genetic background at MTR4 loci by chromosome integration.

5.8S rRNA processing, accumulating the precursor of 5.8S rRNA 7S rRNA if
MTR4 is mutated or depleted (de la Cruz et al. 1998). To further investigate the
effects of structural domain mutants on 5.8S rRNA processing, the levels of 7S rRNA
and 5.8S rRNA were examined by Northern blot (Fig. 3-11). 7S rRNA accumulated
to a significant level in the trm6-504/mtr4-904 strain compared to that of
trm6-504/MTR4 WT, indicates that mtr4-904 mutant causes defects not only in
tRNAiMet turnover but also in 5.8S rRNA processing, implicating the winged helix
domain of Mtr4p as important for it to function inside and outside of the TRAMP
complex.
Trm6-504/mtr4-802 and trm6-504/mtr4-1030 also showed modest increases of
7S rRNA, suggesting that these mutants affect 5.8S rRNA processing, but to a lesser
extent than mtr4-904. The levels of 7S rRNA in arch mutants (trm6-504/mtr4-672,
trm6-504/mtr4-700, trm6-504/mtr4-731, trm6-504/mtr4-802) were not different from
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Figure 3-11. In vivo 7S rRNA and 5.8S rRNA level of Mtr4 structural domain mutants.
7S rRNA and 5.8S rRNA level in wild-type Mtr4 or mutant integrated trm6-504 strains were analyzed
by Northern blot. Total RNA was isolated from each strain that grew at 30 oC, separated on 6%
denaturing acrylamide gel (8M Urea). Radiolabelled probe was used to target 7S rRNA, 5.8rRNA, and
5S rRNA. 5S rRNA was performed as a loading control. Arrow indicates the aberrant shorted form of
5S rRNA.

that of trm6-504/MTR4. Interestingly, an aberrant form of 5S rRNA was observed in
trm6-504/mtr4-904 strain (Fig. 3-11), which was previously reported as present in trf4,
rrp44 and mtr4 mutants (Kadaba, Wang & Anderson 2006). Trf4p was found to be
required for a quick surveillance of this aberrant 5S rRNA, and it is stabilized in
TRF4 deletion strain (Kadaba, Wang & Anderson 2006). Taken together, the
surveillance of aberrant 5S rRNA is regulated by the TRAMP complex rather than
Trf4p itself.
To insure that mutant defects in tRNAiMet turnover are not a reflection of
reduced Mtr4 protein levels, western blot to detect Mtr4p of whole cell extracts (wce)
was done from mutant integrated strains and compared to wce from trm6-504 MTR4
and TRM6 MTR4 strains (Fig.3-12). Integrated wild-type MTR4, mtr4-672,
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Figure 3-12. Western Analysis of Mtr4p level in Mtr4 WT/mutant integrated trm6-504 strains.
Total cell protein was isolated from integrated strains, which were grown at 30oC, separated on 12%
acrylamide-SDS gel. Western blot was performed to detect wild type or mutant Mtr4p levels.
Anti-Mtr4p antibody(de la Cruz et al. 1998) was used to target Mtr4p, and anti-Nab2p antibody was
used to probe Nab2p. Nab2p performed as a loading control.

mtr4-700, mtr4-731, mtr4-802, mtr4-1030 were all expressed at similar levels.
Surprisingly, Mtr4-904p showed significant reduction of expression compared to
integrated wild-type Mtr4. Since the winged helix domain is located in the center of
Mtr4p structure at an interface with other domains, the reduced level of Mtr4-904p
protein may indicate that lysine904 and the winged helix is important for Mtr4p
protein stability. It also confirms that mtr4-1030 caused defects in tRNAiMet turnover
without a corresponding change in protein level, suggesting an important role of the
ratchet domain in Mtr4p in vivo function.
Winged Helix Domain Mutant K904N Reduces tRNAiMet Degradation and Causes
Mtr4p Instability in vivo
The reduced Mtr4p level in trm6-504/mtr4-904 raised the question whether
defects in tRNAiMet turnover are caused by reduced protein levels, or by loss of Mtr4p
function, or both. In order to test whether mtr4-904 defects in tRNAiMet turnover exist
under conditions where Mtr4-904p is expressed at comparable or higher levels than
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wild-type Mtr4p, wild-type and mtr4-904p were expressed from high copy number
plasmids under control of their own promoter. In order to remove the URA3 marker
in the chromosome by integration (provide additional marker for HC plasmids), the
mtr4-904 integrated strain was patched on 5’FOA to select for the colonies that lost
URA3 marker, followed by transformation with mtr4-904 on YEplac195 high-copy
plasmid (HC). Phenotype studies were done at 30oC and 36oC. Trm6-504 strain
transformed with HC mtr4-904 and trm6-504/mtr4-904 integration strain transformed
with HC mtr4-904 showed obvious better growth than trm6-504 with HC wild-type at
30oC (Fig.3-13). They both suppressed trm6-504 ts- phenotype at 36oC (Fig.3-13),
30oC

36oC

TRM6
trm6-504
trm6-504/ MTR4-WT
trm6-504/mtr4-904 + HC vector only
trm6-504/mtr4-904 + HC mtr4-904
trm6-504 + HC vector only
trm6-504

HC MTR4 WT

trm6- 04 + HC mtr4-904

Figure 3-13. Phenotype analysis of trm6 transformed with mtr4-904 on HC plasmid.
Wild-type TRM6, trm6-504, MTR4 WT integrated trm6-504, mtr4-904 integrated trm6-504 transformed
with HC vector, mtr4-904 integrated trm6-504 transformed with HC mtr4-904, trm6-504 transformed
with HC vector only, trm6-504 transformed with HC MTR4 WT and trm6-504 transformed with HC
mtr4-904 were compared. Each strain was spotted on YPD plate by a serial dilution and incubated at
30oC or 36oC for 2 days. Growth of trm6-504 and Y200 are used as positive controls.
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which indicates there is defect in tRNAiMet turnover when Mtr4-904p is expressed at
comparable or higher levels than wild-type Mtr4p. trm6-504/mtr4-904 transformed
with empty vector YEplac195 is a control showed cell growth condition with a lower
mtr4-904 mutant protein level. All the other strains showed in Fig. 3-13, with
endogenous wild-type Mtr4p (Wild-type TRM6, trm6-504, MTR4 WT integrated
trm6-504, trm6-504 transformed with HC vector only) or HC wild-type Mtr4p
(trm6-504 transformed with HC MTR4 WT), all exhibited trm6-504 ts- phenotypes.
Western blotting was done to compare wild-type Mtr4p and Mtr4-904p steady
state levels in trm6-504 yeast expressing endogenous levels of Mtr4p or Mtr4-904p,
HC Mtr4 or HC Mtr4-904p (Fig. 3-14). Western detection of Mtr4p and Mtr4-904p in
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Figure 3-14. Western blot analysis of Mtr4p levels from trm6 strains transformed with HC
Mtr4-904p or HC wild-type.
Strains are labeled above each lane. Total cell protein was isolated from integrated strains, which were
grown at 30 oC, separated on 12% acrylamide-SDS gel. Mtr4p and Mtr4-904p in whole cell extracts
(WCE) were detected by Western blot. Anti-Mtr4p antibody(de la Cruz et al. 1998) was used to target
Mtr4p, and anti-Nab2p antibody was used to target Nab2p. Nab2p performed as a loading control.

whole cell extracts (WCE) revealed that Mtr4p and Mtr4-904p are expressed ~ 10
times higher than chromosomal Mtr4p. Northern blot results confirmed that
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suppressor-like phenotypes of trm6-504 strain containing HC mtr4-904 and
trm6-504/mtr4-904 strain containing HC mtr4-904 were due to dramatically increased
tRNAiMet level (Fig. 3-15). Consistent with the above results, HC mtr4-904 partially
suppresses temperature sensitivity of trm6-504, indicating that even at extremely
elevated protein levels Mtr4-904p leads to reduced TRAMP function in degradation
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of hypomodified tRNAiMet (Figs. 3-13, 3-14, 3-15).

tRNAiMet

5S rRNA

Figure 3-15. Northern blot analysis of tRNAiMet levels of trm6 strains transformed with HC
mtr4-904.
Northern blot was performed with total RNAs isolated from TRM6, trm6-504, trm6-504 transformed
with HC MTR4 WT, trm6-504 transformed with HC mtr4-904, mtr4-904 integrated trm6-504
transformed with HC mtr4-904, mtr4-904 integrated trm6-504 transformed with HC vector only,
trm6-504 transformed with HC vector only, and mtr4-1030 integrated trm6-504 transformed with HC
mtr4-1030. 5S rRNA was used as a loading control.

Our lab previously reported Mtr4p regulates tRNAiMet degradation as a
component of TRAMP complex (Kadaba et al. 2004, Kadaba, Wang & Anderson
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2006, Wang et al. 2008a). Although there is endogenous wild-type Mtr4p in trm6-504,
reduced tRNAiMet turnover were observed when overexpressing mtr4-904p
(HC mtr4-904) (Fig. 3-13 & Fig. 3-15). It should be caused by defective TRAMP
complex with Mtr4-904p in it instead of wild-type Mtr4p, or there shouldn’t be any
defects. From this the conclusion is drawn that mtr4-904p competes with endogenous
mtr4p for residence and that even when expressed to levels 2-3 times that of
endogenous Mtr4p, mtr4-904p is enfeebled in regards to tRNA degradation and 7S
pre-rRNA processing.
To determine what activity ascribed to mtr4p is altered in the mutants
identified and characterized through in vivo analysis, all the structural domain
mutants were studied in details using in vitro biochemical characterizations.

Part II: In vitro Characterization of Mtr4 Structural Domain Mutants
I. Mtr4p KOW Domain Mutants Showed Obvious Defects in RNA Binding and
ATPase Activities, but not in Unwinding Activities
Purification of Recombinant Mtr4p
It has been reported that Mtr4p performs RNA unwinding only in the presence
of hydrolysable ATP, or dATP (de la Cruz et al. 1998, Wang et al. 2008b) and ATP
hydrolysis is fully dependent on the presence of RNA (Bernstein et al. 2008, Wang et
al. 2008b). To further characterize the importance of each structural domain mutant
on different aspects of Mtr4p enzymatic activities in vitro, recombinant single
mutants (Mtr4-672p, Mtr4-700p, Mtr4-731p, Mtr4-802p, Mtr4-904p, and Mtr4-1030p)
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were purified to near homogeneity. Recombinant proteins were used in an
Electrophoretic Mobility Shift Assay (EMSA) to measure RNA-binding, an ATPase
assay to measure ATP binding and hydrolysis, and RNA unwinding assay using a
model substrate to measure the biological function stemming from RNA and ATP
binding and ATP hydrolysis. Recombinant his-tagged wild-type or mutant Mtr4p
were expressed by auto-induced (Studier 2005), purified on Ni2+- affinity resin
(Roche), followed by gel filtration. Purified proteins separated by SDS-PAGE and
stained with coomassie blue to determine the purity of recombinany Mtr4 proteins
(Fig. 3-16). The purity of recombinant proteins ranged from 80% to 95%. In each
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Figure 3-16. Purification of recombinant Mtr4 wild-type & mutant proteins.
Figure legend see next page.
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A. SDS PAGE gel of purified proteins. 6His-tagged Mtr4p was overexpressed by autoinduction in
E.coli, and purified by Nickel affinity chromatography (Clontech), followed by gel filtration
chromatography. Purified proteins were observed on a 8% SDS-PAGE Coomassie-stained gel and used
in all in vitro biochemical studies. B. Gel filtration chromatography of wild-type Mtr4p using HiPrep
16/60 Sephacryl S-200 column (GE Healthcare). Y-axis shows absorbance at OD280. X-axis indicates
the sample run time. The blue line shows the protein flow when the Mtr4p purified by nickel resin was
running through the column. The peak indicated by a red arrow corresponds to Mtr4p. Fractions of the
peak region were collected for in vitro studies.

experiment done, the amount of Mtr4p input was determined by OD280 to measure the
amount of protein in the sample and this amount was corrected based on the purity of
a given recombinant Mtr4p. All experiments were conducted using equivalent molar
amounts of mtr4p.

K700N and P731S Mutations Reduces Mtr4p RNA Binding Activity

RNA binding is the basis and prerequisite for Mtr4p to perform its enzymatic
activities including ATP hydrolysis and substrates (K700N, P731S) unwinding.
EMSA was performed to detect if the KOW domain mutants have RNA binding
defects, using 32P radiolabelled 16nt RNA duplex that contains 6nt 3’end extension
(refer as R1R4, see Table 2-11). Both Mtr4-700p and Mtr4-731p bound RNA at a
substantially lower level, compared to wild-type Mtr4p (Fig. 3-17). Mtr4-700p
showed slightly less RNA binding affinity compared to Mtr4-731p. I conclude that
the positively charged residues lysine 700 and proline 731, which are located in the
long loops of the KOW domain that is positioned towards the RecA domains in the
3-D structure, contribute to RNA binding of Mtr4p in a significant way. It was
reported that the KOW domain is sufficient but not necessary for Mtr4p binding with
structured RNA substrate tRNAiMet in vitro (Weir et al. 2010). However,
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Figure 3-17. RNA binding activity of KOW domain mutants.
EMSA was performed with16bp radiolabelled RNA duplex containing 6nt single-stranded 3’ overhang
(R1R4), using recombinant wild-type or mutant Mtr4p at indicated gradient concentrations. Mtr4p used
in each reaction and its concentrations are all shown above the lanes. Upper bands represent
Mtr4p-RNA complex. Free RNA runs to the bottom of the gel. Cartoon figure on the left shows the
structure of RNA substrates. The asterisk indicates 32P radiolabel.

the KOW domain alone is not able to bind with single-stranded RNA substrate
(Halbach, Rode & Conti 2012a). All evidence suggests that the KOW domain
contributes to structured RNA binding rather than single-stranded RNA. In order to
examine if the KOW domain mutation K700N affects Mtr4p binding with RNA of
different structures, EMSA was performed with R4 (16nt single-stranded RNA, see
Table 2-11) and R161-2 (blunt-end duplex RNA, see Table 2-11). Interestingly,
Mtr4-700p showed binding defects with both substrates. Mtr4-700p RNA binding
activity was significantly reduced with blunt end duplex R161-2, but only slightly
reduced with same-length single-stranded RNA R4 (Fig. 3-18A &B). This
observation provides a new interpretation that, as part of the Mtr4p protein, the KOW
domain also contributes to single-strand RNA binding. Mtr4-700p showed significant
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Figure 3-18. Mtr4-700p had RNA binding defects with both single-stranded RNA and duplex.
EMSA was performed using wild-type Mtr4p or Mtr4p-K700n at the concentrations indicated, which
are shown above the lanes with indicated RNA substrates. Upper bands represent Mtr4p-RNA complex.
Cartoon figure shows the structure of RNA substrates, and the asterisk indicates 32P radiolabel. Free
RNA run to the bottom of the gel. A. EMSA with 16bp radiolabelled single strand RNA (R4). B
EMSA with radiolabelled 16bp blunt end RNA duplex (R161-2). C. EMSA with tRNAiMet. D. EMSA
with 16bp radiolabelled RNA duplex containing 6nt single-stranded 3’ overhang (R1R4).

binding defects when using tRNAiMet and R1R4 (16nt RNA duplex with 6nt
3’overhang) (Fig. 3-18 C& D). The similarity between these two substrates is that
they both contained double-stranded regions and single-stranded regions. From this I
conclude that the KOW domain contributes to multiple aspects of Mtr4p RNA
binding, more dominantly when binding with structured RNA, and to a lesser extent,
then binding with single-stranded RNA.
Mtr4-700/731p was created as a double mutant to test if these two residues in
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the KOW domain assist RNA binding in the same way, or if they act independently to
influence RNA-binding. Using R1R4 as the substrate in EMSA, the double mutant
showed nearly identical binding to RNA as each mutant (Fig. 3-19), suggesting that
effects by the two long loops of the KOW domain playing a redundant role in RNA
binding activity.
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Figure 3-19. K700N and P731S double mutant shows binding affinity similar to single mutant.
EMSA was performed with R1R4 as substrate, using indicated gradient amount of recombinant mutant
Mtr4p. Mtr4p for each reaction and its concentration are all shown above the lanes. Upper bands
represent Mtr4p-RNA complex. Cartoon figure shows the structure of RNA substrates. The asterisk
indicates 32P radiolabel. Free RNA runs to the bottom of the gel.

K700N and P731S Mutations Reduce Mtr4p ATPase activity
Mtr4p plays an important role in nuclear RNA processing and turnover, which
requires RNA dependent ATP hydrolysis to remove RNA secondary structure in a 3’
to 5’ direction (Wang et al. 2008b). Although the KOW domain is separate in 3-D
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space from the active ATPase site in Mtr4p. The ATPase activity dependent on RNA
binding, thus the KOW domain mutations may affect ATP hydrolysis since they
exhibit reduced binding to RNA substrates. To investigate if KOW mutants impair the
ATPase activity of Mtr4p, I conducted a spectrophotometric coupled enzyme assay to
measure ATP hydrolysis of each mutant (Bernstein et al. 2008) (See Materials &
Methods), in the presence of either saturated in vitro transcribed single-stranded RNA
or E. coli total tRNA (Roche) (Fig. 3-20A). Since recombinant proteins failed to
exhibit ATPase activity in the absence of RNA (Fig, 3-20A), all ATP hydrolysis
measured in these assays was carried out by Mtr4p that is activated by RNA.
Michaelis-Menten plots of Mtr4-700p and Mtr4-731p showed reduced ATP
hydrolysis compared to that of wild-type Mtr4p, with E. coli total tRNA as substrate
(Roche) (Fig.3-20A). The double mutant Mtr4-700/731p showed similar ATPase
activity as Mtr4p-700, the more severe mutant of the two, thus there is no synergistic
effect on ATP hydrolysis after combining the K700N and P731S mutations. This
result is consistent with the EMSA result showing that Lysine700 and Proline731
combined have no greater effect on RNA-binding than either single mutant. The
Michaelis- Menten constant (Km) value for substrate binding is not a reliable
measurement for RNA binding in this assay, since RNA can not be accurately defined
as a “substrate” that is catalyzed by Mtr4p into a different product (Fig. 3-20B). In
this assay, Mtr4p binding to RNA substrates, initiates unwinding, and the unwound
RNA (product) can again engage Mtr4p to stimulate ATP hydrolysis and unwinding.
Therefore, characterizations of RNA-binding activity will rely on the EMSA results
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Figure 3-20. ATPase activites of Mtr4p KOW mutants with E.coli total tRNA.
A. Plots of ATP hydrolysis rate versus E.coli total tRNA concentration. ATPase assays were conducted
with fixed concentration of recombinant wild-type or mutant Mtr4p (83.3 nM) at titrated
concentrations of E.coli total tRNA (Roche) (0.088 µM, 0.88 µM, 4.4 µM, 8.8 µM, 13.2 µM, 17.6 µM).
Saturating level of ATP (8 mM) was used in each reaction. ATPase activity was measured via ATPase
assay (Material & Methods). Plots of ATP hydrolysis rate versus RNA concentration showed best fits
to the Michaelis-Menten equation. All measurements were done in triplicates except Mtr4-700/731p
double mutant. B. Kinetic parameters of ATPase activity from curves in panel A.

above. This ATPase assay provides the means to calculate catalytic constant for
Mtr4p (kcat), which measures how rapidly does each mutant Mtr4p hydrolyzes ATP
while varying RNA concentrations. All mutants (Mtr4-700p, Mtr4-731p,
Mtr4-700/731p) contained ~ 30% lower ATPase activities than wild type protein in
term of Kcat (Fig. 3-20B), indicating that the KOW domain influence the efficiency of
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ATP hydrolysis by aiding in the stable binding of RNA.
I have shown that the KOW domain mutants exhibited more severe binding
defects with RNA duplex than single-stranded RNA. In order to test whether Mtr4
mutants show different levels of ATP hydrolysis when bound to different structured
RNA substrates, 75nt and 108nt single-stranded RNAs (see Materials & Methods)
were used to measure ATP hydrolysis. The Michaelis-Menten curves of K700N and
P731S mutants showed a decreased rate of ATP hydrolysis compared to that of
wild-type Mtr4p when either 75nt single-stranded RNA or 108nt single strand RNA
were used (Figs. 3-21A & 3-22A). The catalytic constant (kcat) values suggests that, in
comparison to wild-type protein, Mtr4-700p retained ~70% ATPase activity while
Mtr4-731p retained ~80% ATPase activity using 75nt single-stranded RNA (Fig.
3-21B). Similarly, ~70% ATPase activity was displayed by both Mtr4p-700 and
Mtr4p-731 when the 108nt single-stranded RNA was present in the assay (Fig.
3-22B). The KOW domain residues Lysine 700 and Proline 731 contribute to Mtr4p
ATPase activity similarly, whether using structured or unstructured RNA. In other
words, with different forms of RNA substrate present, Mtr4-700p and Mtr4-731p
always exhibited significant defects in ATPase activity (~30% less), which is
consistent with their defects in RNA binding.
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Figure 3-21. ATPase activities of Mtr4p KOW domain mutants with 75nt single-strand RNA.
A. Plots of ATP hydrolysis velocity versus 75nt single-stranded RNA concentrations. ATPase assay
was conducted using fixed concentration of recombinant Mtr4p (83.3nM) at gradient concentrations of
in vitro transcribed 75nt single-stranded RNA (0.044 µM, 0.088 µM, 0.22 µM, 0.44 µM, 0.88 µM, 1.76
µM, 3.52 µM). Saturating level of ATP (8 mM) was used in each reaction. ATPase activity was
measured via the same ATPase assay (see materials & Methods). Plots were fitted to the Michaelis
-Menten equation. Error bars represent standard deviations of three independent experiments. B.
Kinetic parameters of ATPase activity from curves in panel A.
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Figure 3-22. ATPase activities of Mtr4p KOW domain mutants with 108nt single-stranded RNA.
A. Plots of ATP hydrolysis rate versus 108nt single-stranded RNA concentrations. ATPase assay was
conducted with 83.3 nM recombinant wild-type or mutant Mtr4p at different 108nt single-stranded
RNA concentrations (0.0088 µM, 0.044 µM, 0.088 µM, 0.22 µM, 0.44 µM, 0.88 µM, 1.76 µM, 2.64
µM, 3.52 µM). Saturating level of ATP (8 mM) was used in each reaction. ATPase activity was
measured via the same ATPase assay (see materials & Methods). Plots were fitted to the Michaelis
-Menten equation. Error bars represent standard deviations of three independent experiments. B.
Kinetic parameters of ATPase activity from curves in panel A.

Finally, ATPase assay was performed with ATP titration instead of RNA
titration (Fig. 3-23A). Not like RNA, ATP is treated as a standard substrate, which is
turned over by enzyme Mtr4p in the assay, therefore Michaelis constant (Km)
provides accurate measurement for ATP affinity of Mtr4 protein. The Km value of
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Figure 3-23. ATPase activities of Mtr4p KOW domain mutants with ATP titration.
A. Plots of ATP hydrolysis velocity versus ATP concentration. ATPase assay was conducted with 83.3
nM recombinant Mtr4p at different ATP concentration (0.25 mM, 0.5 mM, 1 mM, 2 mM, 4 mM, 8
mM). Nearly saturating level of Escherichia coli total tRNA (Roche) (9 µM) was used in each reaction
to stimulate Mtr4p. ATPase activity was measured via the same ATPase assay (see materials &
Methods). Plots showed best fits to the Michaelis-Menten equation. All measurements were done in
triplicates. B. Kinetic parameters of ATPase activity from curves in panel A.

Mtr4p-731p were statistically comparable to Km of wild-type (P > 0.1, by T test for
unpaired data), which indicates that ATP binding was not affected by KOW domain
mutation P731S (Fig. 3-23B). Compared to wild type Km, ~ 50% more ATP was
required for half of Mtr4-700p maximum hydrolysis rate (Fig. 3-23B). Therefore,
Mtr4-700p displayed significantly lower ATP affinity (p < 0.01, by T test for
unpaired data). Consistent with ATPase assay of RNA titrations, both KOW domain
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mutants contained ~70% ATPase activities compared to wild-type protein. Overall,
KOW domain mutants display reduced ATPase rate. K700N mutation may influence
ATP affinity indirectly, since ATP binding site located in between the two RecA
domains is far from the KOW domain. Mtr4p was characterized as a RNA-dependent
ATPase, and higher RNA concentration induces higher ATPase rate (Bernstein et al.
2008). Impaired RNA binding abilities of the mutants might be the part of the reason
for their reduced ATPase activities.

Mutation K700N Cause Slight Unwinding Defects

To provide a more mechanistic view of ATPase activity coupled with
RNA-binding and unwinding, I next tested Mtr4p wild-type and mutants in a timed
unwinding assay to enable calculation of the rate of unwinding (Wang et al. 2008b,
Jia et al. 2012). Strand displacement of 16 nt 32P radiolabelled RNA duplexed with a
22 nt complementary RNA that creates a 6 nt 3’overhang (R1-4) was tested for all
recombinant wild-type and Mtr4p mutants. Mtr4-700p mutant showed impaired
unwinding abilities, (Fig. 3-24 A& B), and the observed unwinding rate constant of
K700N mutant (Kobs unw =~0.071 min-1) was ~25% lower than that of wild-type Mtr4p
(Kobs unw =~0.095 min-1), indicating that it had slightly reduced strand separation
activities (Fig. 3-24 C). Mtr4-731p didn’t show any defects in unwinding assay (Fig.
3-24). Together with their wild-type growth phenotypes in vivo, this suggested that
the KOW domain is not necessary for unwinding activities of the entire Mtr4p protein
or the TRAMP complex. Although Mtr4-700p and Mtr4-731p both displayed severe
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Figure 3-24. Unwinding activities of Mtr4p KOW domain mutants.
A. Representative PAGE of unwinding reactions using 0.5 nM R1-4 and 50 nM Mtr4 proteins. Aliquots
of each reaction were removed and stopped at indicated time points below each lane. Mtr4p used in
each reaction was shown above the lanes. Animations on the left indicate duplex and single-stranded
form of RNAs. B. Time courses for unwinding reactions. Data was collected from triplicate
experiments. Plots of single-stranded fraction versus time were fitted to first-order reaction. C. Kinetic
parameters of Mtr4p mutant unwinding activities. Reaction amplitude (A) and observed unwinding rate
constant were drawn from the plots in panel B. Reaction amplitude provides the measure for fraction of
duplex that has been unwound.

RNA binding defects, if it caused Mtr4-731p ATPase defects, then they all suggest
that RNA binding activities of the KOW domain are not necessary for Mtr4p helicase
activity. Mtr4-700p showed ATP binding defects, which could be the reason why its
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defects in unwinding activity correlate with ATPase activity defects. Taken together,
the contributions of the KOW domain for Mtr4p enzymatic activities are not
necessary, and could be complemented by helicase core of Mtr4p or other subunits of
the TRAMP complex. Since the winged helix and ratchet domain mutants showed
obvious in vivo defects, it’s likely that the structural domains in the helicase core are
more important for its enzymatic activities.
Consistent with RNA binding and ATPase activities, K700N/P731S double
mutant didn’t show more severe defects than either of the mutants in strand
displacement measurement (Fig. 3.25). It displayed exactly the same unwinding
activities as Mtr4-700p. I conclude that the two long loops of the KOW domain
cooperate with each other to perform their function through the same pathway.
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Figure 3-25. K700N and P731S double mutant shows similar unwinding pattern as K700N
mutant.
Representative PAGE of unwinding reactions of 0.5nM R1-4 by 50nM WT Mtr4p or mutants. Aliquots
of each reaction were removed and stopped at indicated time points above each lane. Mtr4p used in
each reaction was shown above the time. Animations on the left indicate duplex and single-stranded
form of RNA.

From the in vitro studies of KOW domain mutants, I conclude that the KOW
domain contributes to RNA binding in a significant way, with preference on RNA
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duplex. The KOW domain also affects ATPase activities mostly through influence on
RNA binding, and Lysine 700 indirectly affects ATP binding. It was reported that
3’overhang of RNA substrates is required for Mtr4p to unwind them efficiently,
indicating Mtr4p may first load onto the single-stranded region, which is not a
preferred binding site of the KOW domain (Jia et al. 2011b). It explained why the
RNA binding activities of the KOW domain are not important for enzymatic activities
in strand displacement, and also why KOW mutants didn’t show any defects in vivo.
Overall, the KOW domain is important for Mtr4p RNA binding activities, contribute
to ATP binding and ATP hydrolysis, but not necessary for Mtr4p unwinding
activities.
II. Mtr4p Winged Helix Mutant K904N and Ratchet Domain Mutant R1030G
are Defective in RNA Binding, ATP Hydrolysis and Unwinding Activities in
vitro.
Mtr4-904p and Mtr4-1030p Performed Significant Defects in RNA Binding
Unlike the arch domain, the winged helix and the ratchet domains are located
at the helicase core. RecA domains, winged helix domain (WH) and ratchet domain
forms the globular base of Mtr4p. WH and ratchet domains are across from the two
RecA-like domains (Fig. 3-3). Mtr4p structure crystalized with RNA shows that the
Arginine 1030 is at a location close to RNA substrates, indicating its potential role in
RNA binding (Weir et al. 2010) (Fig.3-3). To investigate whether mutants in the
helicase core C-terminal domains play a role in substrate binding, EMSA was
performed using 32P radiolabelled 16nt RNA duplex with 6nt 3’overhang (R1-4).
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Mtr4-1030p bound RNA at an impressively lower level，in comparison to wild-type
Mtr4p (Fig. 3-26). Upon quantitating the amount of free RNA duplex, Mtr4-904p
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Figure 3-26. RNA binding activities of winged helix mutant Mtr4-904p and ratchet domain
mutant Mtr4-1030p.
EMSA was performed with indicated gradient amount of purified recombinant WT or mutant Mtr4p
and 16bp radiolabelled RNA duplex containing 6nt single-stranded 3’ overhang (R1-4). Mtr4p for each
reaction and its concentration are shown above the lanes. Upper bands representing Mtr4p-RNA
complex were indicated by arrows. Multiple bands might be complexes of multiple proteins. Free RNA
runs to the bottom of the gel. Cartoon figure on the left shows the structure of RNA substrates, and the
asterisk indicates 32P radiolabel.

showed little difference from wild-type Mtr4p in binding. Upon further analysis,
Mtr4-904p EMSA showed reduced amounts of protein-RNA complex formation than
wild-type and slightly higher levels of smearing between unbound and bound RNA
duplex, possibly indicating a weaker binding affinity or greater dissociation of
Mtr4-904p.Together with our in vivo studies that proved a lower protein level of
Mtr4-904p, the RNA binding defects could be also due to an unstable protein
structure. I conclude that the positively charged residues in helicase core structural
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domains, winged helix lysine 904 and ratchet domain arginine 1030, contribute to
RNA substrates binding of Mtr4p.

Mtr4p Winged Helix and Ratchet Domains Mutants Cause Reduced ATPase Rate
in vitro

The crystal structure of Mtr4p suggested that ATP binding site was located in
the cleft between the two RecA domains (Weir et al. 2010), similar to other helicases
of the same superfamily. Therefore, Mtr4p is predicted to recruit in a mechanism
similar to other DNA/RNA helicases in superfamily II (Johnson, Jackson 2013). That
is, ATP binding causes Mtr4p conformational change, which further drives protein
translocation along RNA. To determine whether structural domains in the helicase
core assist ATP affinity and hydrolysis, I conducted the same ATPase assay to
measure ATPase activities of winged helix mutant Mtr4-904p and ratchet domain
mutant Mtr4-1030p (Bernstein et al. 2008), with E. coli total tRNA (Roche). Both
mutants showed reduced ATPase activities (Kcat) compared to wild-type Mtr4p with
either RNA titration or ATP titration (Figs. 3-27 & 3-28). The Michaelis constant (Km)
values for ATP affinity of Mtr4-904p were statistically comparable to Km of
wild-type, which indicates that ATP binding was not affected in the WH mutation (P >
0.1, by T test for unpaired data) (Fig. 3-28 B). Compared to wild type Mtr4p Km, ~ 35%
more ATP was required for half of Mtr4-1030p maximum hydrolysis rate (Fig. 3-28
B). Therefore, ratchet domain mutant Mtr4-1030p displayed lower ATP affinity (P <
0.05, by T test for unpaired data). Both mutations K904N and R1030G reduced ATP
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Figure 3-27. ATPase activity of Mtr4- 904p and Mtr4-1030p with E.coli total tRNA.
A. Plots of ATP hydrolysis velocity versus RNA concentration. ATPase assay was conducted with
recombinant Mtr4p (83.3 nM) at titrated concentrations of E.coli total tRNA (Roche) (0.088 µM, 0.44
µM, 0.88 µM, 4.4 µM, 8.8 µM, 13.2 µM, 17.6 µM). Saturating level of ATP (8 mM) was used in each
reaction. ATPase activity was measured via the same ATPase assay (see materials & Methods). Plots
showed best fits to the Michaelis-Menten equation. All measurements were done in triplicates. B.
Kinetic parameters of ATPase activity from curves in panel A.

hydrolysis rate, in terms of Kcat, K904N held ~70% ATPase activity compared to
wild-type, while R1030G only retained less than 60% ATPase activity（Figs. 3-27 B
& 3-28 B). Overall, the winged helix and ratchet domain mutants exhibited reduced
ATP hydrolysis, which is consistent with their RNA binding defects, in an order of
R1030G < K904N. Therefore, RNA binding defects might cause ATPase defects.
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Ratchet domain also contributes to ATP binding activity of Mtr4p. R1030G is worse
in ATP hydrolysis, not only due to its lower RNA binding activity but also lower ATP
affinity.
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Figure 3-28. ATPase activities of Mtr4-904p and Mtr4-1030p with ATP titration.
A. Plots of ATP hydrolysis velocity versus ATP concentration. ATPase assay was conducted with
fixed concentration of recombinant wild-type or mutant Mtr4p (83.3 nM) at different ATP
concentration (0.25 mM, 0.5 mM, 1 mM, 2 mM, 4 mM, 8 mM). Nearly saturating level of Escherichia
coli total tRNA (Roche) (9 µM) was used in each reaction to stimulate Mtr4p. ATPase activity was
measured via the same ATPase assay (see materials & Methods). Plots showed best fits to the
Michaelis-Menten equation. All measurements were done in triplicates. B. Kinetic parameters of
ATPase activity from curves in panel A.

Mtr4p Winged Helix and Ratchet Domains Contribute to Mtr4p Helicase Activities
I also tested whether Mtr4-904p and Mtr4-1030p are defective in unwinding
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RNA substrates using 16nt 32P radiolabelled RNA duplex with 6nt 3’overhang (R1-4)
(Wang et al. 2008b, Jia et al. 2012). Both mutants showed various degrees of
impaired unwinding activities (Fig.3-29). The observed unwinding rate constant of
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Figure 3-29. Mtr4p C-terminal domain mutants showed different defects in unwinding activities.
A. Representative PAGE of unwinding reactions of 0.5 nM R1-4 by 50 nM Mtr4p. Aliquots of each
reaction were removed and stopped at indicated time points below each lane. Mtr4p used in each
reaction was shown above the lanes. Animations on the left indicate duplex and single-stranded forms
of RNA. B. Time courses for unwinding reactions. Data was collected from triplicate experiments.
Plots of single strand fraction versus time were fitted to a first-order reaction. C. Kinetic parameters of
Mtr4p mutant unwinding activities. Reaction amplitude and observed unwinding rate constant were
drawn from the plots in panel B.

Mtr4-904p (Kobs unw =~0.060-1) and Mtr4p-R1030G (Kobs unw =~0.063-1), were ~ 40%
lower than that of wild-type Mtr4p (Kobs unw =~0.095 min-1), indicating that they both
had reduced strand separation activities (Fig. 3-29B). It suggested that structural
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domains in the helicase core are important for enzymatic activities. K904N who had
better RNA binding and ATPase activities compared to R1030G mutant surprisingly
performed the similar unwinding activities, but consistent with its worse in vivo
growth phenotype, suggesting that the winged helix plays a significant role in Mtr4
function overall. It contributes not only to RNA binding and ATPase activity, but also
to protein stability which was revealed by our in vivo studies. Finally, unwinding
assay suggests that the winged helix and ratchet domains contribute to Mtr4p helicase
activities while unwinding RNA substrates.
III. S672 and P802, at Joints of the KOW and Stalk Domains, are not important
for Mtr4p Function in vitro

The KOW domain plays a significant role in RNA binding, and also assists
ATP hydrolysis and unwinding activities at some level. The structure of Mtr4p
suggested that the KOW domain is a very flexible domain (Weir et al. 2010), and the
stalk domain might control the KOW domain movements via expansion and contract
(Jackson et al. 2010). In order to detect whether the stalk domain is important for
either the KOW domain function or entire protein activities, same series of enzymatic
assays were performed. EMSA didn’t show mutations S672N and P802S cause any
problems in RNA binding, comparing to wild-type protein (Fig.3-30). Similarly,
Mtr4-672p and Mtr4-802p are not defective in ATP binding, and also performed
comparable ATP hydrolysis abilities as wild-type protein (Fig.3-31). Consistently, no
unwinding defects were observed in strand displacement assay by Mtr4-672p and
Mtr4-802p (Fig.3-32). Overall, neither in vivo nor in vitro studies suggested decreased
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enzymatic activities of these two mutants, indicating that the joints region between
the KOW domain and stalk domain are not important for the KOW domain function
or Mtr4p activities.
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Figure 3-30. RNA binding activities of stalk domain mutants Mtr4-672p and Mtr4-802p.
EMSA was performed using R1-4 with indicated gradient amount of recombinant wild-type or mutant
Mtr4p. Mtr4p for each reaction and its concentration are all shown above the lanes. Upper bands
represent Mtr4p-RNA complex. Free RNA runs to the bottom of the gel. Cartoon figure on the left
shows the structure of RNA substrates, and the asterisk indicates 32P radiolabel.
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Figure 3-31. ATPase activities of stalk domain mutants Mtr4-672p and Mtr4-802p.
A. Plots of Mtr4-S672N mutant compared to wild-type. Each experiment contains increasing amount
of ATP substrate (0.01 mM, 0.05 mM, 0.1mM, 0.2 mM, 0.4mM, 0.8 mM, 1 mM, 2 mM, 4 mM, 6 mM,
8 mM, 10mM). B. Kinetic parameters of ATPase activity from curves in panel A. C. Plots of
Mtr4-P802S mutant and wild-type. Each experiment contains different concentrations of ATP
(0.25mM, 0.5mM, 1mM, 2mM, 4mM, 8mM). D. Kinetic parameters of ATPase activity from curves in
panel C. ATPase assay was conducted with fixed concentration of recombinant Mtr4p (83.3nM) at
different ATP concentration. Nearly saturating level of Escherichia coli total tRNA (Roche) (9 µM)
was used in each reaction to stimulate Mtr4p. ATPase activity was measured via the same ATPase
assay (see materials & Methods). Plots showed best fits to the Michaelis-Menten equation. All
measurements were done in triplicates. Plots of ATP hydrolysis rate versus ATP concentration showed
best fits to the Michaelis-Menten equation. Note: Experiments in A and C were carried out separately
using coupled enzymes from different purchases, which dramatically affect reaction efficiency.
ATPase activity of wild-type Mtr4p was always tested under same condition at the same time with
mutants, performing as a positive control.
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Figure 3-32. Unwinding activities of Mtr4-672p and Mtr4-802p.
Unwinding reactions of 0.5 nM R1-4 were performed by 50 nM wild-type Mtr4p or mutants. Aliquots
of each reaction were removed and stopped at indicated time points below each lane, followed by
PAGE separation. Mtr4p used in each reaction was shown above the lanes. Animations on the left
indicate duplex and single-stranded form of RNA.

IV. All Structural Domain Mutants are able to Assemble TRAMP Complex

Mtr4p plays its role as a helicase in RNA metabolisms mostly as a component
of the TRAMP complex rather than itself (LaCava et al. 2005, Wang et al. 2008b,
Vanacova et al. 2005). It also has been shown that arch domain is not required for
Mtr4p binding with Trf4p-Air2 (Weir et al. 2010). Truncated Mtr4p losing C-terminal
half winged helix and entire ratchet domain cannot form TRAMP complex in vitro
(Holub et al. 2012). The winged helix and ratchet domain are residing in the helicase
core of Mtr4p, potentially playing a role in TRAMP assembly. I conducted in vitro
reconstitution of the TRAMP complex and verifed complex formation by a Flag
purification of Flag-tagged Trf4p (see Material and Methods). Pull-down of
His-tagged Mtr4p and His-tagged Air2p were detected by western blot (Fig. 3-33).
All Structural domain mutants can assembe the TRAMP complex in a similar way as
wild-type Mtr4p. This in turns solidified our in vivo dominant-negative screen,
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Figure 3-33. Assembly of the TRAPM complex by Mtr4p structural mutants.
In vitro reconstitution of the TRAMP complex was performed with mixture of total cell proteins from
E.coli expressing his-tagged Mtr4p and E.coli co-expressing flagged-tagged Trf4p & his-tagged Air2p
(See materials & methods). Trf4p was purified by anti-Flag resin, and pull-down of Air2p-Mtr4p were
were visualized by Western Blot using α-HIS antibody. Trf4p was observed by α-Trf4 antibody. Far
left lane was a negative control without Mtr4p in the reconstitution.

which needs Mtr4p mutant enters the intact TRAMP complex by kicking out
wild-type Mtr4p. In other words, mutants found by our initial screen are the ones that
can assemble the TRAMP complex. I conclude that structural domain mutations
characterized in this study don’t affect the TRAMP complex assembly.

Part III: Characterization of Mtr4p Enzymatic Activities
I. Single-stranded RNA is a Preferred Substrate for Mtr4p
Mtr4p Binds Better with Single-stranded RNA than Duplex

Mtr4p has been reported to have various in vivo substrates with different
structures and lengths. How Mtr4p discriminates between different substrates and
Mtr4p’s preference are still unknown. Whether Mtr4p performs different enzymatic
activities with different RNA substrates is not determined yet. The Toth group
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demonstrated that Mtr4p prefers binding with ssRNA that is dependent on length or
more adenosines in the sequence (Bernstein et al. 2008). When I was testing whether
Mtr4-700p had different binding defects with different RNA substrates in EMSA,
Mtr4p (either mutant or wild-type) displayed vastly higher RNA binding activities
using 16nt single-stranded RNA (R4) compared to the same-length 16nt RNA duplex
(R161-2) (Fig. 3-34). The binding affinity of 3 µM Mtr4p with 0.5nM 16nt
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Figure 3-34. Mtr4p binds better with single strand RNA than duplex.
A. EMSA of 16bp radiolabelled single strand RNA. B. EMSA of radiolabelled 16bp blunt end RNA
duplex. EMSA was performed using wild-type Mtr4p at gradient concentrations, which are shown
above the lanes with indicated RNA substrates. Upper bands represent Mtr4p-RNA complex. Cartoon
figure shows the structure of RNA substrates, and the asterisk indicates 32P radiolabel. Free RNA run
to the bottom of the gel.

single-stranded RNA was similar to the binding of 30 µM Mtr4p with 0.5 nM 16nt
duplex RNA, indicating that Mtr4p binding affinities for singled strand RNA was
increased almost 10 fold higher. This suggests that single-stranded RNA is a preferred
substrate for Mtr4p in terms of binding.
In order to further investigate whether RNA structure affects Mtr4p binding,
76nt tRNAiMet that contains 42nt unpaired sequence and 16nt RNA duplex with a 6nt
single strand overhang (R1-4) were tested in EMSA. This result showed that in
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comparison to R1-4, Mtr4p binds better with 16nt single-stranded RNA but worse than
blunt-end 16nt duplex (Figs. 3-34 & 3-35). It indicates that the length of
single-stranded region affects Mtr4p RNA binding in a significant way. This is further
confirmed by EMSA with tRNAiMet that contains longer single-stranded middle
sequence rather than single-stranded overhang at the end. And tRNAiMet is much more
favored by Mtr4p than either 16nt single-stranded RNA or 16nt RNA duplex with 6nt
3’ overhang (Figs. 3-34 & 3-35). I conclude that single-stranded sequence, in the
middle or overhang, are similarly recognized by Mtr4p, and bound by Mtr4p in a
more efficient way than duplex.
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Figure 3-35. Mtr4p binds better with RNA substrates with longer single-stranded region.
A. EMSA of radiolabelled tRNAiMet purified from yeast. B. EMSA of 16bp radiolabelled RNA duplex
containing 6nt single-stranded 3’ overhang. EMSA was performed using wild-type Mtr4p at gradient
concentrations which are shown above the lanes with indicated RNA substrates. Upper bands represent
Mtr4p-RNA complex. Cartoon figure shows the structure of RNA substrates, and the asterisk indicates
32

P radiolabel. Free RNA run to the bottom of the gel.

Single-stranded RNA Stimulates Higher Mtr4p ATPase Activities than Same-length
Structured RNA, in a Length-dependent Manner
Next I asked whether the preferred substrate singled-stranded RNA stimulated
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higher Mtr4p ATPase activities than a similar-length structured RNA. The ATPase
assay was conducted with E.coli total tRNA (~76nt on average) or 75nt in vitro
transcribed single-stranded RNA (R75). The specificity constant kcat/Km was
calculated to compare kinetic efficiencies of wild-type Mtr4p using different RNA
substrates. Mtr4p displayed almost 20 fold higher catalytic efficiency when
stimulated with 75nt single-stranded RNA (kcat/Km ~430) than with E.coli total tRNA
(kcat/Km ~ 25) (Fig. 3-36). Together with the EMSA results of RNA binding,
single-stranded RNA that binds Mtr4p better also activates significantly higher
enzymatic activities of Mtr4p. Since single-stranded RNA cannot be unwound, it
indicates that RNA binding directly modulates ATPase activities of Mtr4p, most
likely through protein conformational change.
To further investigate whether stimulation of single-stranded RNA on Mtr4p
ATPase activities is also in a length-dependent manner like their binding, ATPase
activities of Mtr4p with in vitro transcribed 75nt single-stranded RNA or 108nt
single-stranded RNA were tested. Mtr4p displayed 3 fold higher catalytic efficiency
(kcat/Km) in ATPase assay when using 108nt single-stranded RNA (kcat/Km ~ 1300)
than 75nt single-stranded RNA (kcat/Km ~ 430) (Fig. 3-37). In summery, the data
suggests single-stranded RNA stimulates Mtr4p ATPase activities in a
length-dependent manner. It also demonstrated that single-stranded RNA is a
preferred substrate for Mtr4p not only in terms of binding but also ATPase activities.
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Figure 3-36. Mtr4p performs higher ATPase activities with 75nt single-stranded RNA than
tRNA.
A. Plots of ATP hydrolysis velocity versus RNA concentration. ATPase assay was conducted using
83.3 nM recombinant wild-type Mtr4p at gradient concentrations of RNA substrates. E.coli total
tRNAs at different concentrations (Roche) (0.088 µM, 0.88 µM, 4.4 µM, 8.8 µM, 13.2 µM, 17.6 µM)
were used for its titration. Similarly, gradient concentrations of in vitro transcribed 75nt single-stranded
RNA (0.044 µM, 0.088 µM, 0.22 µM, 0.44 µM, 0.88 µM, 1.76 µM, 3.52 µM) was used for its titration.
Plots of ATP hydrolysis rate versus RNA concentration were fitted to the Michaelis-Menten equation.
Error bars represent standard deviation from three independent experiments. B. Kinetic parameters of
ATPase activity from curves in panel A.
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Figure 3-37. 108nt single-stranded RNA stimulate higher ATPase activities than 76nt RNA.
A. Plots of ATP hydrolysis velocity versus RNA concentration. 83.3 nM recombinant wild-type Mtr4p
was used in each reaction. Gradient concentrations of in vitro transcribed 76nt single-stranded RNA
(0.044 µM, 0.088 µM, 0.22 µM, 0.44 µM, 0.88 µM, 1.76 µM, 3.52 µM ) were used for its titration.
Similarly, 108nt single-stranded RNA at different concentrations (0.0088 µM, 0.044 µM, 0.088 µM,
0.22 µM, 0.44 µM, 0.88 µM, 1.76 µM, 2.64 µM, 3.52 µM) were used for its titration. Plots of ATP
hydrolysis rate versus RNA concentration were fitted to the Michaelis-Menten equation. All
measurements were done in triplicates. B. Kinetic parameters of ATPase activity from curves in panel
A.
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II. Mtr4p Promotes RNA Annealing and Modulate the Balance between
Unwinding and Re-annealing
Higher Mtr4p Concentration Induces Higher Re-annealing Rate
A lot of helicases were found to perform both unwinding activities and
strand-annealing activities. For example, RNA helicase A, which is a member of SF2,
is not only able to unwind various substrates including RNA duplex, DNA duplex and
DNA-RNA duplex, but also to facilitate annealing of tRNA3Lys (Zhang, Grosse 2004,
Xing, Liang & Kleiman 2011). A helicase that belongs to DEAD-box proteins Ded1
was also found to modulate both unwinding and annealing activities. (Yang,
Jankowsky 2005). The Jankowsky lab also reported that both Mtr4p and TRAMP
complex possess strand-annealing activities (Jia et al. 2012). The mechanism of how
Mtr4p facilitates strand annealing is still unknown. I first conducted the re-annealing
test. Re-annealing condition is the same as unwinding assay, with the exception that
the 16nt RNA duplex with 6nt overhang (R1-4) was boiled before adding to the
reactions (Fig.3-38). Control reaction with no Mtr4p showed the natural re-annealing
rate of the complementary single strands. Compared to that, higher Mtr4p
concentration induced faster strand re-annealing. It demonstrated that Mtr4p promotes
strand annealing in a concentration-dependent manner.
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Figure 3-38. Higher Mtr4p concentration induces higher re-annealing rate under re-annealing
conditions.
Re-annealing reactions were performed under the same condition for unwinding reactions, except that
duplex RNA were boiled to denature right before adding to the reactions. 0.5 nM R1-4 was used for
each experiment with different wild-type Mtr4p concentrations (0 nM, 20 nM, 40 nM, 60 nM). Low
Mtr4p concentrations were used to avoid fast unwinding activities. Aliquots of each reaction were
removed and stopped at indicated time points above each lane, followed by PAGE separation. Mtr4p
used in each reaction was shown above the time. Animations on the left indicate duplex and
single-stranded form of RNA.

Mtr4p Modulates the Balance between Unwinding Activities versus Annealing in a
Concentration-dependent Manner
Next question is how Mtr4p controls and balances the two opposite activities,
unwinding and annealing. Interestingly, the unwinding assay with different
concentrations of recombinant Mtr4p revealed that Mtr4p performed increasing
unwinding activities with increasing enzyme concentrations under 100 nM, but
decreasing unwinding activities when enzyme concentration were further increased
(Fig. 3-39). Mtr4p can barely unwind any duplex at the concentration of 800nM
(Fig.3-39). It suggests that RNA re-anneals significantly fast when higher than 100
nM Mtr4p were present in the reaction. Mtr4p was able to modulate the balance
between unwinding and re-annealing, with preference on unwinding at lower protein
concentration, and dominant on re-annealing at higher protein concentration.

127

0 nM

Time

8

100 nM
5

25

40

5

10

20

200 nM
30

5

10

20

400 nM
30

5

10

20

800 nM
30

5

10

20

30

min

bo
du iled
pl
ex

Mtr4p

16-22bp
*
16bp
*

Figure 3-39. Mtr4p modulates the balance between unwinding and re-annealing activities.
Unwinding reactions of 0.5 nM R1-4 were performed using different wild-type Mtr4p concentrations
(100 nM, 200 nM, 400 nM, 800 nM). Aliquots of each reaction were removed and stopped at indicated
time points above each lane, followed by PAGE separation. Mtr4p used in each reaction was shown
above the time. Animations on the left indicate duplex and single-stranded form of RNA.

Mtr4p Modulates the Balance between Unwinding and Annealing in an
ATP-dependent Manner
Mtr4p is known to perform its unwinding activities in an ATP-dependent
manner (Wang et al. 2008a). It was reported that Ded1 protein, which is a DEAD box
helicase that belongs to SFII, modulates the balance between unwinding and strand
annealing activities, dependant on ATP. Since Mtr4p is also a member of SFII
helicases, it may have similar working mechanism. I titrated ATP in unwinding
conditions using the fixed enzyme concentration and RNA concentration (Fig. 3-40).
It suggested that Mtr4p modulated its balance between unwinding and re-annealing
activities in an ATP-dependent manner, similarly with the modulation by protein
concentration. Within lower range of ATP concentrations (0.8 mM to 1.6 mM), Mtr4p
unwound RNA faster. However, compared to the reaction containing 1.6 mM ATP,
4.8 mM ATP negatively influenced Mtr4p unwinding activities, which means
re-annealing became more dominant (Fig. 3-40). Mtr4p was not able to unwind any
substrates with 8 mM ATP present in the reaction, indicating re-annealing was even
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faster than with 4.8mM ATP in the reaction (Fig. 3-40). In summary, at lower ATP
concentration, Mtr4p favors unwinding, but at higher ATP concentration,
re-annealing activities became unbeatable. Thus similar to DEAD box proteins, Mtr4p
modulates the unwinding and re-annealing of RNA substrates in an ATP-dependent
manner. This result also indicates that helicases in SF2 may have the similar
regulations on modulating unwinding activities versus strand-annealing activities.
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Figure 3-40. Increasing concentrations of ATP cause higher re-annealing rate under unwinding
condition.
Unwinding reactions of R1-4 were performed with 50 nM wild-type Mtr4p at different ATP
concentrations (0.8 mM, 1.6 mM, 4.8 mM, 8 mM). Aliquots of each reaction were removed and
stopped at indicated time points above each lane, followed by PAGE separation. Mtr4p used in each
reaction was shown above the time. Animations on the left indicate duplex and single-stranded form of
RNA.
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CHAPTER IV. DISCUSSION

I. Summary
In this study, I created a library of Mtr4p structural domain mutants that are
defective in hypomodified tRNAiMet turnover. KOW domain mutations K700N and
P731S reduced RNA binding affinities and ATPase activities. Mtr4-700p also
displayed lower ATP affinity. However, Mtr4-731p showed normal unwinding
activity and Mtr4-700p retained about 80% of the unwinding activity. Consistent with
the unwinding results, the in vitro defects of KOW domain mutants on RNA binding
and ATPase activity didn’t lead to in vivo defects in tRNAiMet turnover. This strongly
suggests that the RNA binding activity of the arch domain is not essential for Mtr4p
to function in the degradation of hypomodified tRNAiMet. I also characterized two
mutants in the helicase core structural domains, winged helix domain mutant
Mtr4-904p and Ratchet domain mutant Mtr4-1030p. They both showed severe defects
in tRNAiMet turnover in vivo. Mtr4-904p expressed less than 50% of wild type protein,
indicating the winged helix domain contributes to protein stability. Mtr4-1030p
reduced ATP binding affinity. Both K904N and R1030G caused defects in RNA
binding, ATPase activity and unwinding activity at different levels. Taken together,
the results revealed that residues in structural domains affect different aspects of
Mtr4p enzymatic activity.
In the second part of this study, I characterized the substrate preference of
Mtr4p. I found that, compared to RNA duplex, single-stranded RNA is not only a
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better substrate for Mtr4p binding, but also activates the ATPase activity greater. This
indicates that Mtr4p RNA binding ability correlates with ATP hydrolysis, probably
through protein conformational change upon RNA-binding. As a helicase, Mtr4p is
capable of reannealing unwound RNA. When unwinding assays were done with
Mtr4p in excess, the re-annealing rate obscured unwinding due to the rapid rate of
reannealing. The reannealing activity exhibited by Mtr4p was shown to be dose
dependent. Similarly, above certain ATP concentrations, re-annealing became more
dominant and increased with increasing concentrations of ATP.

II. Mtr4p Working Model

My results suggest that a working model might help to explain the results I
have put forward in this dissertation. Since the KOW domain uniquely bound
unmodified tRNAiMet but not fully modified tRNAiMet in vitro (Halbach, Rode &
Conti 2012a), it was believed that the KOW domain plays a supporting role in
identifying RNA substrates, and my data suggests it may also insure delivery of the
bound RNA to the helicase core of Mtr4p. In my study, RNA binding defects found
for KOW domain mutants did not lead to defects in tRNAiMet turnover. If the KOW
domain is important for recognition of hypomodified tRNAiMet, at least some defect in
its degradation should have been observed. Thus, rather than identification of
structured RNA, my results suggest that the KOW domain may only contribute to
RNA binding and not recognition. Comparing the different assay conditions, the
KOW domain mutants displayed defects in RNA binding using EMSA, in the absence
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of ATP, conditions under which Mtr4p is unable to perform as and RNA helicase. In
contrast, the KOW domain mutants showed less or even no defects in the ATPase and
unwinding assays, under conditions where Mtr4p is able to complete cycles of ATP
hydrolysis and RNA unwinding. Overall, it reveals a possibility that the KOW
domain stabilizes initial RNA binding when Mtr4p is loading RNA substrates, but the
KOW domain RNA binding seems to be dispensable for successful rounds of ATP
hydrolysis and RNA unwinding. When the helicase core binds the 3’ single-stranded
overhang of an RNA-RNA duplex, the KOW domain presents the single stranded
3’end to the helicase core through stably binding the double stranded portion of the
RNA. The distance between the helicase core and the KOW domain may provide an
explanation an ~ 4nt single-stranded RNA is the minimum length needed for Mtr4p to
load and become and active helicase (Jia et al. 2011b). If like other SFII helicase
family members that don’t contain an arch domain, Mtr4p helicase domains cooperate
with each other to enhance helicase activity, this may explain why KOW domain
mutants have defects on RNA binding, but much less so on the enzymatic helicase
cycles. Since both arch domain mutants exhibit marginal defects in ATPase activity,
where the K700N mutation also reduced ATP binding of Mtr4p, suggesting that RNA
binding activity of the KOW domain is tightly coupled with ATP binding and
hydrolysis, probably through protein conformational change. It’s already established
that ATP binding and hydrolysis does cause protein conformational changes in
helicase proteins that presumably drive enzyme translocation along RNA (Jankowsky,
Fairman & Yang 2005, Jankowsky, Fairman-Williams 2010, Jankowsky, Fairman
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2007a). The data suggest that during RNA unwinding, the KOW domain may still
bind the duplex region of the RNA for to facilitate RNA movement to the helicase
core, and conformational changes of different domains in Mtr4p may be coordinated
by the winged helix domain, which tethers the helicase core to the arch domain and
may also function in protein stability. The ratchet domain is considered for this
discussion to be dynamic in movement with each successive ATP hydrolysis cycle,
and the observations put forward here are consistent with the conclusion that the
ratchet domain regulates enzymatic activity through conformational changes in the
two RecA domains. Considering the relative positions of Mtr4p domains, RecA
domains are like two casements of a window, and the ratchet domain is like the wall
where the window located. Imagine the arch domain are the eaves hanging over the
window and sticks out. And the winged helix domain is like the hinges that regulates
open and close of the windows. With discussed above, I generated a model for Mtr4p
unwinding mechanism (Fig. 4-1), in which KOW domain is sufficient but not
necessary for substrate binding. The functions of each Mtr4p structural domains are
discussed separately below.
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Figure 4-1. Model of Mtr4p unwinding mechanism.
Color assignments of different domains are indicated in the figure. Brown triangle indicates RecA2
β-hairpin that peels the duplex apart. A typical Mtr4 substrate RNA with 3’ overhang is shown in
Black. 1. Protein loading onto RNA substrates. KOW domain sticks out interacting with RNA duplex
region. RNA 3’ overhang directs into the RNA channel inside of the helicase core. Upon ATP binding,
RecA1 moves towards RecA2. Arrows indicate moving directions of specific domains. 2. Arch domain
contracts towards helicase core, passing the RNA over to RecA2. At the same time, ATP hydrolyzed,
RecA2 moves towards KOW domain, taking over the RNA, unwinding it by the β-hairpin. 3. Upon
another ATP molecule binding, RecA1 moves towards RecA2. KOW domain sticks out again to take
RNA into the helicase core. Following RecA2 movement, this step finishes enzyme translocation along
RNA. During translocation, the ratchet domain interacts and holds RNA inside of helicase core,
avoiding dissociation. 4. Repeat step 2. The winged helix domain controls all the conformational
changes. The cartoon drawing of Mtr4p is modified from previous study(Johnson, Jackson 2013).
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III. The Advantages and Limitations of the Dominant-negative Screen
The dominant-negative screen designed and executed here will provide many
potential mutants in these understudied structural domains. To be considered a Mtr4p
mutant, a phenotype indicating failure or inhibited hypomodified tRNAiMet
degradation (suppressor-like). While the possibility of creating mutants in the region
is expansive, the screen itself only looks at tRNAiMet degradation, so mutations in
Mtr4p structural domains that do not affect how TRAMP facilitates tRNAiMet
degradation would not be identified, even if they were mutant for another Mtr4p
function. The error-prone PCR was designed to produce ~1-3 mutations in the Mtr4
amplified region, but seldom did single mutants get identified and several multiple
mutants were found. The task of screening each mutation stemming from a mutant
with multiple mutations is time consuming, which made it harder to apply
high-throughput techniques for greater coverage. An advantage of the
dominant-negative screen is that it’s a random, nonbiased screen that insures Mtr4p
mutant proteins assemble into the TRAMP complex more or less like the wild-type
Mtr4p. Another advantage is that the screen ignored null MTR4 mutations, since
these would have been inviable after selection against the wild-type MTR4 to reveal
potential phenotypes. It could save a lot of time. Finally, the dominant-negative
screen can be utilized to identify important amino acid residues in other domains like
helicase domain. It could also work in other stains with different genetic background
other than trm6-504, detecting mutations lead to dysfunctional Mtr4p in other RNA
metabolism pathways.
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My screen revealed a very strong mutation, K904N, however, when tested in
an otherwise wild-type strain it showed no growth phenotype. This revealed a
limitation of this dominant-negative screen; when screening for suppression of a
growth phenotype, this screen will less likely provide mutations in MTR4 that exhibit
their own slow-growth phenotype, since this would be masked by the trm6-504
slow-growth phenotype

IV. Functions of Mtr4p Structural Domains
Arch domain Binds RNA through Two Long Loops in the KOW Domain
In Mtr4p structure, RNA 5’end pointing to the interface between KOW
domain and helicase core (Weir et al. 2010), indicating this could be the RNA entry
site (Johnson, Jackson 2013). On the surface of KOW domain, there are two long
loops, β2~β3 and β3~β4, are exposed to the solvent, protruding out, potentially
contacting with the helicase core. Residue lysine 700 is located on loop β2~β3, while
Proline 731 is positioned on loop β3~β4. Double mutant Mtr4-300/731p displays
similar RNA binding defects as K700N mutant instead an additive defects of both,
indicating that these two residues are not synthetic interacted.
KOW motif is composed of Glysine 686 and Lysine 687 in sequence, located
the β1~β2 short loop in KOW domain (Halbach, Rode & Conti 2012b). KOW motif
was found in ribosomal proteins that bind with structured RNA (Kyrpides, Woese &
Ouzounis 1996, Steiner et al. 2002, Selmer et al. 2006, Zhang, Dunkle & Cate 2009).
Gel shift assay results in this study showed that both Lysine 700 and Proline 731
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played a role in RNA binding. Lysine 700 displayed more severe defects on RNA
binding. Mtr4-700p showed defects in binding with single-strand 16nt RNA, 16nt
RNA duplex, 16nt-22nt RNA duplex, as well as tRNAiMet. It was previously reported
that KOW itself alone could bind with structured tRNAiMet in vitro (Weir et al. 2010)
but not single-stranded RNA (Halbach, Rode & Conti 2012a). My investigation on
these two mutants provided a novel finding, that the KOW domain not only binds to
structured RNA directly, but also assists single-stranded RNA binding indirectly. The
KOW domain may function through coordinating the conformational change of the
entire protein, thus contributing to single-strand RNA binding of the helicase core. I
also cannot eliminate a second possibility that the single-stranded RNA with random
sequence used in the assay formed secondary structure, and further induced Mtr4p
binding. In addition, besides the KOW motif, the two long loops of KOW domain
where our two mutations located, performed very important role in RNA binding
activities of the entire protein. It is also worth mentioning that, similarly, the “arch
domain” of Ski2p (which is called “insert”) can bind both single-strand and
double-strand RNA in vitro by itself (Halbach, Rode & Conti 2012b).
Previous results revealed that, without the KOW domain, Mtr4p performs ~80%
ATPase activities and unwinding activities (Jackson et al. 2010, Weir et al. 2010). My
results suggested that Mtr4p KOW mutant Mtr4-700p lacked ~more than half of RNA
binding activities with 16nt-22nt RNA duplex, and only lost ~20% of unwinding
activities using the same RNA substrates. Mtr4-700p also performs roughly ~70%
ATPase activity with different RNA substrates, and has slight effects on ATP binding.
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ATPase and unwinding defects could be partially caused by impaired RNA binding,
since Mtr4p is not able to hydrolyze ATP without RNA present, and not able to
unwind RNA if there is no ATP (Wang et al. 2008a). On the other hand, with ~80%
ATPase activity, Mtr4-731p didn’t show any defects on substrate unwinding activities
or ATP affinity. It revealed that the essential RNA binding effects of KOW domain
wasn’t reflected by the unwinding activities of the entire protein, which indicates that
as a protein that contains multiple substrate binding sites, the RNA binding activities
performed by the KOW domain is not essential for Mtr4p enzymatic activities. This
finding is consistent with the in vivo results, in which none of the arch domain
mutants could suppress trm6-504 phenotype or affected tRNAiMet turnover. Back to
the dominant-negative screen at the very beginning of this study, in another way, this
result confirms the efficiency of the screen. In the screen, K700N is one of the
mutations in a double mutant with R1030G, and the suppressor phenotype is caused
by R1030G alone. While, P731S is a mutation that is not from the screen. As a
negative control, it didn’t show any defects in Mtr4p helicase function. Due to its
special location forming a sharp turn on the long protruding loop, it still shows its role
on RNA binding of KOW domain.
One possible explanation of my in vivo and in vitro results on KOW mutants
is described below. The KOW domain itself binds structured RNA (Halbach, Rode &
Conti 2012b). My investigation revealed its contribution in single strand RNA
binding of Mtr4p in vitro, but this function may not be that important for substrates
containing double-stranded structured region, which is always the case for the
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TRAMP in vivo substrates including tRNAiMet. Mtr4p may control the length of poly
(A) tail that added by Trf4p to the substrates and performs the best unwinding
activities when ~4 adenosines were present (Jia et al. 2011b). If this is the case, Mtr4p
will load onto the 3’ single strand region of the substrates like other Ski2-like
helicases (Zhang, Grosse 2004, Guenther et al. 2009b, Wang et al. 2008b, Takahasi et
al. 2008, Pyle 2008). If this loading site is not a preferred binding site of KOW
domain(Jia et al. 2011b), then the structured RNA binding ability displayed by the
KOM domain becomes subtle. It’s very possible that the helicase core performs the
essential RNA binding activity of Mtr4p, similar to other Ski2-like helicases that do
not contain KOW domain. Since KOW domain mutants displayed significant defects
in RNA binding, as explained in the model, KOW domain is important for RNA
binding at protein loading step, since it could stick out and catch the RNA. But it
becomes less important during unwinding mechanisms since domains in the helicase
core perform similar roles and are sufficient for efficient RNA binding (Fig 4-1). All
of discussed above could also explain why the K700N mutant which is defective in
RNA binding affinity, but didn’t show obvious defects in vivo.
Another possible explanation is that, the defects of KOW mutants on RNA
binding may be compromised by other subunits Tfr4-Air2 of the TRAMP complex.
Archless Mtr4p is defective in 5.8S rRNA processing in vivo, which is an helicase
activity of Mtr4p itself rather than the entire TRAMP complex (Jackson et al. 2010,
de la Cruz et al. 1998). In contrast, none of my arch domain mutants are defective in
hypomodified tRNAiMet, which is a function of the TRAMP complex. It’s possible
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that the arch domain is essential for Mtr4p RNA binding activity if other subunits are
not present to enhance RNA binding, which would explain why Mtr4p without arch
cannot process 5.8S rRNA. However, if Mtr4p performs it role as a subunit of the
TRAMP complex, arch domain becomes less important for RNA binding and
enzymatic activities, since Air2p-Trf4p could complement its function in stabilizing
RNA binding. Studies on the Ski complex structure (Halbach et al. 2013) also
revealed enhanced RNA binding by other subunits Ski3p and Ski8p assists Ski2p
unwinding. The evidence that Mtr4p unwinding activities could be elevated by
Trf4-Air2 could also supports this hypothesis (Jia et al. 2012).
The KOW domain is a flexible unit and sticking back towards the helicase
core in the crystal structures (Weir et al. 2010, Jackson et al. 2010), which structurally
explained our finding that KOW domain may participate in helicase core mechanisms
including ATP binding, ATP hydrolysis and unwinding activities. Lysine 700 may
affect ATP binding affinity by effects on protein conformational change which is also
dependent on RNA binding & translocation. It was reported that the KOW domain is
required for exosome activation in vitro (Holub et al. 2012). Future studies on this
domain will be focused on how the KOW domain coordinates its complicated role,
and what’s the position of this flexible KOW domain relative to other Mtr4p domains,
RNA substrates and the exosome.
S672N and P802S are two mutations that reside in the connecting area of
KOW and stalk regions in the arch domain. They didn’t show any defects in either in
vivo or in vitro analysis. So far, no significant functions have been assigned to the
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stalk domain. It’s possible that the stalk domain doesn’t directly assist helicase core
function, but it might modulate the movements of KOW domain as a bridge
connecting KOW and helicase core. Since the stalk domain is very flexible in the
structure (Johnson, Jackson 2013, Weir et al. 2010, Jackson et al. 2010)，I expect that
it may contain some important residues that play a role in coordinating the
conformational change of the entire protein, similar to the winged helix domain. A
similar Stalk domain is also found in Mtr4p cytoplasmic homolog Ski2p (Halbach,
Rode & Conti 2012b). Stalk of Ski2p also connects the Ski2p β-barrel domain
(conserved with Mtr4p KOW domain, but do not contain KOW motif) to the helicase
core (Halbach, Rode & Conti 2012b). At the beginning of this study, I conducted a
dominant-negative screen to create the library of Mtr4p structural domain mutants
that are defective tRNAiMet turnover. The mutant library still contains lots of other
potential for further analysis, especially to investigate the role of the stalk domain.
My results clearly showed that none of arch mutants affected TRAMP
formation in vitro. Consistent with our results, it has been shown that arch domain is
not required for the TRAMP assembly (Weir et al. 2010). The screen itself was based
on a biased prerequisite that only mutant proteins that could enter TRAMP complex
by replacing wild-type Mtr4p can cause defective function in tRNAiMet turnover
would be detected. This result was consistent with the design of the
dominant-negative screen.
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The Winged Helix Domain is Important for Mtr4p Structure and Function
Winged helix domain mutant Mtr4-904p created significant defects in vivo,
not only due to its malfunctions in Mtr4p helicase function but also due to a lower
protein level. We experienced technical difficulties when purifying full-length
recombinant Mtr4-904p, although it was induced and overexpressed in E. coli at a
similar level to wild-type Mtr4p. It gave us hints that the winged helix domain affects
Mtr4p stability rather than expression. The winged helix domain was positioned as a
connecting unit in both Mtr4p and Hel308, interacting with RecA-like domains and
the ratchet domain in both proteins and also with the arch domain in Mtr4p, acting as
a central controlling hub (Woodman, Bolt 2011, Johnson, Jackson 2013). Lysine 904
is located at the interface of the winged helix domain and the ratchet domain. Linker
position of the winged helix domain corresponds with our finding of its function for
protein stability, as well as explains its role in coordinating helicase core
conformational changes on ATP hydrolysis and unwinding activities.
Structure of Mtr4p crystalized with A10 RNA (Weir et al. 2010) provided a
clear view of a single-stranded RNA binding channel inside of Mtr4p helicase core.
We found that winged helix mutant Mtr4-904p may play a role in RNA binding, but
not in a significant way compared to mutants of other domains. It correlates with
previous studies on Mtr4p homolog Hel308 structure showed its winged-helix domain
contacting with DNA substrate (Buettner, Nehring & Hopfner 2007, Richards et al.
2008). Mtr4-904p exhibits about ~60% of wild type ATPase activity and unwinding
activity, which is more significant compared to its role in RNA binding. I propose that
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the defects of Mtr4-904p in ATPase and unwinding activities are not due to its subtle
role in RNA binding, but possibly its function in coordinating conformational changes.
From studies on unwinding mechanisms of Hel308 which is the predicted model for
Mtr4p (Buettner, Nehring & Hopfner 2007, Richards et al. 2008, Johnson, Jackson
2013), helicase binds and hydrolyzes ATP, resulting in conformational change,
subsequently translocates along DNA substrates. In the mechanism of Hel308
(Buettner, Nehring & Hopfner 2007, Richards et al. 2008), DNA binds through the
central channel in the helicase core, unwound by a β-hairpin located in RecA-2
domain. Ratchet domain acts like a template for substrate binding during helicase
translocation, in other words, serves as a binding track for substrates. In the Mtr4p
structure, the winged helix is located as connecting unit between helicase domains
and arch domain, as well as arch domain and ratchet domain. Our result didn’t reveal
and effects of Mtr4-904p on ATP binding. However, its defects on ATP hydrolysis
and unwinding activity, might be caused by failure of conformational change required
for these Mtr4p enzymatic functions. The role of the winged helix domain in
protein-protein interaction in Hel308 was reported previously (Woodman, Bolt 2011).
I do not exclude the possibility that other residues in this domain may affect TRAMP
assembly.
In the in vivo tetrad analysis of Mtr4-904p in MTR4 heterozygous deletion
strains, we observed defects of Mtr4-904 strain in germination, but not in vegetative
growth without trm6-504 genetic background. This indicates that the winged helix
domain plays a significant role in RNA metabolisms during germination, but not in
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vegetative growth. Mtr4-904p is very possible expressing at a low level in the MTR4
heterozygous deletion strains, similar with its expression condition in trm6-504 strain.
Apparently, the protein level didn’t affect the Mtr4p normal protein function in
vegetative stage. Interestingly, TRF4 was identified as a gene required for normal
germination in a S. cerevisiae screen for germination mutants (Kloimwieder, Winston
2011). Mtr4p and Trf4p are subunits of TRAMP complex, which is known to play a
role in rRNA processing and maturation (de la Cruz et al. 1998). According to a study
on gene expression during yeast germination, expressions of genes participating in
rRNA processing are elevated during germination (Geijer et al. 2012, Joseph-Strauss
et al. 2007), and rRNA processing is significant for protein expression and
preparation of vegetative growth. We propose that TRAMP complex may play a role
in germination through regulating rRNA processing.

The Inside Surface of the Ratchet Domain is Essential for RNA Binding of Mtr4p

Ratchet domain mutant R1030G retained the least RNA binding, ATPase, and
unwinding activities of Mtr4p among all structural domain mutants. Mtr4-1030p
retained ~ 60% of Mtr4p unwinding activities, which is consistent with its severe in
vivo defects in tRNAiMet turnover. All of the investigations in this study revealed an
essential role of ratchet domain in Mtr4p function. Ratchet domain was found in most
SF II helicases, as an essential part of the helicase core structure, playing a role in
DNA/RNA binding (Buettner, Nehring & Hopfner 2007, Johnson, Jackson 2013). It
was believed that ratchet domain serves as a scaffold for RNA binding and act as a
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surface keeping protein-RNA interaction during protein translocation in unwinding
mechanism (Johnson, Jackson 2013). In accordance with our results, Mtr4p structure
crystallized with RNA revealed that, Arginine 1030 seems to be positioned on the
RNA binding surface of ratchet domain (Weir et al. 2010).
Ratchet domain is located in the helicase core, which defines its direct
function in coordinating Mtr4p ATPase and unwinding activities. How this domain
coordinates its complicated functions including RNA binding, ATP hydrolysis and
unwinding activities need further investigation. A possible explanation is that ratchet
domain plays its role mainly through RNA binding. ATP hydrolysis and RNA
translocation are coupled when Mtr4p unwinds RNA substrates. Since the ratchet
domain acts as a binding track while protein translocate along RNA, its defects in
RNA binding might result in protein dissociation, which further reduce its RNA
dependent ATPase activities and unwinding efficiency. The crystal structure
displayed that Arginine1030 is located on the surface of ratchet domain, exposed to
the RNA substrate, which is bound on one side of the cleft in-between the two
RecA-like domains (Weir et al. 2010). But its position is far way from ATP binding
site, which is on another side of the cleft. According to this, it’s possible that ratchet
domain could affect open and closure of RecA-like domains through conformational
change, which further results in effects on ATP affinity, ATP hydrolysis and strand
separation.
A recent study by the Conti lab solved the crystal structure of the entire
TRAMP complex (Falk et al. 2014). Ratchet domain mutations K1015E and M1016E,
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or Y1020A and E1021R disrupted Mtr4p interaction with Trf4p-Air2p. All of these
residues are located on the outside surface of the ratchet domain, exposing to the
solvent. While in my study, R1030G mutant is normal for TRAMP assembly. It might
be that the residues on the inside surface of the ratchet domain facing the two RecAs,
like Arginine1030, are specifically responsible for RNA binding affinity, but do not
participate in protein-protein interaction. While outside surface of the ratchet domain
displays the role for binding with Trf4p-Air2p, but may not be essential for substrate
binding.

V. Single-stranded RNA is a Preferred Substrate for Mtr4p

It has been reported that Mtr4p binds with single-stranded RNA in a length
dependent manner, and also prefers binding with poly (A) sequence than random
nucleotide sequences (Bernstein et al. 2008). Consistent with that, I found that Mtr4p
binds better with single-stranded RNA than duplex in a length-dependent manner by
gel shift assay. Mtr4p also binds better with tRNAiMet than 16nt RNA duplex with 6 nt
3’ overhang, which might be due to longer single-strand region existed in the middle
of tRNAiMet. This also suggests, in substrate binding, Mtr4p does not discriminate
where the single-stranded region is, at middle or overhang, both can be recognized
and bind. However, in the case of unwinding, Mtr4p requires ~ 4nt 3’ overhang to
bind and start unwinding mechanism (Jia et al. 2011b).
Consistently, compared with structured tRNA (~76nt) present in the ATPase
assay reaction, Mtr4p performs a higher ATPase rate with 75nt single-stranded RNA.
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108nt single-stranded RNA activates Mtr4p ATPase activities even better than 75nt
single-strand RNA. This suggests that RNA binding of Mtr4p directly results in
effects on its enzymatic activities. In other words, Mtr4p modulates its ATPase
activities depending on how much and how well RNA binds. Better RNA binding
could induce higher ATP hydrolysis rate of Mtr4p. Since Mtr4p unwind RNA that is
dependent on ATP hydrolysis, if Mtr4p detects a RNA easy to access and bind with, it
could unwind it faster with higher enzymatic efficiency. Another possibility is that
RNA binding and ATPase activity are coupled with each other by protein
conformational change, so RNA binding could promotes ATPase activities.
In summary, single strand RNA is not only a better substrate for Mtr4p
binding, but also can activate high enzymatic activities. It also suggests that Mtr4p
RNA binding affinity is coupled with its ATP hydrolysis as well as unwinding
efficiency.

VI. Mtr4p Modulates the Balance between Unwinding and Re-annealing

A lot of helicases were found to perform both unwinding activities and
strand-annealing activities. A helicase that belongs to DEAD-box helicase family,
Ded1, was also found to modulate both unwinding and annealing activities (Yang,
Jankowsky 2005). The Jankowsky lab also reported that both Mtr4p and TRAMP
complex possess strand-annealing activities (Jia et al. 2012).
In the investigation on Mtr4p unwinding mechanisms, I found that Mtr4p was
able to induce strand-annealing when complementary strands are separate at the
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beginning of the reaction, in a concentration-dependent manner. Similarly, in normal
unwinding reactions when RNA duplex is present, if Mtr4p exceeds the appropriate
amount, higher Mtr4p induces significantly higher re-annealing rate of the unwound
strands in a concentration dependent manner. This resulted in decreasing of the
observed unwinding rate upon enzyme amount is increasing. On the other hand, under
appropriate concentration, higher Mtr4p concentration induces higher unwinding rate,
and re-annealing is too subtle to be observed. It indicates that, Mtr4p was able to
modulate the balance between unwinding and re-annealing, which depends on
enzyme concentration. I also found that Mtr4p could also utilize ATP to modulate this
balance.
There are several explanations for Mtr4p mechanism of modulating two
opposite activities, duplex unwinding and strand annealing. Other than helicase
domains, several helicases contain annealing domains in their N-terminal of
C-terminal structural domains. For example, yeast DNA helicase Sgs1 contains
annealing activity in its N-terminal region (Chen, Brill 2010). So far, conserved
annealing region has not been identified yet, but annealing could be uncoupled with
unwinding activity of helicases (Wu 2012). In future studies, different structural
domains of Mtr4p could be removed to test if any of the structural domains regulate
strand-annealing activity of Mtr4p.
Since this modulation depends on enzyme concentration, if enzyme
concentration stays high, it’s very possible that Mtr4p may form dimers or oligomers,
which prevents its enzymatic activities. Therefore RNA could not be unwound, and
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only strand-annealing could be observed.
The third possibility is that, if Mtr4p is highly concentrated, the enzymes may
simply play a role as a binding template for the RNA accumulation, thus the RNAs
are close together and easy to be annealed. The result that single-stranded RNA is
better substrate for Mtr4p binding could support this idea.
My results revealed that ATP concentration also modulates the balance
between unwinding and re-annealing. Another possibility is ATP binding caused the
conformational change, which acts as a switch from a protein state with higher
unwinding activity to another state with higher annealing activity. There are a lot of
unknowns on Mtr4p helicase activities versus strand-annealing activities that are
worth more investigation.
In summary, I identified residues in each structural domain that are important
for different aspects of Mtr4p enzymatic activities. Mtr4p contains RNA binding
affinity, ATP binding affinity, ATPase activity, unwinding activity and strand
annealing activity. All of these activities require cooperation of different domains. As
a helicase that is capable to recognize various RNA substrates of different structure,
it’ll be interesting to identify how structural domains participate in substrates
recognition especially the arch domain, as well as the importance of each structural
domain when Mtr4p displays distinct enzymatic activities.
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